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Pharyngitis due to oropharyngeal infection with Streptococcus pyogenes is most 
commonly treated by using penicillin-derived antibiotics.While treatment failure in 
the 1950’s was reported in 4-8% of children, more recent studies have alarmingly 
found antibiotic failure as high as 20-40% providing the impetus to study this 
important pathogen. The contiguous mucosa along neighboring oropharyngeal 
surfaces is classically unaffected during Strep ”Throat” suggesting pathogen 
specificity for palatine tonsil epithelium. While recent studies are advancing the 
premise of pathogen-host microenvironment effects on streptococcal virulence, 
the specific interaction between S. pyogenes and the human tonsillar surface 
relative to neighboring tissues remains insufficiently understood. 
 This thesis investigates the unique interaction between the Group A 
Streptococcus, GrAS, and the human tonsil surface. We were particularly 
interested in the transcriptional response exhibited by the bacterium during co-
culture with this tissue epithelium compared to epithelium from an anatomically 
neighboring sight to determine if phenotype might be informed by the genotypic 
profile. During the course of this work, we introduce new palatine tonsil tumor-
derived cell lines for their novel usefulness as a model for studying pharyngitis. 
Using primary tonsil epithelial cells from non-malignant patient samples to 
confirm our studies with the cancer cell line, we were successful in demonstrating 
a tissue-specific phenotype and have begun the process of elucidating the 
genotypic nuances that an M1 strain exhibited in direct response to the tonsillar 
environment. These and further studies should allow us to better understand the 
pathogenic adaptions exhibited by this bacterium at its preferred target niche for 
infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"It must be borne in mind that the tragedy in life doesn't lie in not reaching your 
goal. The tragedy lies in having no goal to reach. It isn't a calamity to die with 
dreams unfulfilled, but it is a calamity not to dream. It is not a disaster to be 
unable to capture your ideal, but it is a disaster to have no ideal to capture. It is 
not a disgrace not to reach the stars, but it is a disgrace to have no stars to reach 
for. Not failure, but low aim is sin."    
 
Dr. Benjamin Elijah Mays – 6th President of Morehouse College  
 
 
 
I dedicate this dissertation to those who I try to be the best Me I can be for…  
 
To the Blue Nile Rites of Passage. To the Explorer mentorship program. To the 
members of the Student National Medical Association. To the members of the 
NYC Minority Graduate Student Network. To the BNGAP initiative. To Dione. To 
Aqil.  
 
To my FAMILY (Dennis, Judie, Taneka, Jinae, Alijah, Asaiah, Anastacia, Herbert, 
Alice, Frank, Justine, Marjorie…) I hope I’ve done you proud.   
I Love You all so much!  
 
 
 
 
 
 
 
 
 
 
 
 
iii 
Acknowledgements 
 
First and foremost, I must thank my advisor, Dr. Vincent Fischetti for welcoming 
me into his laboratory and providing this amazing opportunity. I have grown so 
much, both scientifically and as a person. I do hope to continue to glean from 
your wisdom and experience as I continue on in my career. The Fischetti lab 
“experience” is one that I will always treasure…and I am grateful.  
 
I also must thank my faculty advisory committee, Drs. Sanford Simon, Emil 
Gotschlich, and Dirk Schnappinger for their willingness to provide great insight 
during my committee meetings, and their patience with me. I am additionally 
grateful to Dr. Jon Heinrichs, my mentor from Merck & Co., who has gone above 
and beyond the call of duty. His decision to join my committee, enduring travel 
from out of state on each occurrence leaves me truly humbled. I would be remiss 
to not acknowledge my indebtedness to Dr. Edward Kaplan for his willingness to 
read my dissertation and serve as an outside examiner within the “short window” 
of dates we offered him. 
 
I would also like to thank the surgeon physicians in the Department of 
Otorhinolaryngology at Weill Cornell Medical College (Drs. Max April, Robert 
Ward, Vikash Modi, and Jacquelyn Jones) for their continued support throughout 
this work, providing me with fresh tonsil samples. I must thank in particular Dr. 
Michael Stewart, Department Chairman, and Dr. Erich Voigt for their particularly 
extraordinary support and taking an interest in my success with this work.   
iv 
 Finally I would like to thank the members of the Laboratory of Bacterial 
Pathogenesis. In particular, I must thank Dr. Patricia Ryan for both mentorship 
and friendship. She too has been patient with me and has helped me throughout 
this process.  I do not know what I would’ve done without her. I also thank Drs. 
Barbara Juncosa and Chad Euler for welcoming me into the “cool” Group A Strep 
Group. I MUST also thank Mrs. Clara Eastby 1000X over for her indispensable 
tissue culture support. She NOW has my blessing to retire.  
 
 
Finally, I must thank the Weill Cornell / Rockefeller / Sloan-Kettering Tri 
Institutional MD-PhD program for their continued support and guidance. Dr. Olaf 
Anderson’s ever-insightful conversations have surely been crucial to my success 
to this point.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
 
Table of Contents  
  
1. INTRODUCTION …………………………………………………………………….. 1 
1.1 Genus Streptococcus…………………………………………………………........... 1 
1.2 Classification System(s)…………………………………………………………..…..         1
1.2.1Lancefield Groups ……………………………………………………………… 3 
1.2.2 R and T typing…………………………………………………………….……. 5 
1.2.3 M typing / emm sequencing ………………………………………………….. 6 
1.3 Specialists vs Generalists…………………………………………….…………….... 6 
1.4 Virulence Factors………………………………………….………….……………….. 8 
1.4.1 Adhesins……………………………………………….……………………….. 8 
1.4.1.1 M protein…………………….………………...………………………. 9 
1.4.1.2 Pili……………………………………………….……………………… 9 
1.4.2 Invasins…………………………………………………………………………. 13 
1.4.3 Secreted Factors………………………………………………………….……. 13 
1.4.3.1 SpeA…………...………………………………………………….…… 13 
1.4.3.2 SpeB………………………..………………………...………………… 14 
1.5 Genetics of Virulence……………………………………………………….………… 15 
1.5.1 Chromosomal and Bacteriophage-encoded Virulence Factors…….…….. 15 
1.5.2 Regulation of Virulence………………………………………………….….…. 19 
 1.5.2.1 Stand-Alone Regulators…………………………………………..…. 19 
 1.5.2.1.1 Mga………………………………………………………….. 19 
 1.5.2.1.2 amrA………………………………………………………… 20 
1.5.2.2 Two Component Systems……………………………………….…... 20 
 1.5.2.2.1 CovR/CovS…………………………………………………. 21 
 1.5.2.2.2 SptR/SptS…………………………………………………... 21 
1.6 Pathogenesis…………………………………………………………………………... 23 
1.6.1 Adhesion………………………………………………………………………… 23 
1.6.2 Invasion………………………………………………………………………..… 23 
1.7 Streptococcal Disease Burden...………………………………………………….…. 25 
 1.7.1 Actute Rheumatic Fever and Sydenham Chorea………………….……. 26 
 1.7.2 Pharyngitis…………………………………………………………………… 27 
1.7.2.1 Healthcare Burden.….………………………………………………. 27 
 1.7.2.2 Antibiotic Failure…. …………………………………………….……. 27 
 1.7.2.3 GrAS Pharyngitis Clinical Appearance…………………………….. 
1.7.2.4 Differential Diagnosis of Non-GrAS Pharyngitis………………….. 
1.7.2.5 Surgical Indications………………………………………………….. 
1.8 Human Oropharynx Anatomy……………………………………………………….. 
28 
29 
31 
33 
1.9 Experimental Models of Pharyngitis ……………………………………………….. 37 
 
 
2. OBJECTIVES…………………………………..……………………………..…..….. 39 
  
vi 
  
3. MATERIALS AND METHODS……………………………………………………… 41 
3.1 Bacterial Strains and Growth Conditions…………………………………………... 41 
3.2 Human Immortalized Epithelial Cell Lines and Growth Conditions……….…..… 41 
3.3 Adherence and invasion assay……………………………………………….....…. 
3.4 Bacterial Intracellular Viability………………………………………………..…..…. 
42 
44 
3.5 Human Primary Tonsil Epithelium …………………………………………………. 44 
3.6 Recombinant M-protein preparation ………………………………………………. 48 
3.7 Bacterial Cell Wall preparation …………………………………………………….. 48 
3.8 Conditioned Media Extraction and LC/MS………………………………………… 49 
3.9 Co-Immunoprecipitation……………………………………………………….…….. 50 
3.10 Phase Contract Microscopy…………………………………………………….…. 51 
3.11 Streptococcal transformation with GFP expression plasmid………………..….. 51 
3.12 PlyCB Purification and Alexa Fluor labeling……………………………….…….. 53 
3.13 Fluorescence Microscopy……………………………………………….…………. 53 
3.14 Immunofluorescence microscopy…………………………………………….…… 54 
3.15 Spotted Oligonucleotide microarrays……………………………………...……… 57 
3.16 Epithelial Cell Association Assay (for microarray)…………..………………….. 58 
3.17 RNA Isolation……………………………………………………………………….. 59 
3.18 Synthesis of cDNA and labeling …………………………………………….……. 59 
3.19 Microarray Hybridization and Image Acquisition ……………………………….. 59 
3.20 Data Filtering, Normalization, Statistics …………………………………………. 60 
  
 
4. CULTIVATION AND CHARACTERIZATION OF HUMAN PALATINE 
TONSIL-DERIVED EPITHELIAL CELLS………………………………………. 
                
63 
4.1 Intro…………………………………………………………………………………….. 
4.1.1 Relevant clinical anatomy at times incongruent with cell type of   
convenience…………………………………………………………………… 
4.1.2 UT-SCC-60A / B Epithelial Cell Lines………………………………………. 
4.1.3 Tumor derived cell lines and Toll-Like Receptors expression……………. 
63 
 
63 
65 
66 
4.2 Results………………………………………………………………………………… 69 
4.2.1 Human Primary Tonsil Epithelial (HPTE) Cell cultivation……………..….. 69 
4.2.2 Comparative light microscopy of confluent monolayers…………………... 73 
4.2.3 Immunofluorescence Staining For Epithelial and Fibroblast markers.….. 77 
4.2.4 Secreted Metabolites By Human Epithelial Monolayers ……………..….. 79 
4.3 Discussion ……………………………………………………………………………. 92 
 
 
5. STREPTOCOCCAL ADHERENCE AND INVASION PHENOTYPES SUG-
GESTIVE OF TISSUE-SPECIFIC TROPISM FOR TONSIL EPITHELIUM…... 
           
96 
5.1 Intro…………………………………………………………………………………….. 96 
5.2 Results…………………………………………………………………………………. 99 
5.2.1 Streptococci are Heterogeneously distributed along monolayer ………… 99 
5.2.2 Persistent Adherent GrAS exhibit biofilm – like growth possibly 
refractory to treatment with antibiotics……..….……………………………. 
 
102 
vii 
5.2.3 Streptococcal Tonsil-Specific Phenotypes Suggests Apparent Tissue 
Tropism……………………….……………….………………………………..  
 
106 
5.3 Discussion………………………………………………………………………..…… 114 
  
  
6. STREPTOCOCCAL TRANSCRIPTIONAL CHANGES UPON ASSOCIA-
TION WITH EPITHELIAL CELLS FROM HUMAN NASOPHARYNX 
VERSUS PALATINE TONSIL………………………………................................ 
                                                  
 
118 
6.1 Intro……………………………………………………………………………………. 118 
6.2 Results…………………………………………………………………………………. 124 
6.2.1 Differential expression of individual genes during association with 
human tonsil epithelial cell monolayers……………………………….…. 
 
124 
6.2.2 Applying neighbor clustering algorithms reveal additional insights on 
S. pyogenes gene expression profiles …………………………………… 
 
136 
6.2.3 SF370 Pili Play A Significant Role During Adherence and Invasion 
During Co-Culture with HPTE and Tonsil Tumor-Derived Cell Line…... 
                 
151 
6.3 Discussion ……………………………………………………………………………. 
6.3.1 Regulatory systems………………………………………………….…….. 
6.3.2 Complex carbohydrate vs lipid and secondary metabolic pathways for 
energy………………………………………………………………….…….. 
157 
157 
 
159 
6.3.3 Phage-related genes……………………………………….………………. 
6.3.4 Final Comment………………………………………………………………. 
161 
162 
  
7. STREPTOCOCCAL EPITHELIAL INTERNALIZATION……………………… 164 
7.1 Intro…………………………………………………………………………………….. 
7.1.1 Paracellular Invasive Dissemination………………………………………. 
7.1.2 Transcellular Invasion………………………………………………….…… 
7.1.3 Potential Role of Autophagy……………………………………………….. 
7.1.4 Host Cell Response to Invasion…………………………………………… 
164 
165 
165 
168 
169 
7.2 Results…………………………………………………………………………………. 171 
7.2.1 Streptococcal Intracellular viability may be epithelial cell type-
dependent……………………………..………………………………..….......  
 
171 
7.2.2 Intracellular Compartment of internalized Streptococcus ………………… 175 
7.3 Discussion …………………………………………………………………………..... 181 
  
  
8. CONCLUSIONS…………………………………………………………………… 183 
  
 
APPENDIX / PRELIMINARY FUTURE DIRECTION WORK……………………….. 
 
184 
A4.1  Immunofluorescence Epithelial Markers ……………………………………...... 184 
A6.1  Dye Swap Microarray Slides ……………………………………………………... 186 
 
 
 
 
       
 
 
 
viii 
A8      IDENTIFYING STREPTOCOCCAL BINDING PARTNERS WITH HUMAN   
ORAL EPITHELIUM  …………… ………………………………………………. 
188              
A8.1  Intro…………………………………………………………………………….…… 188 
A8.2  Results……………………………………………………………………………… 191 
A8.2.1 Preliminary Co-Immunoprecipitation…………………………….……………...  191 
A8.2.2 Click Chemistry metabolically labels epithelial surface proteins ……………. 197 
A8.3  Discussion ………………………………………………………………………….. 201 
9. References………………………………………………………………………..  
  
 
      204 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
LIST OF FIGURES   
1.1 Gram Positive Bacterial Cell Wall ………………………………………………….. 2 
1.2 Taxonomic Relationship Tree for Streptococcus Based on 16S rRNA………… 4 
1.3 Proposed Mechanism for How SptR/SptS Contributes to Persistence of GrAS 
in Human Saliva……………………………………………………………………… 
                      
 
22 
1.4 Clinical Presentation of “Strep Throat”…………………………………………….. 32 
1.5 Waldeyer’s Ring……………………………………………………………………… 34 
1.6 The Lymphoepithelium of the Palatine Tonsil…………………………………….. 36 
3.1Schematic of Human Primary Tonsil Epithelium Cell Culture Technique………. 48 
3.2 Genetic and Physical Map of pCM18………………………………………………. 52 
4.1 Human Primary Tonsil Epithelium …………………………………………………. 71 
4.2 Morphology of Human Oropharyngeal Epithelial Cells as Monolayers………… 75 
4.3 Conditioned “spent” Media From Primary Epithelial Cells Exhibit Unique 
Metabolite Production……………………………………………………………….. 
                   
 
83 
5.1 Distribution of S. pyogenes Along Epithelial Monolayer………………………….. 100 
5.2 Efficacy of Using Amidase Lysin, PlyC, on Persisting Adherent S. pyogenes 
versus Antibiotics Alone During In Vitro Assay…….……………………………... 
               
 
104 
5.3 Visualization of Apparent Tissue Specific Tropism Toward Tonsil Epithelial 
Cell Types……………………………………..………….…………………………... 
                 
 
108 
5.4 SF370 Exhibit Greater Adherence Efficiency Towards Tonsil-Derived 
Epithelium…………………………………..……………..…..……………………… 
                 
 
110 
5.5 SF370 Are Internalized More Efficiently by Tonsil-Derived Epithelium………….  112 
x 
6.1 ΔSpy0129 deletion decreases Streptococcal Adherence across all epithelial 
monolayers………………………......................………………………..………….. 
                
 
153 
6.2 Internalization of M type 1 ΔSpy0129 mutant is greatly decreased……………..  155 
7.1 S. pyogenes Intracellular viability is cell type –dependent………………………..  169 
7.2 S. pyogenes Co-localizes with Early Endosomes at 2.5h post-infection………..  173 
7.3 S. pyogenes Also Co-localizes with Autophagasome Marker at 2.5h post-
infection……………………………………………………………………………….. 
Appendix 4.1 Distribution of S. pyogenes Along Epithelial Monolayer……….……... 
Appendix 6.1 Dye swap microarray chips……………………………………………… 
Appendix 8.1. Identification of binding complexes between epithelial cell 
membrane-associated proteins (CMAP) and recombinant M6 protein………… 
Appendix 8.2. In-Gel Fluorescence distinguishes metabolically labeled 
Streptococcal proteins using Click Chemistry…………………………………….. 
 
 
175 
 
184 
 
186 
 
 
 
195 
 
 
 
199 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
LIST OF TABLES  
1.1 Chromosomal emm Patterns and Related Serotypes……………………………. 7 
1.2 Cell Wall-Anchored or Surface- Associated Adhesins…………………………… 10 
1.3 Chromosomally-Encoded Virulence Factors………………………………………. 16 
1.4 Bacteriophage-Encoded Virulence Factors……………………………………….. 18 
1.5 Viral vs Bacterial Differential Diagnosis of Pharyngeal Infection………………... 30 
3.1 Primary and Secondary Antibodies Used for Immunofluorescence……………. 56 
4.1 Summary of Epithelial Cell Markers from Immunofluorescence Studies……….. 78 
4.2 Summary of Preliminary Metabolite Profile of Potential Biomarker……………... 84 
6.1 Sequenced S. pyogenes Genomes………………………………………………… 120 
6.2 Differential Expression of Genes Following SF370 Co-Culture with Human 
Tonsil Epithelium vs Control………………………………………………………... 
           
129 
6.3 Streptococcus Genes Exhibiting Significant Changes During Association with 
UT-SCC-60B Monolayers Compared to Associated with Detroit 562………….. 
           
131 
6.3 Qualifying Neighbor Clusters Identified in the SF370 Genome…………………. 
  
139 
 
xii
  1 
§1. INTRODUCTION 
1.1 Genus Streptococcus  
Streptococcus is a genus of facultative anaerobic bacteria that consists of over 
100 recognized species. Named for it’s morphology, “Strep” from the Greek word 
στρεπτος "streptos" which translates to mean "twisted" or "chained", and the 
word "kokhos" meaning a "berry" or "seed", it is among the most studied gram 
positive pathogens. Early observations by such historic investigators as Van 
Leeuwenhoek in the 17th century and Louis Pasteur in the 19th century identified 
this pathogen in the context of its interaction with human host. Pasteur also 
proposed that these “rounded granules (microorganisms) arranged in the form of 
strings of beads” found in the bodies of diseased women in the maternity wards 
as being the infective cause. In this regard, streptococcus served as one for the 
first microbes identified as a contagious agent.  
 
1.2 Classification System 
Gram Positive bacteria are characterized by a thick cell wall matrix composed of 
peptidoglycan (PG), teichoic acid, polysaccharides (PS), and a cadre of cell wall 
associated proteins (CWPs) (Figure 1.1). Identification of unique cell surface 
antigens have provided some of our earliest understanding of streptococcal 
pathogenesis as well as providing a convenient means for organizing the genus 
into classification schemes of related species.  
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Cell wall associated 
proteins (CWP) 
Polysaccharide (PS) 
Peptidoglycan  (PG) 
Lipoteichoic 
Acids 
Plasma membrane  
Figure 1.1. Gram positive bacterial cell wall contains mainly peptidoglycan (PG), polysaccharide 
(PS), and cell wall associated proteins (CWPs). The CWPs outside the PS and PG layers can be 
removed by proteolytic enzymes, whereas the proteins inside the PG layer are difficult to remove 
without breaking the PG structure. PS binds covalently to the PG layer, and protects PG polymers 
from the degrading enzymes. PG consists of several of sugar chains composed of N-
acetylglucosamine and N-acetylmuramic acid alternately linked each other. Short peptides bound to 
the N-acetylmuramic acid (muramyl peptides) connect the sugar chains.  
 
Image modified from Zhang et al 2001  
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1.2.1 Lancefield Classification 
Despite Leeuwenhoek and Pasteur’s important morphologically descriptive 
accounts on Streptococcal bacteria, a widely accepted classification system for 
this historic bacterium was not adapted until hundreds of years later in the 20th 
century. Developed by Dr. Rebecca C Lancefield at the Rockefeller University, 
this system of grouping related streptococcal species was based on serologically  
active polysaccharides associated with the bacteria’s cell wall (Cunningham 
2000). These aptly named “Lancefield Groups” were stratified by “group specific 
antigens” or C –substances such as polysaccharides (ie. groups A, B, C, E, F, 
and G), techoic acids (ie. groups D and N), and lipoteichoic acids (ie. group H). 
Notably, Group A carbohydrate is composed of N-acetylglucosamine linked to a 
rhamnose polymer backbone. The Lancefield typing system remains a 
cornerstone of the diagnosis of many streptococcal diseases, including the 
identification of S. agalactiae using rapid test kits for the detection of the 
Lancefield Group B carbohydrate (GBC) (Sutcliffe 2008). Streptococcus spp, 
may also be grouped using 16s rRNA gene sequence analysis to produce a 
grouping scheme based on taxonomic relationship: Pyogenic, Bovis, Salivarius, 
Mutans, Mitis, and Anginosus.  These molecular-based groups in some instances 
ungroup and regroup related members from disperate Lancefield Groups. For 
instance, the “Pyogenic” group includes respective members representing 
Lancefield Groups A, B, C, G, and L (Figure 1.1). Streptococcus pyogenes 
constitutes the sole species in the Lancefield Group A of Streptococci.  The 
  4 
Figure 1.2. Taxonomic relationship tree for Streptococcus based on 16S rRNA gene sequence 
comparisons showing positions of selected species.  
Nobbs et al 2009 
name “pyogenes” comes from the word pyogenic, which served to distinguish 
this it’s association with pus formation.  
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1.2.2 R and T typing 
Further classification systems within this group have historically been delineated 
by the surface antigen expressed by the streptococci, including the R, M and T 
proteins.  
R proteins were initially identified in S. pyogenes by Rebecca Lancefield in the 
early1950’s (Lancefield 1952). Later, groups would identify, four immunologically 
distinct R proteins (R1, R2, R3, and R4) occurring in various combinations in 
streptococci of groups A, B, and C. The R protein sequence has yet to be 
elucidated (Paoletti 2000). 
The R, T and M antigens were found to uniquely participate in the serological 
reactions of group A streptococci. In the laboratory, the T typing assay is 
performed as an agglutination test. The T typing of group A streptococci has 
been important in the investigation of epidemiology of group A streptococcal 
infections and has identified strains associated with outbreaks when the M type 
was not identifiable (Cummingham 2000). It was also found that strains 
designated by M antigen may have serologically distinct T types (Lancefield 
1946). Notably, the T protein was not present in streptococcal groups C and G 
(Cunningham 2000). Falugi et al also indicte one of the major drawbacks of the 
T-typing sera is that different centers have reported discrepant results This same 
group has recently described that pili, and in particular the backbone protein (BP) 
subunits, correspond to these Lancefield T antigens, and that the 15 BP variants 
account for all but 4 of the 21 T serotypes (Falugi 2008).  
  6 
 
1.2.3 M typing / emm sequencing  
Most commonly, GrAS typing is based on M protein gene (emm) sequence. The 
emm gene encodes streptococcal M protein, a surface exposed protein 
considered the the primary virulence factor of the organism. Variation within this 
gene’s unique 5’sequence enables researchers to determine distinct “emm-”or 
"M-" types.  Before this molecular approach was introduced, M protein serotyping 
was based on M precipitin reactions in capillary pipettes (Swift 1943).  More than 
200 emm/M-types have been identified (Bessen 2011, Johnson 2006) among 
Group A Streptococcal isolates.  
 
1.3. Specialists vs Generalists 
The primary ecological niches for GrAS are the epithelial surfaces of the upper 
respiratory tract and skin of the human host, and the vast majority of GrAS 
infections involve one of these two tissues, namely pharyngitis and impetigo, as 
aforementioned. Robust historical epidemiological evidence has demonstrated 
the causative strains for a respective tissue-specific infective phenotype have 
discrete sets of M or emm types. Five major emm chromosomal patterns were 
identified based on the number and arrangement of emm subfamily genes 
(Bessen 2010). According to this system, emm pattern groups A–D, are 
considered “specialist” and are all serum-opacity factor (SOF)-negative. S. 
pyogenes strains preferentially isolated from throat (ie. M1, M3, M6, and M18) 
belong to patterns A–C. Pattern D is composed of strains preferentially isolated 
  7 
from skin sites. Bessen and colleagues provide a review of epidemiologic 
surveys on population-based collections of GrAS causing superficial throat or 
skin infections between1989 – 2009. Their robust analysis strongly supported the 
conclusion that GrAS strains harboring the emm pattern A-C genotype are better 
equipped to fill the superficial throat infection niche, as compared to emm pattern 
D (Bessen 2011). Global molecular analysis between groups have also revealed 
three accessory gene regions (AGR) may account for all statistical significant 
difference in genotypic biomarkers separating the throat vs skin specialists. 
Conversely, strains recovered readily from both tissues and are SOF-positive (ie. 
M49) are considered “generalists” and belong to Pattern E. (Bessen 1996, Klenk 
2007). Significantly, emm pattern A-C genotypes are highly diverse in AGR 
content, suggestive of multiple genetic pathways associated with adaptation to 
their narrow niche (Bessen 2011). 
 
Table 1.1Chromosomal emm patterns and related serotypes  
Chromosomal 
Pattern 
Infection emm 
gene 
subfamily 
M 
classb 
Opacity 
factor 
reaction 
Usual tissue 
site of 
isolation 
Typical M 
serotype(s) 
A 
B 
C 
D 
E 
Pharyngitisa 
Pharyngitisa 
Pharyngitis 
Impetigo 
Pharyngitis 
or impetigo 
SF1 
SF1-SF1 
SF1-SF3 
SF4-SF1-
SF3 
SF4-SF2-
SF3 
 
I 
I 
I 
I 
II 
Negative 
Negative 
Negative 
Negative 
Positive 
Throat 
Throat 
Throat 
Skin 
Throat or skin 
1,3,6,12,17,19
,24 
1,5,14 
18 
33,41,42,52,5
3,70 
2,4,11,22,28,4
9,75 
aAll of the studies conducted that will be discussed in this dissertation will be of Chromosomal 
emm patterns A-B. 
bClass I M proteins were identified by reactivity with anti-M protein Mabs 10.B6 and 10.F5; class 
II M proteins do not react with these Mabs. 
 
Table contents originally modified from (Cunningham 2000) 
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1.4 Virulence Factors 
The pathogenicity of Group A Streptococci is exhibited by the structure and 
function of proteins in their arsenal with such roles in virulence as adhesion to 
host cells, stimulation of host responses, binding of soluble factors, and immune 
evasion. The number of virulence factors that GrAS encodes varies, even 
between strains of the same phenotype (Cunningham 2000).  
 
 
1.4.1 Adhesins 
A key characteristic expected for a tissue-specific GrAS adhesin is differential 
binding to throat versus skin-derived cells or tissues of human origin (Bessen 
2010). These microbial surface components recognizing adhesive matrix 
molecules (MSCRAMMs) represent a particular class of proteins expressed on 
the GrAS surface (Nobbs 2009). MSCRAMMs mediate bacterial binding to host 
serum- and extracellular matrix proteins, leading to firm attachment and in some 
cases also to internalization into host cells or paracellular translocation (as later 
described). MSCRAMMs are usually anchored covalently to the peptidoglycan of 
Gram-positive species by the transpeptidase activity of sortase enzymes 
recognizing a specific LPXTG amino acid motif located at the C terminus of these 
proteins (Nobbs 2009). Other important adhesin proteins, however, have been 
found to be either anchorless at the cell surface or linked to the streptococcal 
  9 
surface other non-LPXTG motifs. List 1.2 elaborates on the known adhesins 
expressed by S. pyogenes. 
 
1.4.1.1 M protein  
M protein is one of the classical virulence determinants of S. pyogenes and is an 
important adhesin, This abundant protein appears as hair-like fibrils at the 
bacterial surface. Some of the 50 kDa α-helical coiled-coil M1 protein is 
spontaneously shed from the surface but some is also actively released through 
cysteine protease (SpeB) secreted by the bacteria. M1 protein contains 
fibrinogen-, IgG- and albumin-binding regions, properties that are important for 
adhesion and its overall virulence. In addition, M1 protein is important for the 
adhesion of S. pyogenes to epithelial cells via glucosaminoglycans (GAGs) and 
sialic acid containing cell surface proteins (Ryan 2001). 
 
1.4.1.2 Pilli 
The recent discovery of pili in gram-positive bacteria and their role as a major 
factor in adherence to host cells have been proposed by numerous investigators 
(Abbot 2007, Yeates 2007, Olsen 2008, Ryan 2007, Manetti 2007). Abbot and 
colleagues have used apiliated mutants to demonstrate that early adherence 
events are drastically impaired across multiple epithelial cell types if pili are not 
present or produced (Abbot 2007). The genes for such pili are encoded by the 
pathogenicity island known as the fibronection-binding, collagen-binding, T-
antigen (FCT) region, which has been identified in all sequenced group A 
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streptococcal isolates to date (Manetti 2007, Falugi 2008). The pili are encoded 
within this region by a multi-gene loci. Recently the actual pilus subunit t that 
serves as the epithelial cell adhesin has been proposed to be encoded by locus 
tag Spy0125, although recombinantly expressed minor pilus subunit Spy0130 
has also been shown to adhere to human pharyngeal cells in vitro (Smith 2010). 
Importantly, biofilm formation is a characteristic lifestyle feature of S. pyogenes 
during colonization, and it has been suggested that pili mayplay and particularly 
pivotal role in facilitating biofilm formation (Manetti 2007). 
 
Table 1.2. Cell wall-anchored or surface-associated adhesins 
 Protein group    Protein(s)    Species   
Cell surface 
linkage 
 Function(s) and/or 
substrate(s)   
AgI/II family 
Spy1325   S. pyogenes    LPxTz   Coaggregation; multiple 
substrates 
Alp family 
R28/Alp3   S. pyogenes, S. 
agalactiae   
 LPxTz   Multiple substrates 
  
R proteins (R1–
R4)   
S. pyogenes, S. 
agalactiae, S. 
dysgalactiae  
 LPxTz   Host glycosaminoglycans 
Pili / fimbriae / fibrils 
PI   S. pyogenes    LPxTz   Coaggregation, biofilm 
formation, 
phagocyte resistance; 
multiple 
substrates 
Saliva-binding   proteins   
 AgI/II family S. mutans, S. sobrinus, 
S.   
 LPxTz   Salivary components (gp340,   
 
  gordonii, S. oralis, S.     salivary glycoproteins, 
proline-  
    intermedius     rich proteins)   
  
Pili, fimbriae, 
fibrils 
S. pyogenes, S. 
parasanguinis, S. 
intermedius, S. 
salivarius, S. gordonii 
 LPxTz   gp340   
Fn-binding proteins   SfbI/PrtF1 S. pyogenes    LPxTz   Fn   
  FbaA S. pyogenes    LPxTz   Fn   
  
 
FbaB/PFBP/PrtF2   
S. pyogenes    LPxTz   Fn   
   SOF/SfbII S. pyogenes    LPxTz   Fn   
  SfbX   S. pyogenes    LPxTz   Fn   
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  Fbp54  S. pyogenes    Anchorless   Fn   
  
ScpA (C5 
peptidase)  
S. pyogenes    LPxTz   Fn   
   GAPDH/SDH S. pyogenes    Anchorless   Fn   
  M proteins
   S. pyogenes    LPxTz   Fn   
  M-like proteins S. pyogenes    LPxTz   Fn   
  Shr S. pyogenes    Anchorless   Fn   
 Collagen-binding  proteins    Cpa   S. pyogenes    LPxTz   Collagen   
 
Enolase   S. pyogenes, 
S.pneumoniae, S. oralis, 
S. anginosus, S. 
mutans, S. salivarius, 
S. sanguinis  
 Anchorless   Plasminogen, plasmin   
Plasminogen-binding 
proteins   
M protein S. pyogenes    LPxTz   Plasminogen   
  PAM   S. pyogenes    LPxTz   Plasminogen   
  
GAPDH/Plr S. oralis, S. anginosus, 
S. agalactiae, S. 
pyogenes, 
S. pneumoniae, S. 
gordonii, S. 
dysgalactiae 
 Anchorless   Plasminogen, plasmin   
  
Streptokinase 
(Ska)   
S. pyogenes    None   Plasminogen   
 Laminin-binding proteins   Lbp S. pyogenes    LXXC/XXGC   Laminin   
 
Lsp   S. pyogenes    LXXC/XXGC   Laminin   
  
SpeB   S. pyogenes    
Anchorless/none   
Laminin   
  
Lmb  S. agalactiae, S. 
pyogenes   
 LXXC/XXGC   Laminin   
 Fibrinogen-binding   M protein S. pyogenes    LPxTz   Fibrinogen   
 proteins   SOF/SfbII S. pyogenes    LPxTz   Fibrinogen   
  Fbp54 S. pyogenes    Anchorless   Fibrinogen   
  Mrp S. pyogenes    LPxTz   Fibrinogen   
 Ig-binding proteins   SfbI/PrtF S. pyogenes    LPxTz   IgG   
  Sib35   S. pyogenes    Anchorless   IgG   
  SibA   S. pyogenes    None   IgG, IgA, IgM   
  Protein H   S. pyogenes    LPxTz   IgG   
  Arp   S. pyogenes    LPxTz   IgA   
  Sir   S. pyogenes    LPxTz   IgA, IgG   
  Enn protein   S. pyogenes    LPxTz   IgA   
  M protein S. pyogenes    LPxTz   IgG, IgA   
  M-like proteins S. pyogenes    LPxTz   IgG, IgA   
  Mrp S. pyogenes    LPxTz   IgG   
  FcRA   S. pyogenes    LPxTz   IgG   
Table 1.2 (continued)  
Table 1.2 (continued)  
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Lzp   S. pyogenes, S. 
agalactiae   
 Anchorless   IgG, IgA, IgM   
 Complement-binding 
proteins   
M protein S. pyogenes    LPxTz   Factor H, factor H-like protein 
1   
         
 
M-like proteins  S. pyogenes    LPxTz   Factor H, factor H-like protein 
1    
  
FbaA S. pyogenes    LPxTz   Factor H, factor H-like protein 
1   
Host cell-binding  proteins   ScpA S. pyogenes    LPxTz   Complement C5a   
 
Shr S. pyogenes    Anchorless   Epithelial cells   
 
ScpA S. pyogenes    LPxTz   Epithelial cells   
 
Lbp S. pyogenes    LXXC/XXGC   Epithelial cells   
 
R28   S. pyogenes    LPxTz   Epithelial cells   
 
M protein S. pyogenes    LPxTz   Epithelial/endothelial cells  
(α5β1 integrin, Fn bridge)   
 
SfbI/PrtF S. pyogenes    LPxTz   Epithelial/endothelial cells 
(α5β1 integrin, Fn bridge)   
 
SclA, SclB (Scl1, 
Scl2)   
S. pyogenes    LPxTz   Epithelial cells (α2β1, α11β1 
integrins)   
  
Pili, fimbriae, 
fibrils 
S. agalactiae, S. 
pyogenes,  S. 
pneumoniae, S.  
salivarius    
LPxTz   Epithelial/endothelial cells   
Enzymes   
HtrA   S. mutans, S. 
pneumoniae, S.  
pyogenes   
 Anchorless   Serine protease   
  
GAPDH, α-
enolase, PGK, 
PGM, TPI 
S. pyogenes, S. oralis, 
S. anginosus   
 Anchorless   Glycolytic enzymes   
  
GAPDH/SDH S. pyogenes    Anchorless   Lysozyme, cytoskeletal 
proteins, CD87/uPAR   
  
PulA   S. pyogenes    LPxTz   Pullulanase   
  
GRAB   S. pyogenes    LPxTz   α2-Macroglobulin; protects 
against proteolysis    
(Adadpted from Nobbs 2009) 
 
 
1.4.2 Invasins  
In order to cause invasive diseases as myositis and necrotizing fasciitis, S. 
pyogenes must invade deep tissue through either a paracellular route between 
adjacent cells, or by traversing epithelia through intracellular movement. It is now 
established that the streptococcal M-protein and fibronectin-binding protein 
Table 1.2 (continued)  
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(Protein F) serve as invasins, since latex beads coated with either protein will 
efficiently become internalized by epithelial cells (Fluckiger 1998, Jadoun 1998).  
 
1.4.3 Secreted Factors 
Secreted proteins can include degradative enzymes (SpeB, DNases, 
hyaluronidases), toxins (streptolysins and superantigens), and proteins for 
immune evasion (antibody-degrading factors) (Hynes 2004). The streptococcal 
pyrogenic exotoxins (Spes) have likely been most studies of any of the 
pathogen’s secreted products. Principally, Spes have been shown to induce 
fever as its name implies, among a cadre of other symptoms of disease. The 
Spes have been defined in four distinct antigenic groups, A to D. Types A, B, and 
C are well defined, while type D is not well characterized (Cunningham 2000).  
 
1.4.3.1 SpeA 
The nucleotide sequence of the streptococcal pyrogenic exotoxin A gene was 
reported by Weeks and Ferretti (Weeks 1986) and the gene has been found to 
be expressed in most streptococcal strains isolated from cases of streptococcal 
toxic shock syndrome (Hauser 1991). In this study, 85% of the patients who 
manifested toxic streptococcal syndrome had strains which produced pyrogenic 
exotoxin A. Nucleotide sequencing of the streptococcal pyrogenic exotoxin A 
(speA) gene in strains associated with various outbreaks has revealed that there 
are four naturally occurring alleles of speA (Cunningham 2000). The speA1, 
speA2, and speA3 alleles encode toxins, which differ in a single amino acid, 
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while speA4 encodes a toxin which is 9% divergent from the other three and has 
26 amino acid substitutions. The speA2 and speA3 alleles are expressed in most 
of the recent isolates from toxic streptococcal syndrome (Nelson 1991). 
 
1.4.3.2 SpeB 
SpeB (streptococcal cysteine protease, streptococcal exotoxin B) is a cardiotoxic 
virulence factor of S. pyogenes). The speB gene is carried by all strains of S. 
pyogenes, but the degree of expression varies from strain to strain. Its protease 
activity has the ability to degrade the human extracellular matrix protein 
fibronectin and vitronectin, release inflammatory mediators such as interleukin 1β 
and bradykinin from their precursors, cleave or degrade immunoglobulins and 
complement factors, and also bind to the human cell surface receptors integrins 
(Cunningham 2000). Its expression is directly under the reglation of mg. In 
addition to ropA, the presence of M-protein on the streptococcal surface is 
needed for the maturation of SpeB. The secreted SpeB has an important role in 
S. pyogenes virulence. It degrades host extracellular matrix proteins activates 
interleukin-1β and releases fragments of proteins from the S. pyogenes surface 
(Nelson 2011). 
 
1.5 Genetics of Virulence 
1.5.1 Chromosomal and Bacteriophage-encoded Virulence Factors 
Streptococcal virulence factors can be encoded on the streptococcal 
chromosome or located on lysogenic bacteriophage.   Integrated phages not 
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only contribute to the genetic diversity of GrAS strains, but they can also 
introduce virulence factors that alter the phenotype of a particular strain in the 
infection setting. Although strain SF370 encodes for extracellular DNases, 
hyaluronidases, and superantigens within its bacterial chromosome, additional 
proteins from each category have been introduced by phage transduction as 
evidenced by the four integrated prophage sequences in the SF370 genome 
(Ferretti 2001).  It is important to also note that these factors are often strain and 
serotype-specific. For example, skin- tropic M type strains are often distinguished 
from throat-tropic M type isolates by the presence of the chromosomally encoded 
serum opacity factor (sof) on the former (Cunningham 2000, Bessen 2010). 
Tables 1.2 and 1.3 provide the known annotated known virulence factors for the 
M type 1 strain SF370 with accompanying locus tag and gene name. We 
exclusively use this strain in all of microarray experiments presented later in 
section 6.  
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Table 1.3 Chromosomally Encoded Virulence Factors 
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Table 1.3 (continued) Chromosomally Encoded Virulence Factors 
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Table 1.3 (continued) Chromosomally Encoded Virulence Factors 
Table 1.4 Phage Encoded Virulence Factors 
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1.5.2 Regulation of Virulence 
Regulation of virulence in S. pyogenes is widely considered to be executed at the 
transcriptional level. Studies that have examined the correlation between mRNA 
levels and protein production in S. pyogenes have found good agreement (Lyon 
2001, Chaussee 2002, Ryan 2007, Juncosa 2012). 
 
1.5.2.1Stand-alone Regulators 
Stand-alone regulators can positively or negatively affect virulence factor 
expression in response to environmental signals communicated by unknown 
sensory elements (Kreikemeyer 2003). SF370 encodes over 40 stand-alone 
regulators (Ferritti 2000). 
 
1.5.2.1.1 Mga 
Mga has been so named as the multiple gene regulator of group A 
streptococcus. The mga gene lies immediately upstream of emm, which encodes 
M protein. ga is ubiquitous in GrAS and, due to its regulation of a vast array of 
genes implicated in GrAS pathogenesis, is often referred to as a global regulator 
of virulence (Nobbs 2009). It is now established that Mga activates the 
transcription of several additional genes, including those for C5a peptidase 
(scpA), M-like proteins (mrp, enn, and fcR), serum opacity factor (sof), and 
secreted inhibitor of complement (sic). Mga feeds back to positively regulate itself 
and functions as a 62-kDa protein to bind to the promoter region of the genes 
that it regulates (Cunningham 2000). 
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1.5.2.1.2 amrA 
The amrA locus corresponds to Spy0797 in the serotype M1 GrAS. Based on 
mutation experimental screens, it received its name for activation of Mga regulon 
expression locus A. As amrA is strongly conserved across the sequenced 
streptococcal M types, and inactivation of amrA in an M3 serotype also resulted 
in reduction of emm transcripts. Ribardo et al asserted that the original role the 
noted during their screen identifying amrA does not appear to be serotype 
specific. Although the specific function of AmrA is unknown, its putative 
membrane localiza- tion and homology to transporters involved in cell wall 
synthesis suggest a link between growth and virulence gene expression in GrAS 
(Ribardo 2003). 
 
1.5.2.2 Two-Component Systems 
Working in conjunction with stand-alone regulators, two-component 
systems (TCS) offer GrAS the ability to integrate extracellular signals directly into 
regulatory circuits (Kreikemeyer 2003).The sequenced genomes of S. pyogenes 
have been found to encode 13 two-component systems (Ferritti 2000). 
 
1.5.2.2 .1 CovR / CovS 
Levin and Wessels identified csrR / csrS (CovR / CovS), a pair of genes in group 
A streptococci that encode a two-component regulatory system. It’s name stem 
from “control of virulence” genes. Inactivation of CovR resulted in a striking 
increase in transcription of the capsule synthesis genes of the has operon and a 
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corresponding increase in hyaluronic acid capsule production (Cunningham 
2000). The CovR / CovS is now know to be responsible for negative regulation of 
capsule production, streptokinase, SpeB and streptolysin S, and appears to 
influence the transcription of up to 15% of the genes in GrAS (Ribardo 2003).  
 
1.5.2.2.2 SptR / SptS 
Named for its role in Streptococcal persistence in Saliva, the SptR/SptS TCS 
plays a crucial role during the host–pathogen interaction in saliva. It has been 
proposed that SptR/S links central metabolic processes with the production of a 
broad range of putative and known virulence factors Interestingly, one of the 
major roles of the SptR/SptS is to coordinate expression of genes involved in 
acquisition and processing of complex carbohydrates, with little to no effect on 
the use of simple sugars like glucose (Shelburne 2005). SptR regulates 20% of 
GrAS ORFs during growth in saliva including transcription of spd (DNase), spd3 
(DNase), sic, speB, and hasA (capsule) (Shelburne 2008). These genes have 
been associated with colonization and infection of the oropharynx. (Fig.1.3). 
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Figure 1.3 Proposed mechanism for how the SptR/S TCS contributes (directly or indirectly) to 
persistence of GrAS in human saliva.  
Adapted from Shelburne et al 2005  
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1.6 Pathogenesis 
1.6.1 Adhesion 
The dominant theory describing streptococcal colonization of pharyngeal and 
dermal epithelia is via a two-step adherence mechanism (Hasty 1999, Nobbs 
2009). The first step involves a weak electrostatic interaction likely mediated by 
lipotechoic acid (LTA) in the bacterial cell wall. This amphipathic molecule 
contains a lipid moiety attached to a negatively (-) charged polyglycerol 
phosphate backbone, which reacts with positively (+) charged residues on host 
epithelial surface proteins, such as fibronectin. This electrostatic attraction may 
account for up to 60% of the pathogen’s adhesion to epithelial cells (Cunningham 
2000). 
 
The second stage of adherence occurs by a mechanism that confers tissue 
specificity (Bessen 2010) and involves high-avidity binding that is mediated by 
multiple bacterial adhesins and their associated host cell epitopes, often 
extracellular matrix proteins (Cunningham 2000, Nobbs 2009). 
 
1.6.2 Invasion 
In order to cause invasive diseases as myositis and necrotizing fasciitis, S. 
pyogenes must invade deep tissue through either a paracellular route between 
adjacent cells, or by traversing epithelia through intracellular movement. LaPenta 
et al. were the first to demonstrate in vitro that group A streptococci are able to 
invade (or become internalized by) immortalized cells (LaPenta 1994). These 
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initial findings have been confirmed and expanded by other groups 
demonstrating that streptococci can invade certain cell lines as efficiently as 
certain obligate intracellular pathogens such as Listeria and Salmonella (Greco 
1995, Cunningham 2000). It is now established that the streptococcal M-protein 
and fibronectin-binding protein (Protein F) serve as invasins, since latex beads 
coated with either protein will efficiently become internalized by epithelial cells 
(Fluckiger 1998, Jadoun 1998). The mechanism for fibronectin-mediated invasion 
has been extensively studied. A leading theory proposes streptococci bind host 
serum fibronectin with one of multiple fibronectin-binding proteins (e.g. FnBP, 
Sfb1) and is subsequently engaged by the α5β1 integrin as a consequence of it 
being the host cell fibronectin receptor. Once bound to the integrin, propagation 
of phosphoinositide 3-kinase and integrin-linked kinase-dependent intracellular 
signals induce cytoskeletal rearrangement and internalization of the streptococci 
(Wang 2006a, Wang 2006b). Integrin ligands frequently posses the tripeptide 
sequence RGD, which serves as the integrin recognition or binding site. Other 
peptides with RGD amino acid sequences appear to stimulate uptake without 
either M-protein or serum. Another factor potentially important for invasion is 
laminin, which binds group A streptococci and induce epithelial internalization 
also without serum (Cunningham 2000). 
 
The evolution of presumably many routes to the interior of human epithelial cells 
implies that this otherwise extracellular bacterium might be able to survive, at 
least transiently, intracellularly. Osterlund et al were among the first to 
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convincingly demonstrate that streptococcal internalization may not be an in vitro 
laboratory artifact when they recognized that excised tonsil tissue contained 
viable intra- and extracellular streptococci (Osterlund 1997). This observation led 
to the suggestion that the tonsil may contain an intracellular reservoir of S. 
pyogenes that mediates recurrent infection (Osterlund 1997). Mammalian 
epithelial cells are not well penetrated by β-lactam antibiotics. Multiple groups 
propose that streptococci may persist intracellularly and evading killing by 
antibiotics prescribed to treat pharyngotonsillits. (Cue 2000, Osterlund 1997). We 
further explore the mechanisms of epithelial internalization as well as it’s 
consequence to the host and bacterium in section 7.  
 
1.7 Streptococcal Disease Burden  
This pathogen causes a wide variety of diseases including acute pharyngitis, 
impetigo, scarlet fever, and puerperal sepsis. In many cases, these diseases 
have been attributed to particular M serotypes. For example, M types 2, 49, 57, 
59, 60, and 61, are associated with pyoderma and acute glomerulonephritis while 
M types 1, 3, 5, 6, 14, 18, 19, and 24 arep found associated with throat infection 
and rheumatic fever. More recently, studies have also linked post-streptococcal 
infection sequelae to such neurologic conditions as Tourette’s syndrome, Tics, 
Attention Deficit Disorder (ADD), and Pediatric Autoimmune Neurosychiatric 
Disorders Associated with Streptococcal infections (PANDAS) (Cunningham 
2000, Pavone 2006, Hahn 2005).  Significant outbreaks of streptococcal 
infections and their sequelae have historically occurred in densely populated 
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settings, such as schools and in the military (Kaplan 2009). The annual global 
burden of S. pyogenes related diseases is staggering and includes greater than 
100 million cases of pyoderma, and over 600 million cases of pharyngitis (Bisno 
2000).  An increased global incidence of severe invasive diseases due to S. 
pyogenes has been observed over past decades (Kaplan 1996), often associated 
with bacteremia, streptococcal toxic shock syndrome (STSS), and high mortality. 
It was estimated that nearly 500,000 deaths due to invasive diseases occurred in 
2005 (Carapetis 2005).   
 
1.7.1 Acute Rheumatic Disease and Sydenham Chorea 
Molecular mimicry is proposed to be an important mechanism in the 
pathogenesis of Acute Rheumatic Fever (ARF). Human monoclonal antibodies 
derived from rheumatic heart disease have provided evidence supporting the 
hypothesis that crossreactive autoantibodies that target the dominant group A 
streptococcal epitope of the group A carbohydrate, N-acetyl-beta-D-glucosamine 
(GlcNAc), and heart valve endothelium, laminin and laminar basement 
membrane. This cross reactivity may then lead to the initiation of carditis and 
rheumatic heart. Similarly, Antineuronal antibodies in Sydenham chorea may 
cross the blood–brain barrier and trigger antibody-mediated neuronal cell 
signaling induction of calcium calmodulin- dependent protein kinase II (CaMKII) 
and subsequent dopamine release in the caudate putamen region of the brain, 
which may lead to the movement disorder (Cunningham 2012). 
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1.7.2 Pharyngitis  
1.7.2.1 Healthcare Burden  
The superficial infection of the pharyngeal mucosa is among the important 
primary infections of the throat specialist streptococcal serotypes. M type 1 has 
been of particular importance as it remains the most commonly isolated serotype 
associated with pharyngeal and invasive disease (Bessen 2010). Notably, 
however, there have been an increasing number of adults and children 
hospitalized annually for throat infections over the past decade in the 
industrialized world. In Australia, 4% of all symptomatic presentations to general 
practitioners from 2000 – 2001 were for throat complaints, second only to cough 
at 7%. Sore throat consultations resulted in an antibiotic prescription in 89% of 
cases (WHO 2005). In England from 2000 – 2001, there were 30,942 tonsil 
related admissions for medical treatments. By 2008 – 2009, the figure had risen 
to 43,641 medical admissions for throat symptoms, an increase of over 41% 
(12,700 admissions) in 8 years [http://www.hesonline.nhs.uk], (Vincent  2004). 
The Ambulatory Medical Care Utilization in the United States (AMCUS), 
estimates for 2007 found that acute pharyngitis accounts for 1.1 percent of visits 
in the primary care setting and is ranked in the top 25 reported primary 
diagnoses resulting in office visits (Schappert 2011).  
 
1.7.2.2 Antibiotic Failure 
While treatment failure in the 1950’s was reported in 4-8% of children, more 
recent studies have alarmingly found antibiotic failure as high as 20-40% 
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(Pichichero 1991, 2007). Treatment failure has been attributed to reasons 
inlcluding: 1) carrier state, 2) lack of compliance, 3) recurrent exposure, 4) in vivo 
copathogenicity of beta-lactamase–producing normal pharyngeal flora, 5) in vivo 
bacterial coaggregation, 6) poor antibiotic penetration to tonsillopharyngeal 
tissue, 7) in vivo eradication of normal protective flora, 8) early initiation of 
antibiotic therapy resulting in suppression of an adequate host immune response, 
9) intracellular localization of GrAS, 10) GrAS tolerance to penicillin, 11) 
contaminated toothbrushes or orthodontic appliances, and 12) transmission from 
the family pet (Pichichero 2007). 
 
1.7.2.3 GrAS Pharyngitis Clinical Appearance  
The clinical presentation for group a streptococcal pharyngotonsillits on physical 
examination may be atypical with non-descript physical symptoms or more 
commonly reveals well confined pharyngeal erythema with palatine tonsil 
swelling, an edematous uvula, and anterior cervical lymphadenopathy (figure 
1.4). Ebell and colleagues’ literature review of physical exam findings in strep 
throat cases concluded the signs and symptoms that help rule in GABHS 
pharyngitis include tonsillar exudates (positive likelihood ratio [LR+]: 3.4), 
pharyngeal exudates (LR+: 2.1), and exposure to strep throat in the previous two 
weeks (LR+: 1.9) (Ebell 2000). The presence of a scarlatiniform rash or palatine 
petechiae is uncommon but very specific for the diagnosis of GABHS pharyngitis 
As previously described, more outspread symptoms may increase the likelihood 
of an alternative pathogen (Ebell 2000). 
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1.7.2.4 Differential Diagnosis of Non-GrAS Pharyngitis 
Group A streptococcus remains the most common bacterial cause and is 
estimated to account for 15-30% of cases of pharyngitis in children (<18 y.o.) and 
5-10% of cases in adults. The differential diagnosis is generally a distinction 
between bacterial and viral, since the treatment course between bacterial 
etiologies may not differ dramatically. Among the other bacterial causes, 
Neisseria gonorrhea pharyngitis occurs in sexually active patients18 presents 
with fever, severe sore throat, dysuria, and a characteristic greenish exudate. 
Corynebacterium diphtheria pharyngitis is assumed if examination reveals a 
serosanguineous nasal discharge. Other diphtheria related symptoms may 
include a grayish-white pharyngeal membrane where exudative and extending to 
the uvula and soft palate in association with the pharyngitis, tonsillitis, and 
cervical lymphadenopathy Table 1.5 provides a non-exhaustive review of the 
alternate causes of pharyngitis (Vincent 2004, Bisno 2001). 
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Table 1.5 Viral versus bacterial causes of pharyngeal infection 
PATHOGEN SYNDROME OR 
DISEASE 
ESTIMATED 
PERCENTAGE OF 
CASES 
Viral   
Rhinovirus (100 types and 
1 subtype) 
Common cold 20 
Coronavirus (3 or more 
types) 
Common cold >5 
Adenovirus (types 
3,4,7,14, and 21) 
Pharyngoconjunctival 
fever, acute respiratory 
disease 
5 
Herpes simplex virus 
(types 1 and 2) 
Gingivitis, stomatitis, 
pharyngitis 
4 
Parainfluenza virus (types 
1 and 4) 
Common cold, croup 2 
Influenza virus (types A 
and B) 
Influenza 2 
Coxsackie virus A (types 
2, 4-6, 8, and 10) 
Herpangina <1 
Epstein-Barr virus Infectious mononucleosis <1 
Cytomegalovirus  Infectious mononucleosis <1 
HIV virus type 1 Primary human deficiency 
virus infection  
<1 
Bacterial   
Streptococcus pyrogenes 
(group A B-hemolytic 
streptococci) 
Pharyngitis and tonsillitis, 
scarlet fever 
15-30 
Group C B-hemolytic 
streptococci 
Pharyngitis and tonsillitis 5 
Neisseria gonorrhea Pharyngitis <1 
Corynebacterium 
diphtheria 
Diphtheria <1 
Arcanobacterium 
haemolyticum 
Pharyngitis, scarlatiniform 
rash 
<1 
Chlamydial   
Chlamydial pneumonia Pneumonia, bronchitis, 
and pharyngitis 
Unknown 
Mycoplasmal   
Mycoplasma pneumonia Pneumonia, bronchitis, 
and pharyngitis 
<1 
The list is not exhaustive.Estimates are of the percentage of cases of pharyngitis in persons 
of all ages that are due to the indicated organism.  
                                                                                                        (Adapted from Bisno 2001) 
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1.7.2.5 Surgical Indications 
Tonsillectomy remains the most common operation in Ear, Nose and Throat units 
(Little 1996). While hypertrophy increasingly has become the most common 
indication for this procedure in recent years, recurring tonsillitis continues to be 
an important predisposing factor, creating a significant financial burden with 
potential complications, especially in the very young (Spencer 2012). Indication 
for tonsillectomy relates to surgeon preference as well as effect on the overall 
quality of life for the patient. One longstanding recommendation shared by the 
American Medical Association and the American Academy of Pediatrics, is that 
tonsillectomy be indicated for patients who have four or more documented cases 
of pharyngitis over one year (Gates 1986). 
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Figure 1.4. Clinical presentation of “Strep Throat”.  
 
*Arrows indicate white exudate on the palatine tonsil. Patient was 
cultured to be positive for Group A Streptococci and was treated with 
1.2 million units of penicillin G benzathine intramuscularly with 
benzocaine spray for topical analgesia.   
 
Image adapted from Nimishikavi et al 2005.  
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1.8 Human Oropharynx anatomy 
The tonsils are secondary lymphoid organs that form a first line of defense in 
protecting the oropharyngeal isthmus. Collectively referred to as Waldeyer’s 
Ring (Figure 1.5), humans uniquely have numerous “tonsils”, namely: palatine, 
nasopharyngeal (or adenoids), lingual, and tubal tonsils.). Similar to Peyers 
patches and the vermiform appendix, the tonsils belong to the mucosa-
associated lymphoid tissue (MALT) system and are constantly exposed to 
antigens. In contrast to the material in contact with the intestinal MALTs, 
however, these antigens are in their native form having not been modified by 
gastric acid or digestive enzymes. An additional unique quality is that unlike 
most lymphoid organs/nodes (with the exception of the spleen), tonsils do not 
have afferent lymph vessels (Perry 1998). The palatine tonsils’ anatomic 
placement within Waldeyer’s ring is ideally situated for antigen sampling but are 
themselves more vulnerable to damage and infection than many of the less 
exposed members of this lymphoidal network. Accordingly, tonsillitis caused by 
bacterial and viral infections is usually localized to the palatine tonsils (Clark  
2000), with occasional involvement of the adenoids.  Diseased tonsils are 
associated with decreased antigen transport, decreased antibody production 
above baseline levels, and chronic bacterial infection. 
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Figure 1.5 Waldeyer’s Ring. Pharyngeal lymphoid tissue of Waldeyer’s ring comprises the 
nasopharyngeal tonsil or adenoid (NT), the paired tubal tonsils (TT), the paired palatine 
tonsils (PT) and the lingual tonsil (LT). All four micrographs show that the surface of the 
tonsils is in each case covered with pharyngeal epithelium. Note the branching crypt 
arrangement in the NT and the PT, and the single crypt in the LT. The intimate 
relationship of tonsils with salivary glands is especially obvious in the TT.  
 
Adapted from Perry et al 1998  
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Although healthy tonsils offer immune protection, diseased tonsils are less 
effective at serving their immune functions. Diseased tonsils are associated with 
decreased antigen transport, decreased antibody production above baseline 
levels, and chronic bacterial infection. 
 
 
Of note, the pharyngeal surface of the nasopharyngeal tonsil is covered mainly 
with a ciliated respiratory epithelium. The surface epithelium (or outer capsule) 
of the palatine tonsils, however, is essentially a continuation of the non-
keratinized or parakeratinized stratified squamous of the surrounding 
oropharyngeal mucosa (Perry 1998). Heterogeneity within both the 
nasopharyngeal and palatine tonsil architectures becomes apparent at the tonsil 
crypts as epithelia becomes increasingly reticulated and often desquamated 
(Perry 1994). In an average adult, it has been estimated that the stratified 
squamous epithelium of the superficial oropharyngeal aspect accounts for 
45cm2 of total palatine tonsil surface area while the morphologically non-uniform 
epithelium of the tonsillar crypts accounts for 295cm2 of total surface area (Perry 
1994, 1998).  
 
Antigen sampling in this lymphoepithelial organ occurs at specialized tonsillar 
crypts either through direct contact with infiltrated immune cells or via follicle-
associated epithelium (FAE). FAE refers to the epithelium lining the crypts, and 
includes reticulated specialized M-cells, which are able to sample antigen and 
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translocate them to underlying lymphoid tissue (Perry 1994, Perry 1998). (Figure 
1.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. The lymphoepithelium of the palatine tonsil. The nonepithelial cells, mainly 
lymphocytes, can enter the reticulated epithelium either via vascular (1 and 2) or nonvascular 
routes (3). Routes 1 and 2 involve direct homing into the lymphoepithelium through the walls of 
capillaries and high endothelial venules (HEVs), whereas route 3 involves entry from the 
subepithelial lymphoid compartments through the disrupted basement membrane. 
 
Image adapted from Perry et al 1998 
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While the uniqueness of the specialized epithelium of the palatine tonsil provides 
a functional capacity to sample antigens for immunoprotection, it is well 
documented that this organ is a prudent area for pathogen entry. Various 
investigators have shown a pathogenic focus for oral HIV transmission, EBV 
transmission, and a putative route for prion entry concentrated in tonsillar crypt 
reticulated epithelium (Perry 1998, Pegtal 2004, Maher 2005, Moutsopoulos 
2007).  
 
1.9 Experimental Models of Pharyngitis  
In an animal model, rabbits infected with aerosolized group A streptococci 
revealed streptococci and cell debris-like masses mainly within the micropores of 
the palatine tonsillar crypt while the pharynx, larynx, trachea, bronchi, and lungs 
appeared mostly resistant (Hokonohara 1988).  
 
The rabbit model offers insight that is likely applicable to humans, but potentially 
significant anatomic and pathologic inconsistencies exist between the two 
species. Rabbit palatine tonsils are monocryptic, as compared to polycryptic 
tonsils of humans (Effat 2006). Infected rabbits also do not present symptoms of 
pharyngitis as do infected humans. Tissues equivalent to those of Waldeyer’s 
ring are actually present in all mammals (except rodents), but tonsil crypt 
distribution and epithelial lining differs greatly amongst mammals. These 
differences include the few short wide-tonsil crypts of camels, the few deep 
crypts of the cow, and the many deep crypts of dogs (Effat 2006). Interestingly, 
  38 
the clinical features of acute pharyngitis is absent in all aforementioned 
mammals, and are even not seen in baboons and rhesus macaques that are 
infected with group a streptococci. Cynomolgus macaques however, do reliably 
mimic the clinical features of the human infection (Sumby 2008), but this model is 
prohibitively expensive and therefore could not be used in routine studies. 
Additionally, while numerous studies have used nonhuman primate models for 
pharyngeal colonization and/or infection by GrAS, high inoculating doses of 
bacteria are consistently employed, ranging from more than 3 × 105 to 108 CFU. 
Nonetheless, transcription of several GrAS genes that are upregulated in 
organisms recovered from pharyngitis patients are also expressed at elevated 
levels during infection in the macaque model (Virtaneva 2003, Shumby 2008, 
Shea 2010). 
 
In vitro studies remain a useful alternative to animal models for elucidating basic 
features of complex infection mechanisms. We discuss existing epithelial cell in 
vitro models along with some of their benefits and set backs in section 4.  
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§2.0 OBJECTIVES 
As more is understood about Streptococcus pyogenes pathogenesis, the 
complexity of its adaptive capacity is further revealed. The anatomical 
predisposition of the tonsil makes it an organ prone to streptococcal infections 
although this phenomenon is not well understood from a mechanistic 
perspective. Putative virulence factors appear to guide S. pyogenes infective 
capacity in a serotype specific and environment-dependent manner. The growing 
appreciation of the relationship between streptococcal virulence factors, 
environmental conditions, and surface anatomic architecture necessitate the 
development of systems that better mimic the natural host. Additionally, our 
current ability to investigate mechanisms of pathogenesis by cellular and genetic 
tools may further allow us to understand a simple clinical observation that Group 
A streptococci appears to preferentially infect tonsillar tissue in the oropharynx 
leading to acute tonsillitis. 
The overarching aim of this study was to better understand the tissue-/niche- 
specificity that has been attributed to “throat specialists” strains of Group A 
streptococci, GrAS. While during the process of this investigation, however, we 
successfully established techniques for cultivating primary tonsil epithelial cells, 
as well as characterized two palatine tonsil-derived tumor cell lines for their novel 
use as an in vitro model for tonsillitis. Armed with these new tools, we were able 
to specifically test the bacterium’s ability to discern from its proximate 
environment: tonsil vs non-tonsil epithelium. Using established measures of 
pathogenesis, we observed epithelial cell type-specific phenotypic and genotypic 
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responses by our representative M type 1 strain, SF370, a member of the earlier 
ascribed “throat tropic” group of streptococci. This study has extended our lab’s 
continued work on the transcription shifts observable in S. pyogenes from initial 
contact with host factors in suspension (conditioned media), to transient contact / 
association with neighboring epithelial cells (Detroit 562), to transient contact / 
association with palatine tonsil epithelium (UT-SCC-60B), to adherence with 
nasopharyngeal (Detroit 562) surface. It is clear that, in vivo, the GrAS must 
experience to some extent every step within our model’s continuum. The bacteria 
also may adhere to non-tonsil tissues in the pharynx, particularly during 
asymptomatic carriage of the pathogen in the nasopharynx. While we have 
observed unique qualities that are stage-specific throughout the course of an 
infection, improvements in models and annotation will only produce even greater 
opportunities to ask more precise questions. Our UT-SCC-60A and UT-SCC-60B 
tonsil epithelial model mirrored many of the in vitro effects exhibited by the more 
precious HPTE cells, offering an affective surrogate for determining anatomically 
significant mechanisms underlying streptococcal pharyngotonsillitis.   
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§3.0 MATERIALS AND METHODS 
 
3.1 Bacterial Strains and Growth Conditions. Group A Streptococcus (GrAS) 
strain SF370 (M type 1) was provided by J. Ferretti, University of Oklahoma 
Health Sciences Center. Unless otherwise stated, the spontaneous streptomycin-
resistant derivative of SF370 will be referred to as SF370 Wild Type or 
SF370SMR. The isogenic KO mutant SF3700129 was derived from this GrAS 
background.  GrAS strain D471 (M type 6), and the isogenic M-negative mutant 
JRS75 were from the Rockefeller University culture collection. All GrAS strains 
were grown at 37°C supplemented with 5% C02 in Todd Hewitt broth + 1%Yeast 
Extract (BD, Becton, Dickinson and Company) and on protease peptone blood 
agar (ie. supplemented with 4% defribinated sheep blood (Cleveland Scientific)) 
or Columbia Blood Agar plates (Thermo Scientific). When required, media was 
supplemented with antibiotics at the following concentrations: erythromycin at15 
μg/ml or streptomycin at 200 μg/ml. E. coli strain One Shot DH5α (Invitrogen) 
was cultured in Luria-Bertani (LB) broth and on LB agar supplemented with 
erythromycin at 200 μg/ml at 37°C.  
 
3.2 Human Immortalized Epithelial Cell Lines and Growth Conditions Detroit 
562 (ATCC CCL-138) human nasopharyngeal epithelial cell line obtained from 
the American Type Culture Collection (Manassas, Va.) was maintained at 37°C 
in minimal essential medium (MEM) (Gibco-BRL, Life Technologies, Grand 
Island, NY) supplemented with 10% fetal bovine serum (FBS), 5 mM L-
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Glutamine, and 1mM Na pyruvate. Human immortalized epithelial cell lines UT-
SCC-60A (palatine tonsil primary tumor-derived) and UT-SCC-60B (donor paired 
secondary / metastatic tumor-derived) were generously provided to us for this 
study by Dr. Reidar Grenman (University of Turku, Turku, Finland) (Lange, et al 
2009) (Takebayashi 2004).  UT-SCC cell types were maintained at 37°C in 
Dulbecco’s Modified Essential Medium (DMEM) (Gibco-BRL) supplemented with 
5% fetal bovine serum (FBS) 2 mM L-glutamate.  
 
3.3 Adherence and invasion assay GrAS strains SF370, SF3700129, D471 
and JRS75 cultures were grown to early log phase (OD600 ~0.6) in THY, 
washed twice with 0.1 M Phosphate Buffered Saline (PBS, pH 7.4), collected by 
centrifugation (3000 g, 10 min), and resuspended in Minimum Essential Medium 
(MEM, Invitrogen, Carlsbad, CA) at a concentration of ~1x108 CFU/mL and 
incubated for 1 h at 37°C. Glycerol (10% vol/vol) was added and cultures were 
flash frozen in liquid N2. Culture suspensions were kept at -80°C until the day of 
assay experiment when frozen suspensions were thawed in a 37°C waterbath for 
1h. Thawed bacterial suspensions were diluted with warm MEM (without serum).  
A Falcon® 24-well tissue culture plate with respective human epithelial cell 
type(s) grown as a monolayer to approximately 90% confluency was washed 
twice with PBS.   Approximately 106 bacteria were added per well and plates 
were infected for 2 h at 37°C in a 5% CO2 atmosphere. The wells were then 
washed twice with PBS, and parallel tests were performed to assess bacterial 
adherence and internalization. 
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The presence of intracellular viable intracellular bacteria was quantified by 
the standard antibiotic protection assay as previously described (Ryan 2007). 
Briefly, the extracellular bacteria after 2 h of infection were killed by adding 
prewarmed MEM without serum containing 600mg l−1 penicillin (Sigma) and 100 
mg l−1 gentamicin (Sigma). After 1 h of further incubation, the monolayers were 
rinsed twice with PBS. Purified phage lytic enzyme, PlyC (0.05U / well) (Fischetti 
1971, Nelson 2001) was then added to monolayers and incubated for 5 min at 
37° and washed three times with PBS. Cells were detached from the plate by 
treatment with 100µl of 0.25% trypsin−0.02% EDTA (Life Technologies) and then 
lysed by the addition of 400µl of Triton X-100 (0.025% in H2O). Appropriate 
dilutions were plated on blood agar to determine the number of viable bacteria. 
Antibiotic sensitivity was demonstrated in control experiments with equivalents 
numbers of bacteria and under the same conditions as in the invasion assay 
except that no epithelial cells were present in the well. Internalization results 
were expressed as the average number of bacteria recovered per well for three 
independent determinations in a single assay and the invasion efficiency (% 
invasion) was calculated using the following equation: bacteria recovered (cfu 
ml−1) time 3 hrs in the presence of antibiotics/bacteria inoculated (cfu ml−1) × 100. 
To measure bacterial adherence the monolayers were further incubated 
with fresh media for 1 h. Then, cells were dispersed and lysed, and bacteria were 
plated for enumeration. The numbers of cfu recovered from these wells represent 
total associated bacteria (attached plus internalized), and for simplicity named as 
adherence. Adherence results were expressed as the average number of 
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bacteria recovered per well for three independent determinations in a single 
assay and the percentage of adherence was calculated using the following 
equation: bacteria recovered (cfu ml−1) after 3 h (2 h infection + 1 h incubation) / 
bacteria inoculated (cfu ml−1) × 100. 
Tests were repeated four times and results are expressed as the averages 
+ SD for a representative experiment performed in triplicate. 
 
3.4 Bacterial Intracellular Viability.  Mid- late log phase (O.D.600 ~0.6) bacteria 
were co-cultured with human epithelial monolayers as described previously for 
the Invasion Assay. After extracellular bacteria were killed by antibiotic solution 
(600mg/mL penicillin and 100 mg/mL gentamicin) with subsequent PlyC 
treatment (0.05U / well), monolayers were overlaid with anti-reemergence 
medium consisting of DMEM with 10% FBS, diluted PlyC solution (0.005U/mL), 
and Tannic acid) (Nakagawa 2004). At specified time intervals, post initial 
antibiotic treatment (T0= 0hrs, T2=2hrs, T3= 16hrs, and T4=24hrs), designated 
monolayers were enzymatically detached and lysed to quantify viable 
intracellular bacteria by cfu counts on blood agar plates as previously described  
 
3.5 Human Primary Tonsil Epithelium  At the present time, there remains no 
ATCC deposited human tonsil epithelial cell line. Human palatine tonsils were 
obtained from otherwise healthy patients undergoing routine tonsillectomy by 
surgeons affiliated with NewYork-Presbyterian (NYP) Department of 
Otorhinolaryngology or the National Cancer Institute’s Cooperative Human 
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Tissue Network (CHTN) Eastern, Midwestern, and Western Divisions. Only 
specimens from traditional “full” tonsillectomy (FT) performed either by cold 
dissection (conventional scalpel), electrocautery, laser, the harmonic scalpel, or 
coblation was used for culturing. Specimens from “partial” tonsillectomy 
techniques such as Powered Intracapsular Tonsillectomy with Adenoidectomy 
(PITA) were rejected due to the procedure’s inherent tissue pre-masceration.   
The experimental protocol received Institutional Review Board approvals 
from both the Rockefeller University (VAF-0621-1207) and the Weill Cornell 
Medical College [nos. 0803009695 and 0806009857and individual patient 
consent for the use of tissue in research applications was obtained prior to the 
surgical procedure. Other investigators may have received specimens from the 
same subjects.  Specimens were never refrigerated and unless otherwise noted, 
all subsequent processing was performed using reagents pre-warmed to 37° C. 
Tonsils were transported within 6 h of surgery at room temperature (RT) in 
“transport antibiotic solution” consisting of sterile 0.1M phosphate-buffered saline 
(PBS) (pH 7.4) supplemented with 0.5% bovine serum albumin (SIGMA) and 
antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin [1000 U mL-
1], Streptomycin [10 mg mL-1], Fungizone [25 μg mL-1], and Nystatin [240 U mL-
1])(SIGMA) or shipped overnight at ambient temperature in DMEM supplemented 
with fetal bovine serum (10%) and antibiotic / anti-mycotic cocktail (Penicillin 
[100µg mL-1], Streptomycin [100µg mL-1], Amphotericin B [2.5µg mL-1].   
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Acquired tonsil specimens were carefully dissected about the surface of 
the tonsil capsule under a sterile cell culture  hood using surgical tools in a glass 
Petri dish. Investigator visual inspection was used to separate the exterior 
(epithelial) tissues from underlying follicular lymphocytes and connective tissues 
as best as possible and resulting capsular tissues were further cut into small 
explants measuring ~1-3 mm3. Explants were transferred to a conical tube 
containing fresh, pre-warmed transport antibiotic solution and washed twice by 
briefly vortexing to liberate potentially associated non-epithelial cell types 
(including lymphocytes, innate immune cells, and low density fat), allowing the 
explants to settle by gravity at the bottom of the tube and aspirating off resulting 
supernatant. Explants were then washed an additional two times in pre-warmed 
“high Ca++ media” consisting of Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum, F12, 0.1mM Na Pyruvate, 1mM 
calcium, and antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin 
(1000 U mL-1], Streptomycin [10 mg mL-1], Fungizone [25 μg mL-1], and Nystatin 
[240U mg mL-1]). After final wash, explants were placed in a 100-mm-diameter 
petri dish, submerged in high Ca++ media, and incubated overnight at 37° C in 5% 
CO2. The next day, explants were washed twice with transport antibiotic solution 
before being transferred to a Costar 100-mm-diameter tissue culture plate 
(Figure 3.1). 
 
Culturing the explants was done in three phases. In the first phase, 
Costar® 24-mm-diameter transwell devices (3 per culture plate) was placed on 
  47 
top of tissue explants (~10 pieces) with high calcium media added into and 
around each transwell. Inert sterile glass beads were (~5-8) were added inside of 
each transwell to provide a weight to aid explants adhere to the tissue culture 
dish and stimulate the outward migration of epithelial cells from the tissue. 
Explants with weighted transwells were incubated at 37° C in 5% CO2 for 
approximately 8 days with daily media changes. In the second phase, the 
transwells were removed and the remaining adherent explants were assessed for 
migrating epithelial colonies extending from the tissue. Keratinocyte serum-free 
medium with keratinocyte growth factor (KGF) (Invitrogen) supplemented with 0.1 
mM Ca++ and antibiotic / anti-mycotic cocktail (Gentamicin [50 µg mL-1], Penicillin 
[1000 UmL-1], Streptomycin [240 μg mL-1], Fungizone [240 μg mL-1], and Nystatin 
[240 U mL-1]). The low calcium "keratinocyte medium" supported outgrowth of 
epithelial cells, and kill both fibroblasts and lingering lymphocytes. Keratinocyte 
media was changed daily for 10 days. For the third phase, the explants were 
gently removed leaving only attached epithelial cells. Subsequent epithelial cells 
were then transferred to Falcon PRIMARIA® tissue culture flasks (BD) at ~60% 
confluency in the UT-SCC cell media (MEM).   
Tonsil media was switched to a basal media with serum 5-12 hrs before human 
primary tonsil epithelial cell monolayers were used for co-culturing experiments 
with bacterial pathogen.   
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3.6 Recombinant M- protein preparation  
E. coli bearing plasmid pJRS42.13 (Coli M6) was cultured to amplify recombinant 
M type 6 protein in the host bacteria’s periplasmic space. This material was 
extracted and purified essentially as described by Fischetti et al 1984.  
 
3.7 Bacterial cell wall preparation S. pyogenes cells were fractionated by two 
separate methodological protocols as indicated in the results. The first method is 
modified from a protocol described by Linke et al 2009. S. pyogenes serotype 
strain SF370 was grown in Todd-Hewitt broth supplemented with 1% yeast 
extract (THY) overnight at 37°C and harvested by centrifugation at 4000 rpm for 
5 min. The cell pellet was resuspended in cold lysis buffer (100mM KH2PO4, pH 
6.2, 40% sucrose, 10mM MgCl2) supplemented with Complete EDTA-free 
protease inhibitor cocktail tablets (Roche), 4 mg/ml lysozyme, and 5U/ml 
amidase enzyme, PlyC, and incubated at 37°C for 2.5 h with gentle rotation. 
Figure  3.1. Schematic of Human Primary Tonsil Epithelial Cell Culture technique 
 
Protocol modified from Pegtal et al 2004 
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Cells and debris were sedimented by centrifugation at 12,900 × g for 15 min at 
4°C); the supernatant containing proteins covalently attached to the cell wall such 
as the pili was kept as the cell wall fraction. 
As second method for extracting the bacterial cell fraction, a 50mL culture 
of S. pyogenes SF370 was grown overnight in THY media at 37°C, and 
harvested by centrigugation at 3000 rpm. The pellet was washed three times in 
PBS and resuspended to 1/50 (v/v) in lysis buffer (30% raffinose, 5mM DTT, 
EDTA-free protease Inhibitor [Roche®] in PBS, pH 6.1). PlyC stock (5.0 U/mL) 
was added to the buffer solution at 1/100 (v/v) and the mixture was incubated at 
37°C for 1.5h. Following incubation, lysed material was centrifuged 10 min at 
3000rpm separating protoplasts, membrane, cytoplasmic proteins. The 
supernatant, containing cell wall proteins, was then dialyzed against 50mM Tris-
HCl, pH7.5 for 24h at 4°C. Resulting dialysate was concentrated using 
Centricon® filter devices (Millipore Corp, Bedford, MA).    
 
3.8 Conditioned media extraction and LC/MS  Fresh DMEM was applied to 
Detroit 562, UT-SCC-60A, UT-SCC-60B, or HPTE cell monolayers for 3h (37C 
at 5% CO2). After 3h, the cells were removed from the media by centrifugation 
and filtration. This supernatant or control media (20mL) was then extracted with 
30mL of chloroform:methanol (7:3). The resulting emulsion was resolved by 
centrifugation (3200G, 15min), the aqueous layer was aspirated and the organic 
layer was dried down in a speed vac. This crude organic extract was 
resuspended in methanol (100mL) and analyzed by analytical LC/MS (XBridge 
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C-18, 20min linear gradient from 20:80 methanol/water with 0.1% formic acid to 
100% methanol).  
 
3.9 Co-Immunoprecipatation (whole bug) S. pyogenes grown to mid-log phase 
were Mitomycin C-killed using [25g/mL] in THY for 2h at 37°C. These cells were 
then washed twice in PBS and used to capture natural binding partners from 
fractionated epithelial cell membrane proteins in suspension. Briefly, human 
epithelial cell monolayers were seeded to approximately 60% confluency. 
Adherent cells were then briefly washed of serum with pre-warmed PBS, and fed 
methionine-free / serum-free DMEM (Gibco) for 60 min to deplete monolayer 
epithelial cell methionine reserves. Cells were then l fed methionine free - MEM 
supplemented with ~40M L-Azidohomoalanine (AHA), a synthetic amino acid, 
as well as for ~4 – 8 h to incorporate AHA in newly synthesized mammalian 
surface proteins. Epithelial cells were fractionated as previously described (Linke 
2009) to achieve a final suspension of mammalian cell membrane associated 
surface proteins. Using fractionation and ultracentrifugation techniques to isolate 
epithelial membrane fractions, this protein suspension was exposed to killed 
bacteria, treated with a cross-linker, dithiobis[succinimidylpropionate] (DSP) 
(Pierce Biotechnology, Rockford, IL) to create a covalent bond between the 
human protein and pathogen, then washed to eliminate unbound debris. The 
pathogen-host binding partners will be un-cross-linked with dithiothreitol (DTT) 
(Hoefer Inc., San Francisco, CA) and the liberated human proteins will be eluted 
off in RIPA buffer and salt. Subsequently, the bacteria were lysed and the S. 
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pyogenes cell membrane protein fractions were collected. Bacterial fractionation 
was performed by method described by Linke et al mentioned above. Both eluted 
and membrane associated protein samples were then reacted to alkaline-
Rhodamine using Cu1-catalyzed azide-alkyne cycloaddition (CuAAC) or “Click 
Chemistry” reaction as described previously by (Grammel 2010). Proteins were 
separated by SDS PAGE and bands containing human epithelial proteins cross-
linked to bacterial cell wall fractions were identified by in gel fluorescence directly 
by scanning the gel on a GE Healthcare Typhoon 9400 variable-mode imager. 
Rhodamine-associated signal was detected at excitation 532 nm / emission 
580nm.  
 
3.10 Phase contrast microscopy Detroit 562, UT-SCC-60A, UT-SCC-60B, and 
human primary tonsil epithelial cell monolayers were grown to > 90% confluence 
in Falcon® or Falcon PRIMARIA® 24-well tissue culture plates. Entire plate 
visualized at room temperature using an Olympus IX71 inverted microscope with 
phase contrast optics using 20X and 40X objectives. Images were captured 
using a Hamamatsu Orca ER B/W digital camera with MetaMorph acquisition 
software (Molecular Devices, Sunnyvale, CA). 
 
3.11 Streptococcal transformation with GFP expression plasmid pCM18). 
The pCM18 plasmid vector (Figure 3.2) was a generous gift from Michael Kehoe 
(University of Newcastle, UK). A transformation procedure described by Hansen, 
et al 2001 was performed with minor modification. The plasmid pCM18 was 
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amplified and purified by adding 5μL of pCM18 [3ng/μL] to 80μL E. coli One Shot 
TOP10 and subjected to one freeze / thaw cycle (1h on ice, then 40 seconds at 
42°C, and 2min on ice) immediately followed by adding 1mL SAC media and 
incubation for 2 h at 37°C. After transformed E. coli was plated onto selective 
Luria-Bertani agar and incubated overnight, resistant colonies were selected and 
used to inoculate a 2mL culture in LB for 8h. The purification was then completed 
using the Qiagen HiSpeedTM Plasmid Purification Midi Kit (QIAGEN, Valencia, 
CA) as described by the manufacturer’s protocol, finally eluting in 200μl TE. An 
overnight culture of S. pyogenes strain SF370 grown in Todd–Hewitt broth 
supplemented with 1% yeast extract was diluted 33 fold and incubated for 3h at 
37°C until when an OD600 = 0.3 was reached. The culture harvested by 
centrifugation and washed five times in chilled electroporation medium (10% 
glycerol) for 15 min, rendering the streptococci competent. The pellet was then 
suspended in 1mL of electroporation medium to the mixture and incubated at 
37°C for 2.5h. The cells were then spread on protease peptone blood agar plates 
with 5 μg/mL erythromycin, and transformants were scored after 2d incubation at 
37°C. 
Figure 3.2 Genetic and physical map of pCM18.  
 
 
Adapted from Hansen et al 2001 
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3.12 PlyCB purification and Alexa Fluor labeling. PlyCB purification and 
labeling was performed as previously described by Nelson et al 2006. Briefly, 
PlyCB was induced with 0.5% arabinose overnight from E. coli XL-1 blue 
(Stratagene) transformed with pBAD24 vector containing plyCB gene construct. 
Cells were washed in 20 mM phosphate buffer at pH 7.0 and lysed with 20% wt / 
vol chloroform to yield crude PlyCB. Lysate was then run over a hydroxyapatite 
(MacroPrep Typell 40μm, BioRad) column, undergoing a stepwise elution from 
200mM to 1M phosphate buffer to elute PlyCB.  The enzyme was then dialyzed 
extensively against phosphate buffer with 1mM DTT and 50mM NaCl. Protein 
quantification was determined with the BCA method (Sigma, St. Louis, MO).  
Five hundred micrograms of purified PlyCB was reacted with the carboxylic acid, 
succinimidyl ester of Alexa Fluor 568, or Alexa Fluor 488 (Molecular Probes) 
according to the manufacturer’s instructions. Unreacted dye was removed from 
the labeled protein by application to a 5-ml HiTrap Desalting column (GE 
Healthcare), equilibrated with PBS.  
 
 
3.13 Fluorescence microscopy Bacterial cultures were grown overnight, 
washed in PBS, mixed with 50 μg of labeled PlyCB (PlyCB-Alexa568), washed 
two times in PBS, and wet mounted on a glass microscope slide. For 
experiments to differentiate internalized from adherent bacteria on human 
epithelial monolayers, Detroit 562, UT-SCC-60B, and UT-SCC-60B cells were 
seeded onto coverslips placed at the bottom of wells in Falcon® 24-well plates 
and grown to 90% confluence. The adherence and internalization assays were 
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performed on coverslips as described. Wells were co-cultured with streptococci 
constitutively expressing GFP for 1.5h. After final wash of the ascribed assay, the 
monolayer wells were inoculated with 1mL vol MEM supplemented with PlyCB-
Alexa568 for 5 minutes at 37°C. The wells were then washed an additional 2 
times with PBS. The streptococci and pharyngeal monolayers were fixed in 4% 
paraformaldehyde at room temperature for 15 min, washed 3 times in PBS for 5 
min each wash, and inverted onto 10µL of Prolong® Antifade (Molecular Probes, 
Eugene, OR) mounting media on a glass microscope slide.  An Eclipse E400 
microscope with a Plan Apo -100 objective (both from Nikon) was used to 
visualize all fluorescence samples, and digital images were obtained by using a 
Retiga Exi camera with Q CAPTURE PRO® software (both from QImaging, 
Burnaby, BC, Canada) 
3.14 Immunofluorescence microscopy Cell lines (Detroit 562, UT-SCC-60A, 
UT-SCC-60B, and THP-1) were seeded onto coverslips placed at the bottom of 
wells in Falcon® 24-well plates and grown to 90% confluence. For HPTE and 
THP-1 cells, coverslips were pre-treated with 0.1% poly-L-lysine solution (Sigma) 
for 10 minutes at room temperature, washed one time in sterile water, and 
allowed to completely air dry before seeding. For Streptococcal internalization 
fate experiments, monolayers were co-cultured with S. pyogenes in MEM 
supplemented with PlyCB-Alexa568 for 1hr.  
 
All monolayers were fixed in 4% paraformaldehyde at room temperature for 15 
minutes, washed 3 times in PBS for 5 minutes each wash. For intracellular 
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immunolabeling, monolayers were permeabilized with 0.05% Tween in PBS- 
solution for 1 minute, then washed 3 times in PBS for 5 min each wash. 
Antibodies were diluted in 5% Normal goat serum (in PBS-) as shown in table3.1. 
The coverslips were then distributed 200μL of their appropriate primary 
antibody(s) and incubated at room temperature for 1 hr or overnight at 4°C. 
Following incubation, excess antibiotic solution was aspirated off and coverslips 
were washed 3 times in PBS for 5 minutes each wash. Secondary antibodies 
diluted in 5% Normal goat serum (in PBS-) as described (Table 3.1) were 
distributed to appropriate coverslips if indicated for 1h at room temperature, 
followed by 3 washes in PBS for 5 minutes each wash. The coverslips were then 
inverted onto 10µL of Prolong® Antifade (Molecular Probes, Eugene, OR) 
mounting media on a glass microscope slide.   
Fluorescence microscope, camera, and image software was used as described 
earlier. 
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Table 3.1 Primary and secondary antibodies used for immunofluorescence  
Name/Target  
Epitope Host 
Species 
Reactivity 
Antibody 
concentration 
Dilution of 
Antibody in 
%5 NGSa 
Fluorophore 
label Clone Source 
Primary Ab’s 
       
Anti-Vimentin  Mouse Human, Pig, 
Rat, Chicken, 
Cow, Cat, Dog 
1.0mg mL-1 1:100 N/A  Abcam  
Anti-
Cytokeratin 
19 
Rabbit Human, 
Mouse 
0.2mg mL-1 1:200 N/A  Abcam  
Keratin 8 /18 
Ab-1 
Mouse Humans Unavailable 1:50 N/A 5D3 NeoMarkers 
Keratin, Pan 
Ab-1  
Mouse Human, 
Monkey, Cow, 
Rabbit, 
Mouse, Rat, 
Chicken 
0.2mg mL-1 1:50 N/A AE1/AE3 NeoMarkers 
Human CD44 Mouse Human 0.1mg mL-1 1:100 Fluorescein 
(FITC) 
F10-44-2 Southern 
Biotech  
Early 
Endosome 
Antigen-1 
Mouse Human 0.25mg mL-1 1:100 Fluorescein 
(FITC) 
14/EEA1 BD Biosciences  
Phalloidinb  N/A N/A ~6.6µM 1:200 Alexa Fluor 
555 
 Invitrogen / 
Molecular 
Probes  
Secondary 
Ab’s 
       
F(ab’)2 
fragment of 
goat anti-
rabbit IgG 
Goat Rabbit 2.0mg mL-1 1:200 Alexa Fluor 
488 
 Invitrogen / 
Molecular 
Probes 
Goat Anti-
Mouse IgG 
(H+L)  
Goat Mouse 2.0mg mL-1 1:200 Rhodamine 
Red™-X 
 Invitrogen / 
Molecular 
Probes 
a Normal Goat Serum (Vector Laboratories, Burlington, CA) 
b Not an Antibody, but rather a fuorophore-conjugated water soluble “toxin” that is extremely used to stain F-actin at nanomolar 
concentrations. Unlike antibodies, the binding affinity does not change appreciably with actin from different species or sources. 
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3.15 Spotted oligonucleotide microarrays Sense strand oligonucleotides 
(primarily 55-mers), representing the 1769 open reading frames (ORF) in the 
genome of Streptococcus pyogenes strain SF370 were designed by Invitrogen 
and produced by Eurofins MWG Operon (Huntsville, AL) .  Oligonucleotides were 
spotted onto Corning Epoxide Coated Slides (Corning Inc., Life Sciences, Acton, 
MA) by Microarrays Inc (Huntsville, AL).  Slides were post-processed by 
Microarrays Inc, and adequate oligonucleotide deposition was verified using their 
quantitative Veriprobe QC assay (http://www.microarrays.com/mi-quality.php).  
Each oligonucleotide was spotted six times in a well-spaced configuration to 
generate in-slide replicates.  
 
3.16 Epithelial cell association assay (for microarray). Assays on 
streptococcal association with the human pharyngeal cells were performed, as 
described previously (Ryan 2007), with the following modifications.  Human 
Pharyngeal (Detroit 562) and palatine tonsil-derived (UT-SCC-60B) epithelial cell 
lines were grown to confluence (5 x 106 cells/well) in 6-well Falcon® plates.  
Intact monolayers were washed three times with 2ml PBS to remove serum. 
Streptococcal stock cultures in MEM and glycerol were pre-incubated at 37°C for 
1 hour, and aliquots (1mL) were added to each well of 6-well plates containing 
confluent monolayers at a multiplicity of infection (MOI) of 100 (5 x 108 CFU/well). 
Streptococci in co-culture with their respective epithelial cell line in MEM were 
incubated for 2.5 hours at 37°C in 5% CO2. Associated (non-adherent) 
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streptococci were harvested from the monolayer wells by aspiration.  One PBS 
wash (1ml volume) was performed to ensure collection of all associated bacteria.  
 
3.17 RNA isolation. Streptococci from the pharyngeal association assays were 
washed twice in PBS, resuspended in 0.1X TE (pH 6.0), and flash frozen in a 
bath of ethanol and dry ice.  Bacteria were lysed with the amidase enzyme lysin 
PlyC (Fischetti 1971, Nelson 2001).  Lysin was added to the bacterial samples 
(2U/108 cfu) and incubated for 1 minute at room temperature, which was 
determined to be optimum for complete streptococcal lysis in preliminary 
experiments.  RNA was isolated immediately after lysis with a modified phenol-
chloroform protocol, as described previously (Juncosa 2012), substituting acid 
phenol (Invitrogen) to reduce genomic DNA contamination.   
RNA was digested with DNase I (TURBO DNA-free, Invitrogen).  Removal 
of contaminating genomic DNA was confirmed by the absence of any PCR 
product using ethidium-bromide gel visualization following 40 cycles of PCR.  
Primers specific for the ORF spy0930 were used as this gene was previously 
reported in our laboratory to be constitutively expressed in the host cell 
environment (unpublished observations).  RNA quantity was determined with the 
NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE), and 
RNA quality was assessed with the Nucleic Acid Bioanalyzer 2100 (Agilent 
Tech., Palo Alto, CA).  
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3.18 Synthesis of cDNA and labeling. DNase-treated streptococcal total RNA 
(2.5 μg) was reverse transcribed using the Superscript Indirect cDNA Labeling 
System (Invitrogen).  Random hexamers (Invitrogen) primed the reverse 
transcription reaction that incorporated a 5-(3-aminoallyl)-dUTP into the first 
synthesized cDNA strand.  cDNAs from experimental streptococci and control 
streptococci were indirectly labeled with the N-hydroxysuccinimide activated 
fluorescent dyes cyanine 3 (Cy3) and cyanine 5 (Cy5), respectively, as outlined 
in the Superscript kit.  Amersham CyDyes were purchased for this use from GE 
Healthcare Life Sciences (Piscataway, NJ).  Labeled cDNA samples were 
purified following Superscript kit instructions.  cDNA yield and dye incorporation 
rates were assessed using the NanoDrop 1000 spectrophotometer to ensure 
high-quality labeled probes. 
 
3.19 Microarray hybridization and image acquisition. Biological replicate 
experiments incorporating dye swaps were performed to account for both 
biological and technical variability (Yang & Speed 2002).  To determine 
transcriptional differences between streptococci co-cultured with human 
pharyngeal versus tonsillar epithelial cells, eight biological replicate experiments 
were prepared for both Detroit 562 and UT-SCC-60B cell lines. For microarray 
analysis, 4 replicates for each data set were labeled in the standard dye 
orientation, and 4 replicates were labeled in the flip orientation (total of 16 
separate hybridizations).   
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Microarray slides were blocked with a prehybridization solution containing 
10 mg/ml bovine serum albumin (Sigma).  Labeled cDNA samples were 
hybridized to the arrays under standard glass microscope coverslips in a 
hybridization buffer containing 50% deionized formamide (Sigma), 10X SSC, and 
0.2% SDS for 16 h at 55°C in a stationary hybridization oven.  Slides were 
washed with agitation as follows:  one wash with 0.2X SSC, 0.1% SDS at 55C 
for 15 minutes and two washes with 0.1X SSC at room temperature for 15 
minutes.   
Slides were dried via centrifugation (1000 rpm, 3 minutes) and then 
scanned with the Agilent High-Resolution C Microarray Scanner (Agilent 
Technologies, Santa Clara, CA) at 5 μm per pixel resolution. The resulting 
images were processed using the GenePix Pro program (version 4.0, Axon, 
Union City, CA).  
 
3.20 Data filtering, normalization, statistical significance analysis, and 
calculation of P values for individual genes Following image analysis, low 
level processing of microarray data included probe and array quality filtering to 
remove probes that were saturated, displayed a low signal to noise ratio, and/or 
produced signal in only one dye channel. Lowess standardization was performed 
for data normalization, and a modified t-test (based on CyberT software) was 
implemented to calculate a P value of the log2-fold change (expression ratio in 
the experimental sample to the appropriate control) for each gene, as previously 
described (Ryan 2007).   
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The t-test statistics and P values generated in this analysis were used to 
rank genes undergoing statistically significant changes in expression (P < 0.05) 
during association with UT-SCC-60B tonsil as compared to Detroit 562 
monolayers in MEM.   
No cutoff values were set for the magnitude of the expression change 
necessary to be included in the set of genes undergoing statistically significant 
fold changes.  Although researchers often disregard expression changes that are 
less than 2-fold (log2 value of 1) between the experimental and control 
conditions, gene expression changes as low as 1.5-fold (log2 value of 0.6) have 
been demonstrated to be physiologically relevant (Hughes 2000). 
The GenomeCrawler algorithm, written in the statistical language R 
(http://www.R-project.org), stepped through the expression date and identified 
adjacent gene grouping s that exhibited similar expression fold changes. The 
algorithm then calculated statistical significance of all putative resulting neighbor 
clusters using a permutation algorithm with the sum of the t-test statistics 
(generated by Cyber-T) from each gene within a given cluster as the metric for 
comparison. The output was then inspected visually and groupings were 
disqualified that violate the neighbor cluster definition based on established 
guidelines for functionally coupled gene pairs: (1) genes occur on the same DNA 
strand and (2) adjacent genes are separated by ≤300 bp.  
Since a specified gene could be a member of many different clusters, only 
the cluster that generated the lowest PK value < 0.05 and met all of the defined 
conditions of a neighbor cluster (as detailed in the text) was reported. The 
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GenomeSpyer algorithm, also written in R, provides a method to view the 
GenomeCrawler output and to visualize clusters and their respective gene 
members (Ryan 2007).   
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§4.0 CULTIVATION AND CHARACTERIZATION OF HUMAN PALATINE 
TONSIL-DERIVED EPITEHELIAL CELLS 
 
4.1.0 Introduction: 
 
Epithelial cell monolayers remain the standard in vivo model of pharyngitis for the 
study of basic pathology and mechanisms for infection. Group A Streptococci 
strains belonging to emm pattern groups A-C are referred to as “throat 
specialists”, as epidemiologic evidence demonstrate their collective predilection 
for this specific ecologic niche (Bessen 2009).  
 
4.1.1 Relevant clinical anatomy at times incongruent with cell type of 
convenience 
As the throat specialists GrAS strains come in contact with oramucosa, they must 
come in contact and may even adhere to surface along the way. Indeed, it has 
been reported that S. pyogenes can be found to bind buccal, tongue and other 
non-tonsillar surfaces in vivo (Ellen1974).  Clinically, however, the sites of typical 
streptococcal disease during acute infection tend to occur posterior to the hard 
palate within the pharynx. Thus, clinically informed in vitro models should reflect 
disease pathology with anatomic context. For instance, A549 cells are derived 
from carcinomatous tissue of human alveoli (Lieber 1976), and have been used 
in numerous studies modeling GrAS infections of the oropharynx despite it not 
being an anatomic site that is normally colonized by this bacterium outside the 
the extraordinary rare cases of S. pyogenes pneumonia. Furthermore, most 
cases of GrAS pneumonia are not associated with concurrent or recent 
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pharyngitis infections, drawing into question sebseqent conjecture regarding 
oropharyngeal disease processes from these cells (Barnham 1999). 
 
Another important example of an existing epithelial monolayer model that has 
been revisited recently is the commonly utilized HEp-2 cells to model laryngeal 
disease. Despite previous reports, this line was not derived from an epidermoid 
carcinoma of the larynx, but rather originated from a HeLa cell contamination 
[American Type Culture Collection (ATCC) website: http://www.atcc.org] (Abbot 
2007). Additionally, many cell lines in common use for in vitro studies contain an 
undefined set of mutations and chromosomal abnormalities of undetermined 
effect on cell physiologic properties.  
 
Detroit 562 is a permanent heteroploid human cell line that is similar to HeLa and 
other heteroploid cell lines in morphology, growth, and virus infectibility (Peterson 
1971). The cell line was derived from a metastatic pleural lesion of an adult 
female with nasopharyngeal carcinoma (Brock 2002).  It differs from similar 
permanent human cell lines in having G-6-PD type B isozyme (Peterson 1971).  
The Detroit 562 naspharyngeal cell line has been reported to more faithfully 
display the carbohydrate epitopes, however, which are more representative of 
the native nasopharyngeal cell than certain other transformed cell lines (Ryan 
2001). The well characterized nature of this cell type, along with it’s relative 
proximity to the normal site of clinically observed pharyngotonsillitis has made 
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the Detroit 562 an attractive cell line to model GrAS pathogenesis (Bartelt 1978, 
Ryan 2001, Pancholi 2003).  
 
The extent to which the in vivo microenvironment can be reproduced in vitro may 
likely be of particular importance when modeling tissue-tropic or niche specific 
disease processes. There are currently no “commercially” available immortalized 
tonsil epithelial cell lines.  
 
4.1.2 UT-SCC-60A / B Epithelial Cell Lines  
Palatine tonsil squamous cell carcinoma tumor explants were recently dissected 
and cultivated from a 59 year old male patient in Finland who presented with 
stage IV primary disease to Dr. Reidar Grenman and colleagues from the 
Department of Otolaryngology and Medical Biochemistry at the University of 
Turku (Turku, Finland). A cell line was established using a technique whereby 
malignant outgrowing epithelial cells were harvested from 1 x 1 mm tissue 
explants attached to tissue culture flasks in DMEM supplemented with NEAA, 
FBS and antibiotics as previously described (Grenman 1992). The resulting cells 
were designated University of Turku Squamous Cell Carcinoma line 60A (UT-
SCC-60A). The same patient donor had a metachronous tumor (relative to the 
primary) 3 months later following the onset of radiation treatment. This well-
differentiated secondary tumor was surgically resected from the patient’s neck 
lymph node, also underwent subsequent culturing, and is designated UT-SCC-
60B. The UT-SCC-60B cell line exhibited a loss of heterozygosity in an allele on 
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chromosome arm 18, which has been hypothesized as a common marker for 
growth regulation and enhanced cancer cell survivor in head and neck malignant 
disease (Takebayashi 2004). Pries and colleagues further noted a constitutive 
expression of CD44 on the cell surface of these cells as they noted of nearly all 
head and neck cancers reviewed in their study to differences between tumor 
lines and non-malignant epithelia (Pries 2008).  
 
 
4.1.3 Tumor derived cell lines and Toll-Like Receptors expression  
Lange et al demonstrated that UT-SCC-60A and UT-SCC-60B cell lines are 
similar to primary tonsil epithelial cells in Toll Like Receptor (TLR) expression. Of 
note, while primary and UT-SCC-60A/B lines all express mRNA for TLR and 
TLR-4, neither the primary or UT-SCC-60A cells were observed to actually 
exhibit TLR2 protein expression. UT-SCC-60B, however, was found to produce 
TLR2 protein following Poly I:C stimulation (Lange 2009). UT-SCC-60B’s 
inducibility is significant as TLR-2 has been previously shown to mediate 
intracellular NF-KB activation in epithelial cells following stimulation by soluble 
peptidoglycan and lipoteichoic acid derived from oral pathogens like gram-
positive streptococci (Schwandner 1999). M-protein is also recognized by TLR-2, 
which has been shown by oral epithelia. TLR-2 is also detected on the surface of 
resting Detroit 562 cells and can be further induced to increased expression after 
stimulation with IFN-γ (Eliasson 2007).  
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Relatively few protocols are available in the literature from investigators who 
have attempted to recreate the heterogeneous palatine tonsil epithelial cell 
population in vitro (Cue 2000, Pegtal 2004, Maher 2005, Abbot 2007).  The 
heterogeneity in vivo was underscored by visual inspection of tonsillar epithelium 
as reported by Clark et al (Clark 2000). They observed localized irregularities, 
including lymphocyte invasion of the stratified squamous epithelium covering the 
external surface of the palatine tonsil in 10 of 11 randomly selected tonsils. 
Furthermore, in examining tonsil pieces by SEM, they recognized abrupt 
transition in the topographical structure of the surface. One shortcoming of many 
early primary tonsil epithelial cell culturing protocols is the potential mesenchymal 
influence that may inform the differentiating of epithelial cells to be representative 
of the in vivo heterogeneity (Pegtal 2004),  
 
Work on protocols for harvesting and culturing epithelial cells from human 
palatine tonsils continues to be necessary given the growing evidence for the 
niche specificity of pathogenesis (Wannamaker 1970, Bessen 2010, Bessen 
2011).  Developing a standardized method becomes further complicated by the 
variety of tonsillectomy procedural techniques, which can alter the quality of 
organ samples.  
 
In this chapter, four pharyngo-tonsillar epithelial cell monolayers are described 
and compared for the purpose of contributing to the existing repertoire of in vitro 
model systems for tonsillitis. A cell culturing method was implemented to isolate 
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and culture human primary tonsil epithelial cells (HPTEC) from fresh human 
palatine tonsil specimens. The HPTEC culture method utilized a staged strategy, 
employing both serum-containing and serum-free media to preferentially 
stimulate epithelial growth while mitigating contamination by fibroblast and 
lymphoid organ-associated immune cell types. Preliminary comparative 
characterization studies include visualizing relative cellular morphology, 
confirming epithelial nature of cell cultures, identifying surface expression of a 
known binging receptor, and gross comparison of surface protein banding 
patterns on gel electrophoresis.  
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4.2 Results:  
 
4.2.1Human primary epithelial (HPTE) cell cultivation 
 
Human primary tonsil epithelial cells were cultivated from fresh clinical patient 
samples post-tonsillectomy. Patients ranged in age and disease indication for the 
surgical procedure, although the majority (>90%) of the de-identified patient 
reports list hypertrophy and disordered breathing (i.e., Obstructive Sleep Apnea) 
as the primary complaint. Using a three-phase primary culturing system switching 
between serum-containing and serum-free media, primary epithelial cell 
populations were proliferated outwards from the edges of tonsil tissue explants. 
 
At approximately 15-18 days after receiving the tonsil, the epithelial cells usually 
will have expanded adequately, such that the cells can be split and cultured into 
new tissue flasks or petri dishes. The stability of our attained monolayer was not 
as robust as reported by other researchers creating primary epithelial cell 
systems (Ropke 1997, Pegtal 2004), exhibiting stability only up to a maximum of 
3 – 4 trypsin treatments before significant apoptosis would ensue as observed by 
light microscopy and cell viability staining (not shown).   
 
In general, epithelial cells spread out from the tonsil explants as a carpet mainly 
consisting of flattened cells. The resulting cell populations were often not 
homogeneous in shape and size. As has been reported, it was typical to see both 
small (10-20µm) and large (20-100µm) cells from the start of the culture. 
Additionally, cytoplasmic extensions were frequently observed between adjacent 
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cells (Figure 4.1F). Previous researchers have linked this morphologic 
presentation in ex vivo tonsil cultures to the secretion of lymphokines and 
mediators from infiltrating lymphocytes. Perry et al purports that secretions are 
made that may induce neighboring epithelium to undergo changes specifically in 
cytokeratin expression (Perry 1998). Whether cytokeratin-mediated 
rearrangements or by some other mechanisms, a subpopulation of the stratified 
squamous epithelia in the tonsil appears to undergo this unique morphologic 
transition of undetermined purpose. Based on a similar protocol and their 
observations, Pegtal et al suggested that by virtue of the achieved proliferative 
cells stemming from tissue explants, these tonsil epithelial cells are likely to be 
derived from the basal epithelial layer and/or tonsillar reticulated epithelium 
(Pegtal 2004). 
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Figure 4.1 Human Primary Tonsil Epitheliium 
A-F Light photomicrograph of tissue explants (T) on Day 7 post tonsillectomy. A. 
“Low” magnification (10X objective) view of tonsil explant surrounded by outgrowth of 
migrating epithelial cells. B-E. “High” magnification (25X objective) view of adherent 
primary epithelial cells. F. Image E was digitally zoomed an additional x4 on area 
demarcated in E by white box. White arrow indicates a representative cytoplasmic 
extension  
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4.2.2 Comparative light microscopy of confluent monolayers 
 
Epithelial cell monolayers could be distinguished based on morphology by visual 
inspection using microscopy. The Detroit 562 and the UT-SCC-60B cells appear 
similar in size when visualized as a confluent monolayer on a tissue culture flask.  
When compared with UT-SCC-60A and HPTE cells, the Detriot 562 and UT-
SCC-60B cells are smaller.  Notably, the cultured UT-SCC-60B cells grow with a 
distinctly dichotomous morphologic distribution throughout the monolayer. Soon 
after seeding these cells to ~40% confluence, patches of cells quickly adhere to 
the tissue culture surface and assume a flattened morphology. As the remaining 
“late” cells in suspension settle to fill in the patches, their adherent morphology 
assume a more columnar shape on visual inspection. The appearance of these 
“early” adhering patches seems independent of their starting cell concentration. 
To test this, wells were seeded heavily. While the size of the gaps between 
patches declined, excess cells tended to grow on top of one another at the 
patches rather than necessarily filling open areas remaining on the flask surface 
(not shown). No obvious differences were detected in cytokeratin expression (or 
in any of the other markers) stained for in our study between the “early” adhering 
flat cells and columnar “late” cells. This growth pattern was UT-SCC-60B-specific 
as it was not observed in the UT-SCC-60A monolayer.  
 
Since the UT-SCC-60A tumor line was originally cultivated from a tissue explant 
taken from the primary site of the squamous cell palatine tonsillar cancer, soon 
after diagnosis (and in advance of chemotherapeutic treatments), there is likely 
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significant similarities between this and our cultured HPTC. By extension, it may 
not be surprising that similar characteristics are shared between these cells in 
culture. The relative size similarities between the lines were additionally relevant 
when determining the multiplicity of infection calculations for our in vitro studies. 
Detroit 562 and UT-SCC-60B monolayers both reached 100% confluency on 
Falcon 24-well plates at ~ 1.2 x 106 cells / well, while UT-SCC-60A and HPTEC 
reached confluence at ~2.8 x 105 cells / well and ~1.1 x 105 cell / well, 
respectively. 
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Figur4.2. Morphology of human oropharyngeal epithelial cells as a monolayer 
Phase contrast microscopy images of non-fixed (A) Detroit 562, (B) UT-SCC-60A, (C) UT-SCC-
60B, and (D) Human Primary Tonsil Epithelial Cell [HPTE] monolayers. Cells were grown to 
~95% confluence as previously described (see methods). Images taken at original 
magnification 100X.  
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4.2.3 Immunofluorescence staining for epithelial and fibroblast markers 
 
In order to verify tonsil derived cell cultures were free of non-epithelial cell types, 
Immunofluorescence (IF) staining for epithelial (pankeratin, keratins 8 [K8], K18, 
and K19) and fibroblast (vimentin) markers was performed on Detroit 562, UT-
SCC-60A, UT-SCC-60B, and HPTEC lines. Tonsil epithelium is comprised of 
stratified surface and reticulated crypt epithelia. Clark et al determined pan-
epithelial tonsil markers and demonstrated that surface and reticular crypt 
epithelia may be differentiated by the expression of particular cytokeratins. Their 
in situ staining of tonsil epithelium demonstrated expression of the simple 
epithelial keratins K8 and K18 were mostly limited to the crypt epithelial cells, 
along with K19 (Clark 2000). Pancytokeratins represent a much broader staining 
pattern that captures numerous cytokeratin markers for both simple keratins 
(including K8/18) as well as complex. In this this study, variable pankeratin, K8, 
K18, and K19 (not shown) expression was detected in the HPTE and UT-SCC-
60A, UT-SCC-60B monolayers. Interestingly, the Detroit 562 cells stained 
uniformly across the monolayer for the simple epithelial markers, likely indicative 
of cell type homogeneity. In contrast, the HPTEC cells were more heterogeneous 
with some cells staining significantly brighter than neighboring cells. This was 
less true for UT-SCC-60B cells, which suggests the presence of subpopulations 
of cells, which may be of crypt epithelial lineage (in appendix A4.1) (Table 4.1).  
A non-epithelial cell type of monocyte lineage was used as a negative control 
and demonstrated the appearance of no keratin staining.  
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Table 4.1 Summary of Epithelial Cell Markers from ImmunoFluorescence Studies 
 Cell Marker 
Epithelial Cell 
Type 
K8 / K18 K19 Pan-Keratin Vimentin  
Detroit 562 XXX XXX XXX 0 
UT-SCC-60A XXX XXX XXX 0 
UT-SCC-60B XXX XXX XX 0 
HPTE XX / XXX XXX XXX 0 / X 
XXX – highly expressing marker 
XX – mildly expressing marker 
X – lighty expressing marker  
0 – Not expressing marker 
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4.2.4 Secreted metabolites by human epithelial monolayers 
As with all living cells, the epithelial surfaces of human tissue require nutrients for 
energy production during growth and maintenance of homeostasis. Adherent cell 
types grown in vitro as a model of tissue undergo periods of enhanced 
proliferation soon after being passaged to artificially stimulate cell turnover using 
enzymes to detach them from specially treated plastic or glass to then be re-
“seeded” at sub-confluent concentrations. Cells become increasingly crowded 
until complete monolayer confluence is reached. Environmental limitations such 
as nutrients and dissolved oxygen will decrease the rate of expansion until finally 
reaching a state of senescence. The senescent cell phenotype is characterized 
by a decrease in cellular energy expenditure and subsequent metabolite 
production. The tonsil epithelial surface in vivo is constantly undergoing cell 
turnover, since this site is subject to injury by inhaling antigens.  This is a 
consequence of its anatomic placement at the isthmus of the digestive and upper 
respiratory tracts.  Given the dynamic state of tonsil epithelium in vivo, we have 
designed an in vitro model physiologically reflective of mostly senescent cells 
with an allowed subpopulation undergoing proliferative growth (~90% 
confluence). Using this model, we sought to perform a liquid chromatography 
mass spectrometry (LC/MS)-based metabolomic investigation (Siuzdak 2005) to 
compare the intrinsic differences in metabolite production between our 
experimental human pharyngeal epithelial monolayers under pre-infection 
conditions. Our lab has previously shown how sensing pharyngeal cell soluble 
factors that are secreted into the mileu may augment bacterial pathogenesis 
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(Broudy 2001). This screen aimed to establish a baseline for any such 
differences, which may direct future characterization efforts.  
Fresh DMEM was applied to Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE 
cell monolayers and was collected following 3h of unstimulated, bacteria-free, co-
culture. The supernatant from each cell line was then extracted with 
chloroform:methanol (7:3) and the crude extract was analyzed by LC/MS.  The 
LC/MS analysis of the crude extracts revealed few differences between the four 
tested cell lines and the experimental background when compared to fresh 
media. Not seeing differences between the cells lines and control media 
suggests that either the performed LC/MS experiment was not sensitive enough 
to detect the low titer metabolites produced by cells or that the relatively clean 
chloroform:methanol extraction does not accurately represent the entire 
metabolome of the cell line.  However, two peaks at 789.03 and 703.87 m/z were 
observed in the HPTE crude extract that were not seen in the extracts of the 
other cells lines (Figure 4.3).  
To further interrogate the identity of these putative metabolites differentially 
produced by our primary tonsil epithelia, we performed a preliminary search of 
the Human Metabolome Database, HMDB (available at www.hmbd.ca) (Wishart 
2009.  Briefly, the HMDB is designed as a comprehensive, web-accessible 
metabolomics database that brings together quantitative chemical, physical, 
clinical and biological data about 7,900 experimentally ‘proven’ or experimentally 
detected human metabolites. Inputting our spectra informed measurements on 
molecular weight (789.03 +/- 0.5 m/z) (Table 4.2) yielded 210 matches where 
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80% were either glycerophospholipids (138/210) or diglycerides (22/210). After 
ruling out unlikely ionization adducts and Diguanosine triphosphate, which is 
likely too polar to be consistent with the observed hydrophobic retention time, the 
remaining compounds in the search queue were glycerophospholipids. A 
hydrophobic glycerophospholipid or diglyceride compound would be consistent 
with the retention time of the 789.03 m/z peak. A diglyceride structure, as 
suggested from a similar speculative HMDB search, would be consistent with the 
more polar retention time of the 703.87 m/z peak. Phospholipids are ubiquitous in 
cells and are key components of the lipid bilayer of cells. They are also available 
to be metabolized as an energy source or as well as signaling intermediates. 
Diacylglycerols are precursors to triglyceride and, biochemically, function as a 
2nd messenger-signaling lipid that directly activates protein kinase C during 
numerous intracellular signaling pathways.  
While particularly crude and speculative, these results demonstrate the potential 
for differences in metabolites excreted into the conditioned media between our 
cell lines. For the HPTE monolayer, these differences appear most prominently in 
liberated lipid products. This finding may have some implications on 
streptococcal colonization, however, as was observed by Ellen and Gibbson in 
1974. Using a throat isolated, M type 12 reference strain STAT628, they noted a 
relative increase in adherence to oral epithelium by 9% and 25%, respectively, 
after adding 80µl phosphatidyl serine or phosphatidyl ethanolamine to bacterial 
suspension (Ellen 1974). A role relating free phospholipids to virulence or 
persistence at the tonsil has not been previously established, however, so our 
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“interesting” putative metabolite hit will require much greater context to have 
meaning, if any.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Conditioned “spent” media from primary epithelial cells exhibit unique 
metabolite production.   Detroit 562, UT-SCC-60A, UT-SCC-60B and HPTE cells 
were grown to near 90% confluency, and subsequently co-cultured with fresh 
MEM media for 3h. Crude extraction by a chloroform methanol precipitation was 
performed and analyzed by Liquid Chromatography and Mass Spectrometry. 
Peak of interest at 789.03 m/z circled on bottom panel.  
Note: 2nd Peak at 703 m/z NOT SHOWN  
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HMDB ID Common Name Chemical Formula 
Adduct MW 
(Da) 
[Matching 
HMDB MW]  
MW Difference (Da) 
/ [QueryMass - 
AdductMass] 
Adduct 
HMDB01379 Diguanosine triphosphate C20H27N10O18P3 
789.079041 
[788.071777] 0.049011 M+H [1+] 
HMDB09741 PE(24:0/P-16:0) C45H90NO7P 
788.652771 
[787.645508] 0.377258 M+H [1+] 
HMDB09511 PE(22:0/P-18:0) C45H90NO7P 
788.652771 
[787.645508] 0.377258 M+H [1+] 
HMDB11388 PE(P-18:0/22:0) C45H90NO7P 
788.652771 
[787.645508] 0.377258 M+H [1+] 
HMDB11362 PE(P-16:0/24:0) C45H90NO7P 
788.652771 
[787.645508] 0.377258 M+H [1+] 
HMDB08266 PC(20:0/16:1(9Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08102 PC(18:1(9Z)/18:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08069 PC(18:1(11Z)/18:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08038 PC(18:0/18:1(9Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08037 PC(18:0/18:1(11Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08010 PC(16:1(9Z)/20:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB09747 PE(24:1(15Z)/15:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08915 PE(15:0/24:1(15Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08558 PC(22:1(13Z)/14:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08526 PC(22:0/14:1(9Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB07978 PC(16:0/20:1(11Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB07919 PC(14:1(9Z)/22:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB07887 PC(14:0/22:1(13Z)) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB08298 PC(20:1(11Z)/16:0) C44H86NO8P 
788.616394 
[787.609131] 0.413635 M+H [1+] 
HMDB12400 PS(18:2(9Z,12Z)/18:0) C42H78NO10P 
788.543579 
[787.536316] 0.48645 M+H [1+] 
HMDB12390 PS(18:1(9Z)/18:1(9Z)) C42H78NO10P 
788.543579 
[787.536316] 0.48645 M+H [1+] 
HMDB12380 PS(18:0/18:2(9Z,12Z)) C42H78NO10P 
788.543579 
[787.536316] 0.48645 M+H [1+] 
HMDB11933 Ganglioside GQ1c (d18:0/14:0) C103H177N5O55 
789.047485 
[2364.120605] 0.017456 M+3H [3+] 
HMDB10243 
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(9Z)/18:1(9Z)) C81H146O17P2 
789.048889 
[1453.003540] 0.01886 M+3ACN+2H [2+] 
HMDB10242 
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(9Z)/18:1(11Z)) C81H146O17P2 
789.048889 
[1453.003540] 0.01886 M+3ACN+2H [2+] 
HMDB10239 
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(11Z)/18:1(9Z)) C81H146O17P2 
789.048889 
[1453.003540] 0.01886 M+3ACN+2H [2+] 
HMDB10238 
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:
1(11Z)/18:1(11Z)) C81H146O17P2 
789.048889 
[1453.003540] 0.01886 M+3ACN+2H [2+] 
Table 4.2. Summary of preliminary metabolite profile potential biomarkers based on 
molecular weight   
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HMDB00217 NADP C21H29N7O17P3 
789.054443 
[744.083252] 0.024414 M+2Na-H [1+] 
HMDB11912 Ganglioside GM2 (d18:1/23:0) C73H132N2O26 
789.000549 
[1452.906860] 0.02948 M+3ACN+2H [2+] 
HMDB04943 
Ganglioside GM2 
(d18:1/26:1(17Z)) C75H135N3O26 
789.000488 
[1493.933350] 0.029541 M+2ACN+2H [2+] 
HMDB04917 
Ganglioside GD3 
(d18:1/24:1(15Z)) C76H135N3O29 
788.957275 
[1553.918091] 0.072754 M+H+Na [2+] 
HMDB11867 
Ganglioside GD3 
(d18:0/24:1(15Z)) C76H135N3O29 
788.957275 
[1553.918091] 0.072754 M+H+Na [2+] 
HMDB01155 Diadenosine triphosphate C20H27N10O16P3 
789.115417 
[756.081909] 0.085388 M+CH3OH+H [1+] 
HMDB05017 Pantoprazole C16H15F2N3O4S 
789.139465 
[383.075134] 0.109436 2M+Na [1+] 
HMDB00912 Succinyladenosine C14H17N5O8 
789.204651 
[383.107727] 0.174622 2M+Na [1+] 
HMDB06583 Poly-N-acetyllactosamine C14H25NO11 
789.274719 
[383.142761] 0.24469 2M+Na [1+] 
HMDB06575 Lacto-N-biose I C14H25NO11 
789.274719 
[383.142761] 0.24469 2M+Na [1+] 
HMDB06535 
Beta-1,4-mannose-N-
acetylglucosamine C14H25NO11 
789.274719 
[383.142761] 0.24469 2M+Na [1+] 
HMDB01542 N-Acetyllactosamine C14H25NO11 
789.274719 
[383.142761] 0.24469 2M+Na [1+] 
HMDB05021 Quetiapine C21H25N3O2S 
789.322693 
[383.166748] 0.292664 2M+Na [1+] 
HMDB12214 Dihydrozeatin-O-glucoside C16H25N5O6 
789.350159 
[383.180481] 0.320129 2M+Na [1+] 
HMDB12213 Dihydrozeatin-9-N-glucoside C16H25N5O6 
789.350159 
[383.180481] 0.320129 2M+Na [1+] 
HMDB12211 Dihydrozeatin-7-N-dihydrozeatin C16H25N5O6 
789.350159 
[383.180481] 0.320129 2M+Na [1+] 
HMDB06737 CE(22:2(13Z,16Z)) C49H84O2 
788.702271 
[704.647156] 0.327759 
M+IsoProp+Na+H 
[1+] 
HMDB07799 DG(24:0/18:2(9Z,12Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07658 DG(22:2(13Z,16Z)/20:0/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07630 DG(22:1(13Z)/20:1(11Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07602 DG(22:0/20:2(11Z,14Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07434 DG(20:2(11Z,14Z)/22:0/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07406 DG(20:1(11Z)/22:1(13Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07378 DG(20:0/22:2(13Z,16Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07267 DG(18:2(9Z,12Z)/24:0/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07239 DG(18:1(9Z)/24:1(15Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07210 DG(18:1(11Z)/24:1(15Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07827 DG(24:1(15Z)/18:1(9Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB07826 DG(24:1(15Z)/18:1(11Z)/0:0) C45H84O5 
788.687012 
[704.631897] 0.343018 
M+IsoProp+Na+H 
[1+] 
HMDB12638 20-hydroxy-E4-neuroprostane C22H31O5 
789.397461 
[375.217163] 0.367432 2M+K [1+] 
HMDB12601 17-hydroxy-E4-neuroprostane C22H31O5 
789.397461 
[375.217163] 0.367432 2M+K [1+] 
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HMDB12580 14-hydroxy-E4-neuroprostane C22H31O5 
789.397461 
[375.217163] 0.367432 2M+K [1+] 
HMDB12855 7-hydroxy-D4-neuroprostane C22H31O5 
789.397461 
[375.217163] 0.367432 2M+K [1+] 
HMDB12777 4-hydroxy-D4-neuroprostane C22H31O5 
789.397461 
[375.217163] 0.367432 2M+K [1+] 
HMDB04972 Glucosylceramide (d18:1/18:0) C42H81NO8 
788.661499 
[727.596191] 0.36853 M+IsoProp+H [1+] 
HMDB10709 Galactosylceramide (d18:1/18:0)  C42H81NO8 
788.661499 
[727.596191] 0.36853 M+IsoProp+H [1+] 
HMDB04973 Glucosylceramide (d18:1/20:0) C44H85NO8 
788.661011 
[755.627502] 0.369019 M+CH3OH+H [1+] 
HMDB10710 Galactosylceramide (d18:1/20:0)  C44H85NO8 
788.661011 
[755.627502] 0.369019 M+CH3OH+H [1+] 
HMDB12643 20-Trihydroxy-leukotriene-B4 C20H31O7 
789.403137 
[383.206970] 0.373108 2M+Na [1+] 
HMDB10705 CerP(d18:1/24:1(15Z)) C42H82NO6P 
788.653320 
[727.587952] 0.376709 M+IsoProp+H [1+] 
HMDB10168 SM(d18:0/16:0) C39H82N2O6P 
788.651428 
[705.591064] 0.378601 M+2ACN+H [1+] 
HMDB07788 
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/
22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) C47H68O5 
789.425659 
[712.506653] 0.39563 M+2K+H [1+] 
HMDB09312 PE(20:2(11Z,14Z)/P-16:0) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11441 PE(P-18:1(9Z)/18:1(9Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11440 PE(P-18:1(9Z)/18:1(11Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09115 PE(18:2(9Z,12Z)/P-18:0) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11408 PE(P-18:1(11Z)/18:1(9Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11407 PE(P-18:1(11Z)/18:1(11Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09084 PE(18:1(9Z)/P-18:1(9Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09083 PE(18:1(9Z)/P-18:1(11Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11376 PE(P-18:0/18:2(9Z,12Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09051 PE(18:1(11Z)/P-18:1(9Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09050 PE(18:1(11Z)/P-18:1(11Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB11349 PE(P-16:0/20:2(11Z,14Z)) C41H78NO7P 
788.616943 
[727.551575] 0.413086 M+IsoProp+H [1+] 
HMDB09576 PE(22:2(13Z,16Z)/P-16:0) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB09313 PE(20:2(11Z,14Z)/P-18:0) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB09282 PE(20:1(11Z)/P-18:1(9Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB09281 PE(20:1(11Z)/P-18:1(11Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB11447 PE(P-18:1(9Z)/20:1(11Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB11414 PE(P-18:1(11Z)/20:1(11Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB11382 PE(P-18:0/20:2(11Z,14Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
HMDB11357 PE(P-16:0/22:2(13Z,16Z)) C43H82NO7P 
788.616394 
[755.582886] 0.413635 M+CH3OH+H [1+] 
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HMDB07782 
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/
22:0/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07754 
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:
1(13Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07725 
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1
(13Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07697 
DG(22:4(7Z,10Z,13Z,16Z)/22:2(13
Z,16Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07669 
DG(22:2(13Z,16Z)/22:4(7Z,10Z,13
Z,16Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07642 
DG(22:1(13Z)/22:5(7Z,10Z,13Z,16
Z,19Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07641 
DG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z
,16Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07614 
DG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,
19Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07587 
DG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1
(15Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB07839 
DG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z
,17Z)/0:0) C47H80O5 
788.616333 
[724.600586] 0.413696 M+ACN+Na [1+] 
HMDB11577 MG(20:3(8Z,11Z,14Z)/0:0/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB11576 MG(20:3(5Z,8Z,11Z)/0:0/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB11575 MG(20:3(11Z,14Z,17Z)/0:0/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB11547 MG(0:0/20:3(8Z,11Z,14Z)/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB11546 MG(0:0/20:3(5Z,8Z,11Z)/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB11545 MG(0:0/20:3(11Z,14Z,17Z)/0:0) C23H40O4 
788.608459 
[380.292664] 0.42157 
2M+3H2O+2H 
[2+] 
HMDB13330 
3-Hydroxy-cis-5-
tetradecenoylcarnitine C21H39NO5 
788.599487 
[385.282837] 0.430542 2M+NH4 [1+] 
HMDB00770 N-Glycoloylganglioside GM2 C43H85NO8 
788.598633 
[743.627502] 0.431396 M+2Na-H [1+] 
HMDB10577 PG(16:0/18:3(9Z,12Z,15Z)) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10576 PG(16:0/18:3(6Z,9Z,12Z)) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10675 PG(18:3(9Z,12Z,15Z)/16:0) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10660 PG(18:3(6Z,9Z,12Z)/16:0) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10646 PG(18:2(9Z,12Z)/16:1(9Z)) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10590 PG(16:1(9Z)/18:2(9Z,12Z)) C40H73O10P 
789.465332 
[744.494141] 0.435303 M+2Na-H [1+] 
HMDB10682 
PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z
,15Z)) C42H71O10P 
789.467651 
[766.478455] 0.437622 M+Na [1+] 
HMDB10681 
PG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,
12Z)) C42H71O10P 
789.467651 
[766.478455] 0.437622 M+Na [1+] 
HMDB10667 
PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,
15Z)) C42H71O10P 
789.467651 
[766.478455] 0.437622 M+Na [1+] 
HMDB10666 
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,1
2Z)) C42H71O10P 
789.467651 
[766.478455] 0.437622 M+Na [1+] 
HMDB10567 PE-NMe(16:0/16:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
HMDB08988 PE(18:0/15:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
HMDB08892 PE(15:0/18:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
  89 
HMDB07965 PC(16:0/14:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
HMDB07934 PC(15:0/15:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
HMDB07869 PC(14:0/16:0) C38H76NO8P 
788.591248 
[705.530884] 0.438782 M+2ACN+H [1+] 
HMDB12868 9'-Carboxy-gamma-chromanol C23H35O4 
789.470215 
[375.253540] 0.440186 2M+K [1+] 
HMDB08196 PC(18:3(9Z,12Z,15Z)/14:0) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB08163 PC(18:3(6Z,9Z,12Z)/14:0) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB08131 PC(18:2(9Z,12Z)/14:1(9Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB08903 PE(15:0/20:3(8Z,11Z,14Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB08902 PE(15:0/20:3(5Z,8Z,11Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB09351 PE(20:3(8Z,11Z,14Z)/15:0) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB09318 PE(20:3(5Z,8Z,11Z)/15:0) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB07907 PC(14:1(9Z)/18:2(9Z,12Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB07876 PC(14:0/18:3(9Z,12Z,15Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB07875 PC(14:0/18:3(6Z,9Z,12Z)) C40H74NO8P 
788.580566 
[727.515198] 0.449463 M+IsoProp+H [1+] 
HMDB08199 PC(18:3(9Z,12Z,15Z)/16:0) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08166 PC(18:3(6Z,9Z,12Z)/16:0) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08134 PC(18:2(9Z,12Z)/16:1(9Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08006 PC(16:1(9Z)/18:2(9Z,12Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB07975 PC(16:0/18:3(9Z,12Z,15Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB07974 PC(16:0/18:3(6Z,9Z,12Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB07913 PC(14:1(9Z)/20:2(11Z,14Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08394 PC(20:3(8Z,11Z,14Z)/14:0) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08361 PC(20:3(5Z,8Z,11Z)/14:0) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08329 PC(20:2(11Z,14Z)/14:1(9Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB07882 PC(14:0/20:3(8Z,11Z,14Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB07881 PC(14:0/20:3(5Z,8Z,11Z)) C42H78NO8P 
788.580017 
[755.546509] 0.450012 M+CH3OH+H [1+] 
HMDB08259 PC(18:4(6Z,9Z,12Z,15Z)/dm18:0) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08228 PC(18:3(9Z,12Z,15Z)/P-18:1(9Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08227 PC(18:3(9Z,12Z,15Z)/P-18:1(11Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08195 PC(18:3(6Z,9Z,12Z)/P-18:1(9Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08194 PC(18:3(6Z,9Z,12Z)/P-18:1(11Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
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HMDB11312 PC(P-18:1(9Z)/18:3(9Z,12Z,15Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11311 PC(P-18:1(9Z)/18:3(6Z,9Z,12Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11279 PC(P-18:1(11Z)/18:3(9Z,12Z,15Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11278 PC(P-18:1(11Z)/18:3(6Z,9Z,12Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11247 PC(P-18:0/18:4(6Z,9Z,12Z,15Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB13415 
PC(o-
16:1(9Z)/20:4(8Z,11Z,14Z,17Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11221 PC(P-16:0/20:4(8Z,11Z,14Z,17Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11220 PC(P-16:0/20:4(5Z,8Z,11Z,14Z)) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08488 PC(20:4(8Z,11Z,14Z,17Z)/P-16:0) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB08455 PC(20:4(5Z,8Z,11Z,14Z)/P-16:0) C44H80NO7P 
788.556458 
[765.567261] 0.473572 M+Na [1+] 
HMDB11154 LPA(P-16:0e/0:0) C19H39O6P 
789.504089 
[394.248413] 0.47406 2M+H [1+] 
HMDB10572 PG(16:0/18:0) C40H79O10P 
789.504211 
[750.541077] 0.474182 M+K [1+] 
HMDB10600 PG(18:0/16:0) C40H79O10P 
789.504211 
[750.541077] 0.474182 M+K [1+] 
HMDB08126 PC(18:1(9Z)/P-16:0) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB08093 PC(18:1(11Z)/P-16:0) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB08028 PC(16:1(9Z)/P-18:0) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11305 PC(P-18:1(9Z)/16:0) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11272 PC(P-18:1(11Z)/16:0) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11240 PC(P-18:0/16:1(9Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11210 PC(P-16:0/18:1(9Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11209 PC(P-16:0/18:1(11Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB07997 PC(16:0/P-18:1(9Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB07996 PC(16:0/P-18:1(11Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11151 PC(O-16:0/18:2(9Z,12Z)) C42H82NO7P 
788.554077 
[743.582886] 0.475952 M+2Na-H [1+] 
HMDB11908 
Ganglioside GM2 
(d18:0/26:1(17Z)) C76H138N2O26 
789.510681 
[1494.953735] 0.480652 M+2ACN+2H [2+] 
HMDB12363 PS(16:1(9Z)/14:0) C36H68NO10P 
789.513184 
[705.458069] 0.483154 
M+IsoProp+Na+H 
[1+] 
HMDB12353 PS(16:0/14:1(9Z)) C36H68NO10P 
789.513184 
[705.458069] 0.483154 
M+IsoProp+Na+H 
[1+] 
HMDB12343 PS(14:1(9Z)/16:0) C36H68NO10P 
789.513184 
[705.458069] 0.483154 
M+IsoProp+Na+H 
[1+] 
HMDB12333 PS(14:0/16:1(9Z)) C36H68NO10P 
789.513184 
[705.458069] 0.483154 
M+IsoProp+Na+H 
[1+] 
HMDB08229 PC(18:4(6Z,9Z,12Z,15Z)/14:0) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB08197 PC(18:3(9Z,12Z,15Z)/14:1(9Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
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HMDB08164 PC(18:3(6Z,9Z,12Z)/14:1(9Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB09417 PE(20:4(8Z,11Z,14Z,17Z)/15:0) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB08905 PE(15:0/20:4(8Z,11Z,14Z,17Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB08904 PE(15:0/20:4(5Z,8Z,11Z,14Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB09384 PE(20:4(5Z,8Z,11Z,14Z)/15:0) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB07909 PC(14:1(9Z)/18:3(9Z,12Z,15Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB07908 PC(14:1(9Z)/18:3(6Z,9Z,12Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB07877 PC(14:0/18:4(6Z,9Z,12Z,15Z)) C40H72NO8P 
789.515320 
[725.499573] 0.485291 M+ACN+Na [1+] 
HMDB10580 PG(16:0/20:4(5Z,8Z,11Z,14Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10575 PG(16:0/18:2(9Z,12Z)) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB10679 PG(18:3(9Z,12Z,15Z)/18:1(9Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10678 PG(18:3(9Z,12Z,15Z)/18:1(11Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10664 PG(18:3(6Z,9Z,12Z)/18:1(9Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10663 PG(18:3(6Z,9Z,12Z)/18:1(11Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10650 PG(18:2(9Z,12Z)/18:2(9Z,12Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10645 PG(18:2(9Z,12Z)/16:0) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB10637 PG(18:1(9Z)/18:3(9Z,12Z,15Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10636 PG(18:1(9Z)/18:3(6Z,9Z,12Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10631 PG(18:1(9Z)/16:1(9Z)) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB10622 PG(18:1(11Z)/18:3(9Z,12Z,15Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10621 PG(18:1(11Z)/18:3(6Z,9Z,12Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10616 PG(18:1(11Z)/16:1(9Z)) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB10594 PG(16:1(9Z)/20:3(8Z,11Z,14Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10593 PG(16:1(9Z)/20:3(5Z,8Z,11Z)) C42H75O10P 
788.543579 
[770.509766] 0.48645 M+NH4 [1+] 
HMDB10589 PG(16:1(9Z)/18:1(9Z)) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB10588 PG(16:1(9Z)/18:1(11Z)) C40H75O10P 
788.543579 
[746.509766] 0.48645 M+ACN+H [1+] 
HMDB13332 
3-Hydroxy-5, 8-
tetradecadiencarnitine C21H37NO5 
789.523560 
[383.267181] 0.49353 2M+Na [1+] 
HMDB02082 Bisnorcholic acid C22H36O5 
788.535706 
[380.256287] 0.494324 
2M+3H2O+2H 
[2+] 
* Glycerophospholipids are highlighted yellow. Diglycerides are highlighted green. 
 
Abbreviations: PC = Phosphatidylcholine, PG = Phosphatidylglycine, PS = Phosphatidylserine,  
DG = Diacylglycerol (Diglyceride) 
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4.3 Discussion: 
 
The specificity of all cell types within the palatine tonsil niche is not yet fully 
understood, functionally or anatomically, as recent studies regularly describe new 
information on the substructure of the lymphoepithelium (Clark 2000), the 
possible existence of M cells (Park 2003), and the production of surface anti-
microbial peptides (Ball 2007, Schwaab 2010). The need for reliable in vitro 
models to model niche-specific disease remains an important impetus to explore 
the utility of primary organ sources and tumor-derived lines. Lange and 
colleagues concluded that their own preliminary characterization of UT-SCC-60A 
and UT-SCC-60B cell lines with respect to Toll-Like receptor expression “justify 
the use of the [UT-SCC-60A and UT-SCC-60B] cell lines as a model system to 
examine…tonsillar epithelial cells” (Lange 2009). 
 
As was recently shown by Pegtal et al using a similar primary cell cultivation 
scheme, we established a reasonably clean population of HPTE using 
commercially available serum-containing and serum-free media supplemented 
with growth factors (Pegtal 2004). In our current study, Detroit 562, UT-SCC-60A, 
UT-SCC-60B, and HPTE cells on visual inspection all stained positive for 
keratins k8, k18, k19 and pankeratin markers but were negative for the fibroblast 
marker, ant-vimentin.  These data suggest that the cultures were principally of 
epithelial lineage (Clark 2000).  
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Most epithelial tissues are complex, and therefore simple keratin protein 
expression may be useful in probing the origin of epithelial cells.  While Clark et 
al described pan-tonsillar markers in their in situ analysis of tonsil biopsies, their 
ascribed specificity for simple keratins to identify crypt cells are likely most 
significant with the support of anatomical orientation and within context of an 
intact tissue. Notably, the same three keratins identified within the tonsil to 
designate crypt cells are also typical of adenocarcinomas, and are present in 
certain other carcinomas (Omary 2009). Non-specificity was seen in our study 
with epithelial monolayers since all keratins tested were present in all of our cell 
types with similar staining intensities as determined solely by visual inspection. 
Detroit 562 cells derived from a nasopharyngeal squamous cell carcinoma do not 
likely contain crypt cell epithelia, so simple keratin distribution may not be the 
most effective means for distinguishing our cell types. Our findings are consistent 
with Weber et al, who in 1984 also verified that Detroit 562 cells expressed 
keratin K8, K18, and K19 in their analysis of the relationship between these 
proteins and a human tumor marker, tissue polypeptide antigen (TPA). Keratin 
distribution differences may, however, provide a crude visual assessment of 
heterogeneity in tonsil-derived epithelial monolayers that thus far remain poorly 
characterized in the literature. A more rigorous analysis of our primary epithelial 
cells versus the Detroit 562 line may be able to better resolve this difference than 
the techniques described above.  
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Challenges and benefits to culturing primary epithelial cells  
 
Several intrinsic challenges exist when relying on human samples, such as  
tissue availability, incomplete medical history, and inter-sample variability.  Our 
IRB-approved protocol did not provide us the ability to further acquire patient 
records to confirm patient history of culture-positive (rather than “suspected”) 
GrAS infection. As the first step of our culturing procedure, tonsil samples were 
immediately placed in an antibiotic / anti-mycotic solution. This solution greatly 
mitigated inappropriate bacterial growth, but fungal contamination continued as a 
significant problem that sporadically confounded our primary culture. Multiple 
anti-fungals across differing concentrations were used with similar apparent 
inefficiency in completely eliminating this fungal threat. The extended length of 
time our cells were in culture surely served as a contributor to this propensity for 
eventual fungal contamination.  
 
In her Methods in Molecular Medicine protocol entry on culturing primary cells, 
Louise Donnelly underscored the importance of recognizing that cell lines are 
only models of human primary epithelial cells. To her point, she compares 
responses of A549 cells, BEAS-2B and passaged human primary epithelium to 
stimulation with “cytomix” (interleukin-1β, tumor necrosis factor-α, and interferon-
γ). A significantly higher level of granulocyte macrophage-colony stimulation 
factor (GM-CSF) was produced by the primary cells relative to the immortalized 
cell lines by up to a 4-fold differential (Donelly 2001). In our present study, the 
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use of LC-MS in ESI positive mode detected 3 potential metabolite biomarkers 
found uniquely in primary tonsil epithelial cell spent media versus our three tumor 
cell lines. Further investigation suggested that one of these markers is likely a 
phospholipid or diglyceride.  
 
Due to the constraints of primary culturing, Donnelly concluded that cell lines 
remain of critical importance and contends that they be used to interrogate 
mechanistic pathways, requiring the use of many expendable cells. She warns 
that data should not necessarily be extrapolated to in vivo conditions, or even to 
the activity of in vitro primary cells. Indeed, it is undetermined the effect that our 
findings from our metabolome investigation might have on experiments remains 
undetermined but it represents an important reminder about the limitations of 
assertions made solely based on immortalized cell date. She concludes that 
more definitive conformational experiments may be performed using primary 
cells as the presumably more relevant model (Donnelly 2001). It is with this latter 
premise in mid that we have moved forward with performing many of our larger 
experiments with our UT-SCC-60B and UT-SCC-60B cell to follow up with 
primary cells, when available. We report in our subsequent studies, whenever 
possible, the results from both the immortalized and HPTE cells to demonstrate 
confirmatory or disparate findings 
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§5.0 M1 STREPTOCOCCUS ADHERENCE AND INVASION PHENOTYPES 
SUGGESTIVE OF TISSUE-SPECIFIC TROPISM FOR TONSIL EPITHELIUM 
 
 
5.1 Introduction:  
 
Our understanding of how S. pyogenes can asymptomatically colonize its human 
host and/or cause disease has revealed a cadre of virulence factors that are M 
type and strain-specific conferring the pattern specificity between the so 
classified specialists and generalists. Transmission of the “throat tropic” M types 
is largely mediated through respiratory droplets or secretions and direct contact 
with host mucus surfaces. Onset of a group A streptococcal infection requires 
that this immotile pathogen not only avoid clearance by opposing mucociliary 
flow by the upper respiratory tract, but while so doing, traverse over much of the 
oropharyngeal mucosal surface before finally adhering to- and then colonizing its 
target epithelium (Beachey 1987). Clinical observations convincingly indicate that 
group A streptococci have a pronounced predilection for colonizing tonsillar 
epithelium in vivo (Ellen 1974, Hokonohara 1988, Lija 1999, Roberts 2012). The 
number of in vitro studies described in the literature demonstrative of human 
pharyngeal tissue adherence tropism is surprisingly few (Ellen 1974).  
 
Park and colleagues’ murine intranasal infection model confirmed that GrAS has 
a tropism towards an ascribed tonsil-homolog of paired lymphoid lobes along the 
animal’s lateral nasopharyngeal wall (nasal-associated lymphoid tissue, NALT) 
(Park 2003). The mechanism of the latter model rests greatly on M cell-specific 
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adherence properties, which has subsequently not been reliably extended to 
human or primate tonsillitis models. This example reveals a major shortcoming of 
experimental animal models to accurately represent diseases caused by this 
human-specific pathogen and the challenge to studying GrAS tissue tropisms. 
Bessen et al also notes that extensive genetic diversity among strains often give 
rise to strain-dependent phenotypes in various in vitro and in vivo models 
(Bessen, Lizano 2010)  
 
The Detroit 562 human nasopharyngeal cell line is a well-characterized epithelial 
line that has been used extensively by many groups to model streptococcal 
infection and to specifically explore GrAS pharyngeal adherence properties 
(Duncan 1978, Fluckiger 1998, Ryan 2001, Pancholi 2003, Hong 2005, Ryan 
2007, Manetti 2007). Our laboratory in particular has used this as an important 
tool for understanding characteristics of the early host-pathogen colonization 
process, which may help explain the clinically observed tropism exhibited by this 
pathogen. Our studies with this cell type have recently revealed novel receptors 
for M protein - sialic acid- mediated host-pathogen interactions as well as 
important global transcriptional data on GrAS gene expression upon adhering to 
Detroit 562 cells (Ryan 2001, 2007).  
 
Morphologic heterogeneity of our human primary tonsil epithelial (HPTE) 
monolayer has demonstrated characteristics in shape and keratin staining 
suggestive of a subpopulation of cultured crypt – like lymphoepithelia cells. While 
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we continue to characterize this subtype, the effect the tonsil has already shown 
to have on its local microenvironment, as evidenced by the monolayer’s distinct 
metabolite production, may prove significant in our ability to more reliably 
recreate an in vitro system more closely resembling the in vivo 
microenvironment. The palatine tonsil tumor-derived UT-SCC-60A and UT-SCC-
60B epithelial cell lines may contribute an additional model to study tonsil-specific 
disease pathogenesis. The reliability of these tumor lines to mimic primary tonsil 
epithelial cells and, by extension intact tonsil, during streptococcal infection has 
yet to be explored.  
 
In this chapter, we revisit the widely used Detroit 562 nasopharyngeal cell based 
in vitro co-culture assay to observe streptococcal colonization and infection 
phenotype of a clinically isolated M type 1 strain of Group A streptococcus, 
SF370. We then explore the relative differences in streptococcal adherence 
predilection during co-culture with Detroit 562, UT-SCC-60A, UT-SCC-60B, and 
human primary tonsil epithelial cells. Following a brief update on a modification to 
the classically described standard internalization assay, we immediately employ 
this method to compare GrAS internalization across respective epithelia.   
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5.2 Results 
 
5.2.1 Streptococci are heterogeneously distributed along monolayers  
 
Early observations of the interaction between S. pyogenes and our pharyngeal 
cell monolayers revealed a non-homogeneous distribution of the bacterium 
following co-culture with Detroit-562. When monolayers with adherent bacteria 
were examined under the microscope, it appeared that not all Detroit 562 cells 
were alike in their ability to allow streptococcal adherence. While some cells had 
many bacteria adhering to them, no bacteria were associated with other epithelial 
cells in the same area (Figure 5.1). Viewed under lower magnification (wider 
view), it becomes apparent that the bacteria consistently attach as clumps 
occupying patches along the monolayer (Figure 5.1). Sonication did not appear 
to affect this tendency towards irregular distribution (unpublished observation). 
UT-SCC-60A, UT-SCC-60B, and HPTE cell monolayers infected with S. 
pyogenes demonstrated a less pronounced heterogeneity between bound and 
unbound epithelia as compared to Detroit-562 cells (not show). In summary, 
there was some degree of aggregation exhibited by GrAS during association with 
the surface of all epithelial monolayers examined. Notably, our observation on 
cell surface streptococcal aggregation is consistent with previously reported 
accounts of this phenomenon by other investigators co-culturing streptococci with 
Detroit 562 cells. (Bartelt 1978, Manetti 2007).  The implications from the 
numerous speculative mechanisms proposed by different groups will be 
discussed later in this section.   
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Figure 5.1. Distribution of S. pyogenes along epithelial monolayer 
S. pyogenes strain SF370SMR was transformed with pCM18 (see Methods) to 
constitutively express GFP (green). SF370-pCM18 in serum-free DMEM (~5 x 107 cfu / 
ml) was co-cultured with Detroit 562  (A-C) and UT-SCC-60B (D) epithelial cell 
monolayers on glass coverslips for 30 minutes at 37ºC, supplemented with 5% CO2. 
Associated bacteria were removed by vigorous washing with PBS and monolayers were 
briefly fixed with 4% paraformaldehyde. Fluorescence micrographs of representative 
monolayers are presented, visualized with phase contrast and / or FITC filter (480nm).  
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5.2.2 Persistent adherent GrAS exhibit biofilm-like growth possibly refractory to 
treatement with antibiotics  
 
Mannetti and colleagues recently described a link between the streptococcal 
aggregation phenotype, GrAS pili and biofilm formation on Detroit 562 
nasopharyngeal cells. Employing a similar experimental set up, their team 
showed S. pyogenes strain SF370 adhered to Detroit 562 monolayers 
following15 minutes of being co-cultured and formed extensive clumps of cells 
typical of biofilm microcolonies by 2hrs. The clumped microcolonies extended 
into 3D space, a characteristic arguably pathognomonic of biofilms, as was 
confirmed by three-dimensional immunofluorescence imaging. It is well 
established that biofilm formation, via matrixes of secreted proteins, 
polysaccharides, and nucleic acids, offer a means of protection for member 
bacteria against host antimicrobial peptides and antibiotic therapies. Recently, 
Ogawa et al showed a hyper-biofilm forming M type 1 GrAS strain produced fully 
matured biofilms, where penicillin, erythromycin, and clindamycin, either 
individually or in combination, could not inhibit growth / viability even when the 
concentration of each antibiotic was greater than the 10-fold minimum inhibitory 
concentration (MIC) for planktonic bacteria (Ogawa2011). 
Consistent with these finding, we have verified that a subpopulation of adherent 
SF370 remain visible microscopically on the surface of Detroit 562 cells following 
1h of antibiotic treatment with Penicillin and Gentamycin, as indicated by the 
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standard invasion assay (Figure 5.2A,B). Given this observation, we first sought 
to determine the effectiveness of using the amidase lytic enzyme, PlyC (Fischetti, 
1971, Nelson 2001) at a modest concentration of 0.05U per well, to more 
effectively eliminate persistent adherent bacteria. Our study consistently 
demonstrated a marked decrease in visibly attached bacteria following PlyC 
treatement, although monolayer surface sterilization was infrequently achieved. 
We decided against increasing the concentration of PlyC or the increasing the 
length of incubations since Nelson et al have recently shown that PlyC may 
become internalized by epithelial cells when applied at high concentrations 
(Nelson DC, unpublished). Incubating the monolayers with antibiotics for 1h 
followed by PlyC treatment proved to consistently sterilize the monolayer surface 
as was confirmed microscopically (Figure 5.2), which suggests a synergistic 
effect between the two therapies on our in vitro assay.  
 
Significantly, the viability of the persisting adherent streptococci was never 
confirmed. Invasion viability and invaded-streptococci re-emergence experiments 
rely on accurate removal of extracellular bacteria. We performed experiments 
where aliquots of antibiotics from infected-wells during invasion assays were 
plated on blood agar plates. Our results from these tests were usually negative 
but they notably do not account for adherent bacteria that are alive but dormant 
within a biofilm.   
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Figure 5.2. Efficacy of using amidase lysin, PlyC, on persisting adherent S. pyogenes 
versus antibiotics alone during in vitro assay 
SF370-pCM18 (green) in serum-free DMEM (~5 x 107 cfu / ml) was co-cultured with 
Detroit 562 (ATCC, CCL-138) epithelial cell monolayers on glass coverslips for 120 min at 
37ºC, supplemented with 5% CO2. Associated bacteria were removed by vigorous 
washing with PBS and subsequently treated with Antibiotics cocktail (Penicillin 100ng / 
µL+ Gentamicin 100ng / µL) and /or PlyC (0.05U / well) for 60min. Monolayers were 
washed with PBS and briefly fixed with 4% paraformaldehyde. Fluorescence micrographs 
of representative monolayers are presented, visualized under phase contrast and / or 
FITC filter (480nm).  
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5.2.3 Streptococcal tonsil-specific phenotype suggests apparent tissue tropism  
 
 
Clinical observations demonstrate a generally confined presentation during 
Group A Streptococcal induced pharyngo-tonsillitis, or “Strep Throat”. One of the 
major symptoms distinguishing this from non-streptococcal infection is a localized 
inflammation and erythema at the palatine tonsil with or without exudate (Dajani 
1995). Extended pharyngeal membrane discoloration involving the soft palate is 
not seen in GrAS disease, but rather is indicative of other etiologies of 
pharyngitis such as gonococcus spp (Vincent 2004).  
 
Ellen et al established almost 40 years ago tonsil tissue specificity in a virulent 
strain of streptococci. In their study, tonsil epithelial cells scraped from a healthy 
male patient, along with a panel of epithelia from other sites, were cultured with 
GrAS and Escherichia coli (Ellen 1974). They demonstrated greater adherence 
of GrAs to tonsillar cells as compared to the other cell types, a finding 
incongruent with observed E. coli adherence predilections. The disparate 
locations from which they tested the streptococcal tropism limits the implications 
of their finding between other neighboring oral mucosa, normally spared during 
streptococcal disease. While numerous investigators have identified 
streptococci’s ability to adhere to oral tissues including tongue and buccal 
surfaces, comparisons between these surfaces have not convincingly 
demonstrated tropism towards the tonsil in man, either in vivo or in vitro.  
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In order to preliminarily explore whether streptococci exhibit higher affinity to 
palatine tonsil-derived epithelial cells compared with anatomically proximate 
nasopharyngeal-derived cells, a representative cell lines and a throat-tropic 
(emm pattern A-C) strain, M type 1 SF370, were chosen for our model system. 
We conducted a mixed cell infection experiment in which Detroit 562, UT-SCC-
60A, UT-SCC-60B, and Human Primary Tonsil Epithelial cells were infected 
simultaneously in the same well (Amelung 2011). 
 
Consistent with the apparent clinical presentation, our M1 strain exhibited a 
strong preference for all three palatine tonsil cell lines over the Detroit 562 
(nasopharyngeal) cells as assessed by visual comparison of infected cells 
(Figure5.3. We quantitatively verified this observation by conducting an 
adherence assay comparing all four (4) cell types using established standard 
techniques as previously described (Romero 2003, Ryan 2001, Manetti 2007, 
Ryan 2007). Our assays demonstrated that adherence was greater than 5-times 
more efficient in tonsil cell lines, consistent with our observations by microscopy 
(Figure 5.4). This enhanced adherence efficiency was reproducible and 
calculated to be very significant (p < 0.001) demonstrating a clear difference 
between tonsil versus non-tonsil monolayers when simultaneously infected with 
the same inoculum. A similar epithelial cell type-specific response was 
observable when measuring invasion efficiency (Figure 5.5). 
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Figure 5.3 Visualization of apparent streptococcal tissue-specific tropism toward 
tonsil epithelial cell types. Cultured epithelial cells were seeded to ~90% 
confluency*, respectively, on glass coverslips. Coverslips were placed adjacent 
to one another in the same well of a Falcon® 6-well tissue culture plate and 
simultaneously inoculated with M type 1 S. pyogenes (~5 x 107). (A) Diagram of 
experimental set up for a single well containing coverslips with the four epithelial 
cell types. Fluorescence micrographs of infected (B) Detroit 562, (C) UT-SCC-
60A, (D) UT-SCC-60B, and (E) Human Primary Tonsil Epithelial [HPTE] cells are 
presented. GrAS was labeled with PlyCB conjugated with Alexa 554 (red). 
Epithelial nuclei were stained with DAPI (blue). All images captured at 20X 
magnification. 
*Note: Size and morphology differences between epithelial cell types influence 
cell density of confluent monolayers.  At 95% confluence: Detroit 562 = 1.2 x 106, 
UT-SCC-60A = 5.0 x 105, UT-SCC-60B = 1.3 x 106, and HPTE = 4.5 x 105 (see 
Section §4.0 for additional description) 
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Figure 5.4 M type 1 streptococci exhibit greater adherence efficiency towards 
tonsil-derived epithelium. 
S. pyogenes strain SF370SMR was co-cultured with nasopharyngeal-derived 
(Detroit 562- grey bar) and tonsil-derived (UT-SCC-60A, and HPTE – black bars) 
epithelial monolayers, respectively at multiplicity of infection (MOI) ~100:1.  
Associated bacteria were removed with PBS and cfu’s were counted on blood 
agar as described in the methods.  Results are the mean  standard deviation of 
at least three independent experiments performed on separate days in triplicate. 
Statistical significance (reported as p value) was determined by Student’s t-test.  
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Figure 5.5. M type 1 streptococci are internalized more efficiently by tonsil-
derived epithelium  
S. pyogenes strain SF370SMR was co-cultured with nasopharyngeal-derived 
(Detroit 562- grey bar) and tonsil-derived (UT-SCC-60A, and HPTE – black bars) 
epithelial monolayers, respectively at multiplicity of infection (MOI) ~100:1.  
Adherent bacteria were killed with antibiotics and treatment with amidase lysin, 
PlyC, as described in the methods.  Results are the mean  standard deviation of 
two to four independent experiments performed on separate days in triplicate. 
Statistical significance (reported as p value) was determined by Student’s t-test.  
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5.3 Discussion: 
 
In vitro assays were used to investigate a key early event in streptococcal 
infections, initial adherence to mucosal surfaces of the human oropharynx. This 
approach may mimic a child inhaling aerosolized droplets of S. pyogenes and 
effectively inoculating their upper airway. Our in vitro investigations demonstrate 
clear differences in adherence phenotypes between streptococcal strain-matched 
assays and epithelial monolayers derived from two neighboring sites in the 
human oropharynx. These findings are consistent with the clinical observation 
that group A streptococcal infection appears to occur preferentially at the palatine 
tonsil. 
 
Our monolayer model system revealed thought provoking findings that have 
been previously noted by other researchers, but remain unclear or otherwise 
poorly explained. Among these observations is the non-homogeneous 
distribution of GrAS, especially across our Detroit 562 monolayer. Bartelt et al 
were the first to document the heterogeneity of streptococcal distribution on a 
Detroit 562 monolayer nearly 30 yrs ago. Furthermore, they also reported that 
the percentage of the bacterial inoculum followed an inverse relationship with 
concentration as adherence percentage decreased as more bacteria was 
applied. In cell cultures “saturated” with GrAS, they observed using microscopy 
that only about 50% of the Detroit epithelial cells contained adherent 
streptococci.  
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In our current study, we used a multiplicity of infection of ~100:1 as an 
inoculumdose that has been published in numerous streptococcal adherence 
assays with Detroit 562 cells (Pancholi, 2003, Edwards 2008) as we sought to 
identify streptococcal binding preferences between these and tonsil derived cell 
types. We also regularly performed repeat experiments at 10 times our reported 
MOI (1000:1) and also noted a decrease in the percentage of inoculum that 
adhered (unpublished observations). Interestingly, we see an apparent maximum 
to the number of absolute number of bacteria that can bind a monolayer. Based 
on hemocytometer counts of confluent monolayers and CFU calculations on 
blood agar, we found a maximum streptococcal saturation that was cell type-
specific, ranging from 100:1 CFU (per Detroit 562 cell) to >350:1 CFU (per UT-
SCC-60B cell). Numbers no longer increased in our assays repeated in duplicate 
on consecutive independent days at MOI’s 1000 - 3000:1 (data not shown). 
Higher MOI’s were not attempted based on visual inspection of compromised 
monolayer integrity.   
 
The heterogeneous distribution observed in our study as well as by others may 
be indicative of the well-established phenomena of oral streptococcal 
aggregation. Numerous investigators have purported that GrAS bind human 
salivary components, which in turns induces bacterial aggregation (Edwards 
2008, Courtney 1991). While some of the described binding ligands responsible 
for this process are unique to saliva (ie. gp340), other components such as 
albumin and fibronectin can be readily found in standard growth media and along 
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the surface of our epithelial cells. These components are known to provide a 
“bridge” that facilitates enhanced epithelial adherence by the bacterium. Though 
unlikely, it is possible that serum or epithelial surface matrix components not 
evenly removed during washing steps might account for areas of localized 
aggregation. Since this is a recurring observation seen specifically during Detroit 
562 cell adherence assays, however, we reject the plausibility that this is the 
case.  
 
Another more intriguing explanation might be that there is heterogeneity within 
the epithelial cell cultures. It may be that "receptor sites" on the epithelial cells 
are present only during certain stages of the cell division cycle or  that the 
epithelial cells consist of subpopulations that differ in their ability to allow 
streptococcal adherence. Since our in vitro assay uses epithelial monolayers at 
nearly complete confluence (~90-95%), we make an assumption that the 
respective cell types being compared (nasopharyngeal versus tonsil-derived), are 
at similar stages of senescence with minimal proliferate subpopulations. This 
may indeed be a more likely difference between Detroit 562 cells and other types 
if their surface topography is exceptionally more affected by cell cycle stage. 
Further analysis of the Detroit 562 cell surface in vitro is needed to continuously 
revisit the implications for how this reflects the in vivo pharyngeal surface 
whether this serves as a reliable model in vitro for streptococcal 
pharyngotonsillitis.  
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In summary, using epithelia from an anatomically relevant, clinically – derived 
source, the palatine tonsil, has allowed us to reproduce an appreciable “tropism” 
in vitro. These observations, however, have many caveats that require further 
investigation regarding the precarious difference in distribution patterns across 
these anatomically related cell types, possibly alluding to tissue-specific 
differences. The novel tonsil tumor lines UT-SCC-60A and UT-SCC-60B may 
provide a powerful tool as a reliable system to investigate mechanisms for these 
phenotypes and establish a basis for eventual confirmation by primary cells and 
in vivo screens. 
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§6.0 STREPTOCOCCAL TRANSCRIPTIONAL CHANGES UPON 
ASSOCIATION WITH EPITHELIAL CELLS FROM HUMAN NASOPHARYNX 
VERSUS PALATINE TONSIL 
 
 
6.1 Introduction: 
 
 
The arsenal of extracellular proteins and secreted virulence factors wielded by 
Group A Streptococci GrAS have been extensively studied for the past 70 years, 
which is a testament to the impact this bacterium has had on human disease. 
While the extracellular presentation of these proteins is well studied, their 
regulation and connectedness with other bacterial responses has only recently 
become better understood.  Advances in genome wide analysis over the last 15-
20 years has ushered in an enhanced appreciation of GrAS virulence by studying 
the underlying molecular causes of disease pathogenesis. Since the first 
complete sequence of the Streptococcus pyogenes genome was reported in 
2001 by Ferretti et al, numerous laboratories have developed in vitro systems 
using microarrays to capture snapshots of transcriptome –level shifts within the 
pathogen in response to specific environmental stresses and conditions (Ferretti 
2000, Shelburne, Sumby 2005) Sitkiewicz & Musser 2006). Studies have also 
been performed in vivo using sample isolates from infected primates (Virtaneva 
2005, Shea 2010) and humans (Livezey 2011). These studies have offered new 
insights while bringing forth new questions. Previously described virulence 
factors have been elaborated in a more genome-wide context while no fewer 
than 13 new proteins involved in pathogenesis were found within the first ten 
years of the advent of genome wide microarray (Musser 2009). Insight provided 
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from studies using these molecular tools has already aided the design of 
potential therapeutic and vaccine approaches to combatting streptococcal 
disease (Ferretti 2001).  
There are now 14 completed GrAS genome sequences (Table 6.1). Each 
genome is approximately 1.9 Mb in size, with approximately 10% of the overall 
gene content encoded on variably present exogenous genetic elements such as 
prophages and integrated conjugative elements (ICE). It has been shown that 
even among GrAS of the same M type, there is considerable variation in 
prophage content and overall prophage-associated virulence factor profile 
(Musser 2009). While phage represent only a minor fraction of the total GrAS 
genome, they may account for up to 74% of the variation between strains 
(Banks, Beres 2002).  
Towards the effort of exploiting this new sequenced information and molecular 
tools, our lab has recently developed novel oligonucleotide microarrays, which 
represent every identified unique open reading frame from published group A 
streptococcal serotypes.  Moreover we have designed a suite of statistical 
algorithms to extract biologically meaningful data generated from microarray 
experiments that explore various streptococcal-host interactions. Uniquely, this 
novel software suite provides analysis that incorporates the physical position of 
genes on the bacterial chromosome to identify groupings of potentially related 
genes and speculative operons. This powerful tool named GenomeCrawler 
(www.rockefeller.edu/vaf/streparray.php) has been applied to investigate 
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transcriptional changes in streptococci during various environmental conditions 
and stages of infection (Ryan 2007, Aziz 2010, Juncosa 2012). 
 
 
The pathogen adapts transcriptionally to the host environment  
 
While much of the earlier work on pathogen response to the host were focused 
on changes in pH, temperature, carbohydrate sources, and superoxide 
availability, our laboratory recently reported that streptococci actively responded 
to a host cell small molecule, named SPIF, leading to phage induction and phage 
encoded virulence expression (Broudy 2001, Broudy 2002). In order to cause 
infection, the bacteria must first enter the oral cavity, generally via a low-glucose 
   Table6.1. Sequenced S. pyogenes genomes 
S. pyogenes 
strain M-type 
Genome 
Size (bp) 
CDS 
Count 
% of CDS 
with no 
assigned 
funtion  
No. of 
prophages Reference 
SF370  1 1,852,441 1,697 37.1 4 Ferretti, et al. 2001 
MGAS5005  1 1,838,554 1,865 16.6 3 Sumby, et al. 2005 
MGAS10270 2 1,928,252 1,987 17.2 5 Beres, et al. 2006 
MGAS315  3 1,900,521 1,865 35.5 6 Beres, et al. 2002 
SSI-1  3 1,894,275 1,861 37.17 6 Nakagawa, et al. 2003 
MGAS10750  4 1,937,111 1,979 17.2 4 Beres, et al. 2006 
Manfredo  5 1,841,271 1,803 28.4 5 Holden, et al. 2007 
MGAS10394  6 1,899,877 1,886 22.7 8 Banks, et al. 2004 
MGAS2096  12 1,860,355 1,898 17.3 2 Beres, et al. 2006 
MGAS9429 12 1,836,467 1,878 16.7 3 Beres, et al. 2006 
MGAS8232  18 1,895,017 1,845 38.6 5 Smoot, et al. 2002 
MGAS6180  28 1,897,573 1,894 18 4 Green, et al. 2005 
NZ131 49 1,815,724 1,699 25.7 3 Mcshan, et al. 2008 
Alab49  53 1,827,308 1,773  4 Bessen, et al. 2011 
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saliva aerosol, or by hand contact with nasal discharge from an  infected 
individual. This early inoculum then mixes with the oral milieu of the new host 
eliciting adaptive transcriptional modifications appropriate to their new 
environment.  
 
An attempt to contextualize streptococcal adaptation to its host with respect to its 
global effect transcriptionally has been recently undertaken by numerous groups. 
Our lab has investigated the adaptive dynamics of the initial infection sequence 
in an in vitro epithelial model measuring streptococcal transcriptome shifts during 
co-culture with epithelial cell-free conditioned media (prepared from Detroit 562 
cells). In comparison to bacteria cultured in freshly MEM as a control, GrAS 
elaborated a global transcriptional response where over 430 individual genes 
were differentially expressed. Similarly, after transient contact or “association” 
with pharyngeal monolayers + conditioned media, streptococci differentially 
expressed over 490 genes in comparison again to bacteria only cultured in fresh 
MEM. Significantly, there was found to be a great deal of overlap in the genes 
affected (337 genes) by the two experimental conditions (Juncosa 2012). The 
bacterial transcriptome was sampled at various times post-exposure to host cells, 
which revealed that streptococcal gene expression is dramatically remodeled 
following initial exposure to the host environment but generally maintains its 
directional change (up- or downregulated) through loose association with the 
host cell surface (Juncosa 2012).  
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Following the continuum of stages that lead to infection and disease, our lab 
identified 79 genes differentially expressed by S. pyogenes upon adherence with 
Detroit 562 monolayers in comparison to those bacteria only loosely associated 
with this epithelium (Ryan 2007). The relatively few genes that were differentially 
expressed in Ryan’s analysis points to a noteworthy distinction between this and 
Juncosa et al’s experimental design. The bacterial group being compared for 
relative “differences” in expression (adherent versus associated bacteria) has 
presumably undergone the same large-scale transcriptome shifts upon initial 
adaption to the host-modified environment. Differences in expression for 
streptococci that have tightly bound to host cells (versus those only loosely 
associated) may represent additional fine-tuning of the transcriptional program 
necessary to initiate and maintain close contact with target epithelial cells (Ryan 
2007, Juncosa 2012).  These sets of experiments represent the first reported 
account of transcriptional changes following S. pyogenes adaptive responses 
from initial infection to adherence on the pharyngeal epithelial cell surface. 
 
 
While we have shown that a single streptococcal strain may alter its adaptation 
and colonization mechanisms based on host environment and stage of infection, 
it has yet to be demonstrated whether this pathogen elicits a unique and 
transcriptionally discernable response to different mucosal epithelial cells types 
associated with the human pharynx following mere transient contact as might 
naturally occur in vivo during infection. Due to anatomical proximity, comparing 
the bacteria’s response to the related epithelia of the nasopharynx and palatine 
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tonsil may offer a unique appreciation for the extent to which a “throat selective” 
GrAS M type strain might distinguish between two host cells within their only 
natural reservoir. Developing an in vivo system would likely prove irreconcilably 
challenging to sufficiently control for the expected dispersal of the inoculum 
throughout the pharyngeal mucosa by the action of host mucocilliary secretions. 
Furthermore, bacterial sampling post-inoculation would be limited to only 
adherent bacteria, which misses the important transcriptional status following 
introduction to the oropharynx likely important for determining tropism.  As 
reported earlier, we have observed significant phenotypic differences in adhesion 
and invasion of host cells by streptococci following co-culture with tonsil-derived 
epithelial cells versus nasopharyngeal cells. Informed by these observations, we 
hypothesize that there are dynamic transcriptional shifts elaborated by the 
bacteria during co-culture, which may differ significantly between the respective 
epithelial cell types.  
 
In the following chapter, we describe our study capturing the relative changes in 
S. pyogenes transcriptional responses to co-culture with a newly described 
human palatine tonsil tumor cell line, UT-SCC-60B, as compared to the Detroit 
562 nasopharyngeal epithelial cell line. Using a custom microarray platform and 
novel clustering algorithms, our results revealed the upregulated operons that we 
then test to further confirm our novel cell line’s ability to model a previously 
described response to human primary tonsil epithelial cells  
 
 
  124 
§6.2 Results 
 
 
§6.2.1 Differential expression of individual genes during association with human 
tonsil epithelial cell monolayers  
 
 
Streptococcus pyogenes M type 1 strain SF370 was co-cultured in vitro with 
epithelial tumor lines derived from two anatomically proximate locations often 
regarded indistinguishably as parts of the human “throat”: the nasopharynx 
(Detroit 562) and palatine tonsil (UT-SCC-60B), respectively. We employed an 
established association assay (Ryan 2007) (Juncosa 2012), as previously 
described.  Associated bacteria were recovered and RNA was immediately 
extracted for analysis of transcript expression, capturing a snapshot of the 
streptococcal transcriptional profiles following 2.5h co-culture with their 
respective monolayers. We performed 8 independent experimental replicates on 
separate days to incorporate biological variation into our experimental design.  
 
Our control for this experiment was the cDNA isolated from bacteria co-cultured 
with Detroit 562 cells. Accordingly, our “standard” color configuration 
incorporated Cy3 (green) to control Detroit 562 cDNA, while Cy5 (red) was 
incorporated into UT-SCC-60B cDNA. Dye swap experiments were included to 
account for technical variability in dye incorporation. (Appendix 6.1) 
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Using robust summary statistics and permutation algorithms, our analysis of the 
replicate arrays identified 78 individual genes (4.4% of the total SF370 genome) 
differentially expressed when streptococci are exposed to palatine tonsil 
epithelial cells as compared to Detroit 562 cells.  Only genes expressing log2-fold 
changes with p-values <0.05, as determined by the Westfall-Young step down 
permutation algorithm, were considered significant and included in Tables 6.1 
and 6.2.  To further understand the relative transcriptional shifts taking place in 
the bacteria co-cultured with palatine tonsil epithelia, we classified these 
differentially expressed genes according to the COGs (Clusters of Orthologous 
Groups of proteins) database. This classification system predicts function based 
upon phylogenetic relationships and assigns genes to the broad categories of 
basic cellular processes (Tatusov 2000). While nearly 40% of our gene list 
belonged to uncharacterized phage or had otherwise unknown / predicted 
functions, the remaining COGs list includes a range of functions from regulation 
of virulence, to lipid transport and metabolism, to control of the cell cycle. We 
found that the majority of the significantly affected genes in our study were up 
regulated (58%, 45/78) as compared to control (Tables 6.2 and 6.3). 
Interestingly, while most COGs contained genes that were either up- or down-
regulated, fourCOGs included genes that were only up-regulatedted: (1) lipid 
transport and metabolism; (2) post translational modifications, protein turnover, 
and chaperones; (3) cell well / membrane / envelope biogenesis; and (4) 
nucleotide transport and metabolism.  We note thatof the down-regulated genes 
across all COGs, approximately 64% were of unknown function and/ or were 
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phage-associated, leaving the consequence of these shifts in expression difficult 
to speculate until more information is collected on the putative roles of these 
genes.  
 
Phage-associated genes  
33 of the genes significantly down-regulated during co-culture with the tonsil-
derived line, 12 (36%) were phage-related. In fact, we found that all of the phage 
genes which underwent significant fold changes were downregulated.  Although 
SF370 contains one inducible (Φ370.1) and three defective (Φ370.2, Φ370.3 and 
Φ370.4) integrated prophages, we noted the differential expression of genes 
from both inducible and non-inducible phage and the prophage integrated 
conjugative elements (ICE)-like region of difference, designated Φ370.RD1, 
which putatively encodes a streptin lantibiotic product (Musser 2007).  
Among the known phage genes that were differentially expressed, 6 (50%) 
encoded structural proteins necessary for bacteriophage assembly. Of note, the 
head morphogenesis gene (Spy0681) for inducible SF370 prophage, Φ370.1 
was down-regulated, and both the head morphogenesis (Spy1464) and tail fiber 
(Spy1441) genes for a non-inducible prophage, Φ370.3, were downregulated.  
 
Virulence-associated genes 
We did identify four differentially expressed genes that are known to be 
associated with streptococcal virulence: SagA (Spy0738), vrf (Spy0887), pilus 
minor subunit (spy0130,) and amrA (Spy0797). Three of these virulence genes 
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were observed to be upregulated while the Streptolysin S associated gene A, 
SagA, was down-regulated. Interestingly, the largest log2-fold change observed 
in our analysis in either the positive or negative directions occurred by virulence 
genes. SagA experienced the most highly negative Log2-fold change of -2.20 
while the average fold decrease among downregulated genes was only about -
1.13 Log2-fold change. Pilus minor subunit spy0130 (also regarded as ancillary 
protein 2), however, had an increased relative expression by Log2-fold of 3.2 
while the average increase in up regulated genes was 1.46. In addition, the most 
significant (lowest p-value) of all differentially expressed genes meeting our 
algorithm’s criteria was also Spy0130. The remaining upregulated virulence 
genes will be discussed following our further analysis of this data with the 
additional context of neighbor gene clustering and its implications. 
 
Based on the known relationship between subgroups of genes being differentially 
expressed, preliminary speculation can be made regarding the bacteria’s 
adaptive differences between co-culture in UT-SCC-60B versus Detroit 562 cells. 
For example, there may be differences in metabolism, indicated by the increase 
in gene expression for lipid transport and metabolism mechanisms, concomitant 
with the down regulation of two carbohydrate metabolism genes. Alternatively, it 
is possible that the bacteria are dividing more in the presence of the tonsil-
derived monolayer as indicated by the increased expression of cell wall 
biogenesis and post-translational modification genes, both of which would require 
lipid metabolism and transport.  
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As this information is only a snapshot of the bacteria’s transcriptional state a 
single moment in time, greater context regarding the prior transcriptional status 
would provide a more comprehensive picture of individual genes. Additional 
context however may be achievable by incorporating information based on the 
expected contribution additional related genes and pathways may play not 
represented under our initial analysis  
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Table 6.2. Differential expression of genes following SF370 co-culture 
with human tonsil epithelium versus control 
Streptococcal genes exhibiting significant changes in expression during 
association with palatine tonsil-derived cells compared with bacteria 
associated with Detroit 562 (nasopharyngeal) cells. Genes are organized by 
Clusters of Orthologous Groups of proteins (COG) classification* as described 
in the annotated S. pyogenes SF370 genome.  
*Note – “Virulence” designation assigned to known transcriptional regulators of 
virulence and any gene encoding established virulent factors / products 
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COG Classification  Total Up-regulated 
genes  
Down-regulated 
genes 
Function Unknown 17 8 9 
Phage 12 0 12 
Translation, ribosomal structure and 
biogenesis 
9 7 2 
Lipid transport and metabolism 7 7 0 
Post-translational modification, protein 
turnover, chaperones 
6 6 0 
Nucleotide transport and metabolism 4 4 0 
Virulence* 4 3 1 
Carbohydrate transport and 
metabolism 
3 1 2 
Inorganic ion transport and 
metabolism 
3 2 1 
cell wall / membrane / envelope 
biogenesis 
3 3 0 
Amino acid transport and metabolism 2 1 1 
Replication, recombination, and repair 2 0 2 
Cell cycle control, cell division 2 1 1 
Energy production and conversion 1 0 1 
General function prediction only 1 1 0 
    
Total 78 45 33 
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Table 6.3 Streptococcal genes exhibiting significant changes during association with UT-
SCC-60B monolayers compared to association with Detroit 562. 
aGenes rank is ordered by highest significance (lowest p-value calculated using Westfall-
Young permutations).  
bLocus tag, COG designation, and gene function / product designations from the 
annotated SF370 genome. Phage-associated genes have been highlighted in purple.   
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Rank
a
 Locus Tagb 
Gene 
Nameb  COG Designationb  
Known or proposed function / 
product  
 p-Value     
(Westfall-                                                                                                                                  
Young) 
Log2-Fold 
Change 
1 M1_Spy_0130   virulence Minor Pilin subunit; Links pilus to cell wall (AP2)  0.00E+00 3.62 
5 M1_Spy_0887 vfr virulence  Stand-alone regulator. Repression of speB via RopB 0.00E+00 1.49 
34 M1_Spy_0797 amrA virulence Stand-alone regulator. Activation of Mga regulon 5.20E-03 1.05 
66 M1_Spy_0738 sagA virulence (sagA) streptolysin S associated protein 3.06E-02 -2.20 
8 M1_Spy_0047 rpsJ Translation, ribosomal structure and biogenesis  30 S ribosomal protein S10 2.00E-04 2.62 
31 M1_Spy_0461 rplA Translation, ribosomal structure and biogenesis   50S ribosomal protein L1 3.40E-03 1.90 
43 M1_Spy_0886 engB Translation, ribosomal structure and biogenesis  
ribosome biogenesis GTP-
binding protein YsxC 1.07E-02 1.05 
49 M1_Spy_1770 gatB Translation, ribosomal structure and biogenesis  
aspartyl/glutamyl-tRNA 
amidotransferase subunit B 1.63E-02 1.31 
55 M1_Spy_1888 rpmB  Translation, ribosomal structure and biogenesis  50S ribosomal protein L28 2.02E-02 1.54 
74 M1_Spy_0913 rpsA Translation, ribosomal structure and biogenesis  30S ribosomal protein S1  3.87E-02 1.24 
26 M1_Spy_0504 smpB Translation, ribosomal structure and biogenesis tmRNA-binding protein 1.90E-03 -0.88 
64 M1_Spy_1161 rgbA Translation, ribosomal structure and biogenesis ribosomal biogenesis GTPase 2.82E-02 -1.01 
65 M1_Spy_0849 trmD Translation, ribosomal structure and biogenesis 
tRNA (guanine-N(1)-)-
methyltransferase 2.95E-02 1.14 
33 M1_Spy_1755   Transcription MarR family [REGULATOR]  4.40E-03 1.25 
41 M1_Spy_0503   Transcription exoribonuclease R 8.50E-03 -0.81 
27 M1_Spy_1163 smf 
Replication, 
recombination, and 
repair 
Smf family DNA processing 
protein 2.90E-03 -1.19 
76 M1_Spy_1510 mutT 
Replication, 
recombination, and 
repair 
mutator protein / Oxidative 
damage repair enzymes 4.25E-02 -1.18 
3 M1_Spy_0288 csdA 
Post-Translational 
modifications, protein 
turnover, chaperones 
aminotransferase  0.00E+00 1.37 

39 M1_Spy_1173 gid 
Post-Translational 
modifications, protein 
turnover, chaperones 
tRNA (uracil-5-)-
methyltransferase  8.00E-03 1.05 
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56 M1_Spy_0885 clpX 
Post-Translational 
modifications, protein 
turnover, chaperones 
ATP-dependent protease ATP-
binding subunit 2.04E-02 0.90 
61 M1_Spy_1374 nrdH 
Post-Translational 
modifications, protein 
turnover, chaperones 
glutaredoxin 2.52E-02 1.86 

69 M1_Spy_0287 sufD 
Post-Translational 
modifications, protein 
turnover, chaperones 
ABC-type transport system 
involved in Fe-S cluster 
assembly  
3.32E-02 1.01 

7 M1_Spy_0850   
Post-Translational 
modification, protein 
turnover, chaperones 
thioredoxin reductase 2.00E-04 1.89 

11 M1_Spy_1464   Phage - structural (Φ370.3) Head morphogenesis 2.00E-04 -1.34 
14 M1_Spy_1465   Phage - structural (Φ370.3) putative structural protein  2.00E-04 -1.35 
38 M1_Spy_0945   Phage - UNKNOWN  (Φ370.2) hypothetical protein 7.20E-03 -1.05 
50 M1_Spy_1487   Phage - UNKNOWN  (Φ370.3) hypothetical protein  1.65E-02 -0.92 
67 M1_Spy_1442   Phage - UNKNOWN  (Φ370.3) hypothetical protein  3.09E-02 -1.05 
71 M1_Spy_1075   Phage - UNKNOWN  (Φ370-RD.1) hypothetical protein 3.50E-02 -1.11 
18 M1_Spy_1441   Phage - structural  (Φ370.3) Tail fiber gene 5.00E-04 -1.06 
30 M1_Spy_0681   Phage - structural  (Φ370.1) Head morphogenesis 3.30E-03 -0.98 
53 M1_Spy_1457   Phage - structural  (Φ370.3) putative structural protein  1.78E-02 -1.01 
57 M1_Spy_0661   Phage - structural  (Φ370.1) putative structural protein  2.09E-02 -0.72 
29 M1_Spy_1438   Phage - pathogenesis  (Φ370.3) Muramidase  3.00E-03 -1.10 
21 M1_Spy_0943   Phage - Lysogeny  (Φ370.2) Lysogeny 6.00E-04 -1.15 
6 M1_Spy_2206 guaB Nucleotide transport and metabolism 
inosine 5\'-monophosphate 
dehydrogenase 2.00E-04 1.20 
9 M1_Spy_1378 nrdF.2 Nucleotide transport and metabolism 
ribonucleotide-diphosphate 
reductase subunit beta 2.00E-04 1.65 
24 M1_Spy_1375 nrdE.2 Nucleotide transport and metabolism 
ribonucleotide-diphosphate 
reductase subunit alpha 1.40E-03 1.40 
72 M1_Spy_0894 deoD2 Nucleotide transport and metabolism 
purine nucleoside 
phosphorylase 3.69E-02 0.78 
13 M1_Spy_1751 fabK Lipid transport and metabolism trans-2-enoyl-ACP reductase II 2.00E-04 1.66 
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16 M1_Spy_1749 fabG Lipid transport and metabolism 3-ketoacyl-ACP reductase 4.00E-04 1.45 
19 M1_Spy_0880 mvaS.1 Lipid transport and metabolism 
3-hydroxy-3-methylglutaryl-
coenzyme A 5.00E-04 1.23 
28 M1_Spy_1747 accB Lipid transport and metabolism 
acetyl-CoA carboxylase biotin 
carboxyl carrier protein subunit 3.00E-03 1.57 
44 M1_Spy_0881 mvaS.2 Lipid transport and metabolism 
3-hydroxy-3-methylglutaryl-CoA 
synthase 1.11E-02 1.17 
48 M1_Spy_1745 accC Lipid transport and metabolism acetyl-CoA carboxylase biotin  1.56E-02 1.77 
60 M1_Spy_1746 fabZ Lipid transport and metabolism 
(3R)-hydroxymyristoyl-ACP 
dehydratase 2.35E-02 1.37 
23 M1_Spy_1240 phoU Inorganic ion transport and metabolism 
phosphate uptake regulatory 
protein 1.20E-03 1.09 
52 M1_Spy_0319   Inorganic ion transport and metabolism 
ABC transporter substrate 
binding protein  1.74E-02 -1.57 
75 M1_Spy_1242 pstB2 Inorganic ion transport and metabolism 
phosphate transporter ATP-
binding protein 4.09E-02 1.00 
62 M1_Spy_0867   General function prediction only 
ABC transporter ATP-binding 
protein 2.60E-02 0.87 
10 M1_Spy_1193   Function unknown  hypothetical protein 2.00E-04 -1.08 
12 M1_Spy_2153   Function unknown  hypothetical protein  2.00E-04 1.71 
15 M1_Spy_1591   Function unknown  hypothetical protein  3.00E-04 -1.44 
17 M1_Spy_1736   Function unknown  hypothetical protein  5.00E-04 1.64 
20 M1_Spy_1460   Function unknown  hypothetical protein  5.00E-04 -1.64 
32 M1_Spy_1731   Function unknown  hypothetical protein  4.20E-03 -1.02 
36 M1_Spy_0796   Function unknown  hypothetical protein  6.20E-03 1.34 
37 M1_Spy_0439   Function unknown  hypothetical protein  6.70E-03 1.01 
40 M1_Spy_1940   Function unknown  hypothetical protein  8.00E-03 2.23 
42 M1_Spy_1290   Function unknown  hypothetical protein (signal peptide) 1.01E-02 1.39 
46 M1_Spy_1482   Function unknown  hypothetical protein  1.31E-02 -1.24 
51 M1_Spy_0382   Function unknown  hypothetical protein  1.74E-02 -0.70 
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54 M1_Spy_1263   Function unknown  small membrane integral protein  1.86E-02 -0.94 
59 M1_Spy_0604   Function unknown  hypothetical protein  2.30E-02 0.67 
68 M1_Spy_1945   Function unknown  hypothetical protein  3.14E-02 1.90 
70 M1_Spy_1530   Function unknown  hypothetical protein  3.36E-02 -0.78 
73 M1_Spy_1405   Function unknown  hypothetical protein  3.75E-02 -1.71 
78 M1_Spy_1192 citC Energy production and conversion  citrate lyase synthetase 4.77E-02 -0.60 
22 M1_Spy_1897   cell wall / membrane / envelope biogenesis 
Small conductance 
mechanosensitive channel 8.00E-04 1.23 
25 M1_Spy_0794   cell wall / membrane / envelope biogenesis glycosyl transferase 1.80E-03 0.87 
47 M1_Spy_1358 murZ cell wall / membrane / envelope biogenesis 
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase  1.52E-02 1.50 
2 M1_Spy_2185 gidA Cell cycle control, cell division  
tRNA uridine 5-
carboxymethylaminomethyl 
modification enzyme  
0.00E+00 2.42 

77 M1_Spy_1730 hit Cell cycle control, cell division  
Diadenosine tetraphosphate 
hydrolase 4.35E-02 -0.79 
35 M1_Spy_1854 glpF.2 Carbohydrate transport and metabolism glycerol uptake facilitator protein 5.80E-03 1.23 
58 M1_Spy_1711   Carbohydrate transport and metabolism 
PTS system galactose-specific 
transporter subunit IIA 2.22E-02 -1.66 
63 M1_Spy_1399 nagB Carbohydrate transport and metabolism 
N-acetylglucosamine-6-
phosphate isomerase 2.75E-02 -1.02 
4 M1_Spy_1506   Amino acid transport and metabolism  
amino acid ABC transporter 
ATP-binding protein 0.00E+00 2.26 
45 M1_Spy_1542   Amino acid transport and metabolism  
Dipeptidase (glutathione-
mediated detox) 1.20E-02 -1.21 
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6.2.2 Applying neighbor clustering algorithms reveal additional insights on S. 
pyogenes gene expression profiles 
  
 
“GenomeCrawler is a dynamic windowing (“GenomeCrawler”) algorithm that 
sequentially steps through the microarray data and identifies clusters of adjacent 
genes exhibiting similar fold changes in expression.   Neighbor clustering was 
designed to identify expanded groupings of potentially related genes from our 
array data by incorporating two reliable predictors of genes that share common 
function or regulation, namely physical proximity and similar expression profiles 
GenomeCrawler applies a separate permutation algorithm, using the sum of 
each gene’s t-statistics to calculate adjusted P values for each cluster.” We 
applied the algorithms to our microarray data set and then visually inspect the 
resulting clusters, omitting those incongruent with the neighbor cluster definition 
as described in the Methods section.  
 
A number of different sized clusters containing the same gene(s) remained 
following initial visual curating. To avoid overlapping cluster groups, we curate 
clusters and chose the most significant grouping containing the largest number of 
members A total of 55 clusters containing 216 genes were identified by this. 
Clusters ranged in grouping sizes from including 2 to 32 genes. (Table 6.4) 
 
In some cases, resulting clusters identified previously described or predicted 
operons (i.e. Spy0127 – Spy 130). In others, our analysis identified novel 
groupings of genes, which may indicate functional relationships not previously 
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known. Of the 78 individual genes we identified in our initial analysis as 
undergoing significant differential expression, 62 (78%) were components of 
significant clusters whereas 16 remained un-grouped. In approximately 25% of 
the resulting groupings (n = 14), we identified significance gene clusters, even 
though none of the cluster members had initially identified as undergoing 
significant log2-fold changes in expression. In such clusters, our algorithm 
revealed that the combined contributions of the non-significant gene fold changes 
resulted in a significant cluster. Ryan et al initially coined this concept of 
“significance by combined gene contributions” in their published work employing 
the Genome Crawler algorithm (Ryan 2007).  
 
A nearly equivalent number of clusters were up regulated (29) as were down 
regulated (26). We identified eight significantly down-regulated phage gene 
clusters, which accounting for 30% of all gene clusters with noted decreases in 
expression.  
 
Using a previously described scheme for organizing neighbor clustering analysis 
data (Ryan 2007), we qualitatively subdivided our clusters into three categories 
based on the availability of functional information on their gene content.  Twenty-
three (42%) of our 55 neighbor clusters were designated as Type I clusters, 
composed of genes that have been functionally defined either in the annotated 
genome or in subsequent published reports. Twenty-seven (49%) were 
designated Type II clusters containing both known and unknown genes. Finally, 5 
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(.09%) were categorized as Type III, which contained only unknown genes. 
(Table 6.4) 
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Table 6.4 Qualifying neighbor clusters identified in the S. pyogenes SF370 genome 
by GenomeCrawler analysis of palatine tonsil epithelia – associated bacteria versus 
nasopharyngeal – associated microarray data. Type I gene clusters – contain only 
genes of known function (highlighted in shades of yellow). Type II gene clusters – 
combination of both genes of known and unknown function (highlighted in shades of 
green). Type III gene clusters – contain only genes of unknown function (highlighted 
in shades of blue) 
aLocus (Spy) numbers and common gene names are as designated in the annotated 
SF370 genome. Genome function designations are also from annotated genome. 
Fold change P values calculated by Cyber-T and Westfall-Young permutations as 
previously described. Bold Log2Fold indicate downregulation ( - ) change in 
expression ratios between palatine tonsil epithelia – associated streptococci versus 
control nasopharyngeal –associated streptococci. Astericks indicates individual gene 
not scored as significant as p<0.05.  
  140 
Start Stop Function / COGa 
p-valueb 
(Cluster) 
Cluster 
Membera  
Gene 
Namea 
Description / Gene 
Product 
 p-valuec     
(Indiv. 
genes) 
∆ 
Log2
Fold  
 
Spy0047 
- Spy0078 
Translation, 
ribosomal structure, 
and biogenesis 1.00E-04 Spy0047 rpsJ 
30S ribosomal protein 
S10 2.00E-04 2.62 
 
        Spy0049 rplC 
50S ribosomal protein 
L3 0.1109* 2.28 
 
        Spy0050 rplD  
50S ribosomal protein 
L4  0.3993* 2.34 
 
        Spy0051 rplW 
50S ribosomal protein 
L23  0.4364* 1.22 
 
        Spy0052 rplB  
50S ribosomal protein 
L2  0.2411* 1.54 
 
        Spy0053 rpsS 
30S ribosomal protein 
S19 0.7039* 1.30 
 
        Spy0054     0.1009* 1.12  
        Spy0055 rplV 
50S ribosomal protein 
L22  0.1605* 1.28 
 
        Spy0056 rpsC 
30S ribosomal protein 
S3  0.3367* 1.79 
 
        Spy0057 rplP 
50S ribosomal protein 
L16  0.1226* 0.94 
 
        Spy0058     0.1373* 1.12  
        Spy0059 rpmC 
50S ribosomal protein 
L29  0.6973* 1.35 
 
        Spy0060 rpsQ 
30S ribosomal protein 
S17  0.2557* 1.17 
 
        Spy0061   
50S ribosomal protein 
L14 0.2004* 1.35 
 
        Spy0062 rplX 
50S ribosomal protein 
L24  0.7391* 1.57 
 
        Spy0063 rplE 
50S ribosomal protein 
L5  0.4231* 1.12 
 
        Spy0064 rpsN  
30S ribosomal protein 
S14 0.0945* 1.43 
 
        Spy0065 rpsH 
30S ribosomal protein 
S8 0.7465* 1.48 
 
        Spy0066 rplF 
50S ribosomal protein 
L6 0.2186* 1.36 
 
        Spy0067 rplR 
50S ribosomal protein 
L6 0.3756* 1.37 
 
        Spy0068     0.3446* 1.81  
        Spy0069 rpsE 
30S ribosomal protein 
S5  0.56* 1.51 
 
        Spy0070     0.5687* 1.72  
        Spy0071 rpmD 
50S ribosomal protein 
L30  0.8102* 0.49 
 
        Spy0072 rplO  
50S ribosomal protein 
L15  1* 0.01 
 
    
Intracellular 
trafficking and 
scretion    Spy0073 secY 
putative preprotein 
translocase  1* 0.06 
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Nucleotide transport 
and metabolism   Spy0074 adk adenylate kinase  0.9893* 0.35 
 
        Spy0075 infA 
putative translation 
initiation factor IF-1 0.8102* 0.49 
 
        Spy0076 rpmJ 
50S ribosomal protein 
B 1* 0.01 
 
        Spy0077 rpsM 
30S ribosomal protein 
S13  1* 0.06 
 
        Spy0078 rpsK 
30S ribosomal protein 
S11  0.9893* 0.35 
 
Spy012
7 - Spy0130 virulence 7.00E-04 Spy0127 SipA1 
putative signal 
peptidase I 0.7331* 1.38 
 
        Spy0128   
major pilus (shaft) 
subunit 0.553* 2.46 
 
        Spy0129 SrtC1 
pilus associated 
sortase C1 0.9934* 0.93 
 
        Spy0130   
pilin minor subunit / cell 
wall linker  0 3.62 
 
Spy028
5 - Spy0290 
Post-Translational 
modification,  
protein turnover, 
chaperones   Spy0285 sufC 
putative ABC 
transporter (ATP-
binding protein) 0.2725* 0.83 
 
        Spy0287 sufD 
ABC-type transport 
system involved in Fe-S 
cluster assembly 0.0332 1.01 
 
    
Amino acid transport 
& metabolism   Spy0288 csdA 
putative 
aminotransferase  0 1.37 
 
    
Energy production 
and conversion   Spy0289   similar to NifU protein  0.2108* 1.22 
 
        Spy0290   
conserved hypothetical 
protein  0.445* 1.34 
 
Spy031
9 - Spy0321 
Inorganic ion 
transport and 
metabolism 0.0134 Spy0319   
ABC transporter 
substrate binding 
protein 0.0174 -1.57 
 
        Spy0320   
putative ABC 
transporter (ATP-
binding protein)h 0.3305* -1.50 
 
        Spy0321   
putative ABC 
transporter (permease 
protein) 0.367* -1.14 
 
Spy032
6 - Spy0327 
Inorganic ion 
transport  0.0329 Spy0326   
K+ transport systems, 
NAD-binding 
component 0.0655* 0.76 
 
        Spy0327 ntpJ 
V-type Na+ -ATPase 
subunit J 0.3148* 0.94 
 
Spy046
0 - Spy0461 
Translation, 
ribosomal structure, 
and biogenesis 0.0155 Spy0460 rplK 
50S ribosomal protein 
L11  0.4118* 1.98 
 
        Spy0461 rplA 
50S ribosomal protein 
L1  0.0034 1.90 
 
Spy050
3 - Spy0505 Transcription 0.0042 Spy0503   
putative 
exoribonuclease R / 
RNAse 0.0085 -0.81 
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Translation, 
ribosomal structure, 
and biogenesis   Spy0504 smpB tmRNA-binding protein 0.0019 -0.88 
 
    
Post-Translational 
modification,  protein 
turnover, chaperones   Spy0505   
putative glutamine 
cyclotransferase  0.128* -0.78 
 
Spy051
1 - Spy0513 
Amino acid 
transport and 
metabolism 0.0407 Spy0511 gloA 
putative 
lactoylglutathione lyase 0.7264* -0.73 
 
    
Energy production 
and conversion   Spy0512   
putative NAD(P)H-flavin 
oxidoreductase 0.1863* -0.84 
 
        Spy0513 pepQ 
putative XAA-PRO 
dipeptidase; X-PRO 
dipeptidase  0.2885* -0.75 
 
Spy075
5 - Spy0761 
Energy production / 
conversion 0.0088 Spy0755 atpB 
putative proton-
translocating ATPase a 
subunit 0.8932* 0.39 
 
        Spy0756 atpF 
putative proton-
translocating ATPase, 
subunit b  0.6166* 0.52 
 
        Spy0757 atpH 
putative proton-
translocating ATPase, 
delta subunit  0.348* 0.70 
 
        Spy0758 atpA 
putative proton-
translocating ATPase, 
alpha subunit 0.593* 0.86 
 
        Spy0759 atpG 
putative proton-
translocating ATPase, 
gamma subunit  0.1905* 0.78 
 
        Spy0760 atpD 
putative proton-
translocating ATPase, 
beta subunit  0.3601* 0.79 
 
        Spy0761 atpC 
putative proton-
translocating ATPase, 
epsilon subunit  0.0874* 0.73 
 
Spy084
9 - Spy0852 
Translation, 
ribosomal structure, 
and biogenesis 0.0016 Spy0849 trmD  
putative tRNA 
(guanine-N1)-
methyltransferase 0.0295 1.14 
 
    
Posttranslational 
modification, protein 
turnover, chaperones   Spy0850   
putative thioredoxin 
reductase 0.0002 1.89 
 
    
General function 
prediction only   Spy0851   
probable regulatory 
protein  0.8808* 1.26 
 
    
Coenzyme transport 
and metabolism   Spy0852 apbA 
putative 2-
dehydropantoate 2-
reductase 0.05 1.16 
 
Spy088
0 - Spy0881 
Lipid transport and 
metabolism 0.005 Spy0880 mvaS.1 
putative 3-hydroxy-3-
methylglutaryl-
coenzyme A 0.0005 1.23 
 
        Spy0881 mvaS.2 
putative 3-hydroxy-3-
methylglutaryl-
coenzyme A synthase 
(HMG-CoA synthase) 0.0111 1.17 
 
Spy109
7 - Spy1100 
Coenzyme transport 
and metabolism 0.021 Spy1097 folE GTP cyclohydrolase 0.7809* -0.36 
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        Spy1098 folP 
dihydropteroate 
synthase  0.4987* -0.52 
 
        Spy1099 folQ 
dihydroneopterin 
aldolase 0.1257* -0.58 
 
        Spy1100 folK 
hydroxymethylpterin 
pyrophosphokinase  0.1925* -0.57 
 
Spy116
1 - Spy1163 
Translation, 
ribosomal structure, 
and biogenesis 0.0066 Spy1161   Predicted GTPases 0.0282 -1.01 
 
    
Replication, 
recombination and 
repair   Spy1162 rnh 
putative ribonuclease 
HII  0.4548* -0.59 
 
        Spy1163 smf 
putative DNA 
processing protein (Smf 
family) 0.0029 -1.19 
 
Spy124
0 - Spy1243 
Inorganic ion 
tansport and 
metabolism 0.0055 Spy1240 phoU 
putative phosphate 
uptake regulatory 
protein 0.0012 1.09 
 
        Spy1241 pstB  
phosphate ABC 
transporter (ATP-
binding protein) 0.8424* 0.48 
 
        Spy1242 pstB2 
putative phosphate 
ABC transporter (ATP-
binding protein 0.0409 1.00 
 
        Spy1243 pstC 
putative phosphate 
ABC transporter  0.2706* 0.89 
 
Spy125
4 - Spy1257 
Defense 
mechanisms 0.0333 Spy1254     0.473* -0.65 
 
        Spy1255 SalY? 
COG577: ABC-type 
antimicrobial peptide 
transport system, 
permease component 0.1656 -0.84 
 
        Spy1257 SalX? 
COG1136: ABC-type 
antimicrobial peptide 
transport 
system,ATPase 
component 0.4026 -0.96 
 
Spy135
8 - Spy1359 
Cell wall/membrane 
biogenesis 0.0332 Spy1358 murZ 
putative UDP-N-
acetylglucosamine 1- 0.0152   
 
    
Coenzyme transport 
and metabolism   Spy1359 metK 
S-adenosylmethionine 
synthetase  0.7516* -0.07 
 
Spy137
4 - Spy1375 
Post-Translational 
modification,  protein 
turnover, chaperones 0.0055 Spy1374 nrdH putative glutaredoxin 0.0252 1.86 
 
    
Nucleotide transport 
and metabolism   Spy1375 nrdE.2 
 putative ribonucleotide 
reductase alpha-chain  0.0014 1.40 
 
Spy137
8 - Spy1379 
Nucleotide transport 
and metabolism 0.0159 Spy1378 nrdF.2 
ribonucleotide 
diphosphate reductase 
small subunit  0.0002 1.65 
 
    
Inorganic ion tansport 
and metabolism   Spy1379   
putative chloride 
channel protein  0.9943* 0.49 
 
Spy174
5 - Spy1749 
Lipid Transport and 
metabolism  0.0019 Spy1745 accC 
acetyl-CoA carboxylase 
biotin  0.0156 1.77 
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        Spy1746 fabZ 
(3R)-hydroxymyristoyl-
ACP dehydratase 0.0235 1.37 
 
        Spy1747 accB 
acetyl-CoA carboxylase 
biotin carboxyl carrier 
protein subunit 0.003 1.57 
 
        Spy1749 fabG 
3-ketoacyl-ACP 
reductase 0.0004 1.45 
 
Spy175
1 - Spy1758 
Lipid Transport and 
metabolism  1.40E-03 Spy1751 fabK 
putative trans-2-enoyl-
ACP reductase II 0.0002 1.66 
 
        Spy1753 acpP 
putative acyl carrier 
protein 0.5995* 0.58 
 
        Spy1754 fabH 
fabH putative beta-
ketoacyl-[ACP] 
synthase III  0.3849* 0.96 
 
        Spy1755   
[REGULATOR]  
MarR family 0.0044 1.25 
 
        Spy1758 phaB 
putative enoyl CoA 
hydratase 0.1324* 0.93 
 
Spy177
0 - Spy1772 
Lipid Transport and 
metabolism 0.0101 Spy1770 gatB 
aspartyl/glutamyl-tRNA 
amidotransferase 
subunit B 0.0163 1.31 
 
    
Post-Translational 
modification,  protein 
turnover, chaperones   Spy1771 gatA 
Glutamyl-tRNA Gln 
amidotransferase 
subunit A 0.1124* 1.07 
 
    
Translation, 
ribosomal structure, 
and biogenesis   Spy1772 gatC 
Glu-tRNA Gln 
amidotransferase 
subunit C 0.3028* 0.90 
 
Spy194
0 - Spy1941 
Translation, 
ribosomal structure, 
and biogenesis 0.0424 Spy1940   hypothetical protein  0.008 2.23 
 
        Spy1941 cysS 
cysteinyl-tRNA 
synthetase  0.9493* 0.85 
 
Spy209
2 - Spy2093 
Translation, 
ribosomal structure, 
and biogenesis 0.0312 Spy2092 rpsB 
30S ribosomal protein 
S2 0.1349* 1.85 
 
        Spy2093 tsf 
putative elongation 
factor TS  0.1684* 2.05 
 
Spy028
1 - Spy0282 
General function 
prediction only 2.00E-04 Spy0281 mecA 
putative negative 
regulator of genetic 
competence 0.8124* 0.68 
 
    
Cell wall/membrane 
biogenesis   Spy0282 rgpG 
possibly involved in 
regulation of genetic 
competence  0.4895* 0.71 
 
Spy035
8 - Spy0367 
General function 
prediction only 0.014 Spy0358   
putative membrane 
spanning protein 0.1413* 0.53 
 
    Function unknown   Spy0359   
Uncharacterized protein 
conserved in bacteria 0.9308* 0.36 
 
    
Cell wall/ membrane/ 
envelope biogenesis   Spy0361 glr glutamate racemase 0.9301* 0.47 
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Nucleotide transport 
and metabolism   Spy0362   
Xanthosine 
triphosphate 
pyrophosphatase 0.5768* 0.53 
 
    
General function 
prediction only   Spy0363   phosphoesterase 0.6548* 0.48 
 
    Multifunctional   Spy0364   CBS domain 0.5062* 0.61  
    
Replication, 
recombination and 
repair   Spy0365 XerD 
site-specific tyrosine 
recombinase XerD-like 
protein 0.5139* 0.67 
 
    Function unknown   Spy0366 scpA 
segregation and 
condensation protein A 0.5124* 0.47 
 
    Transcription   Spy0367 scpB 
segregation and 
condensation protein B 0.6457* 0.53 
 
Spy037
9 - Spy0382 
Posttranslational 
modification, protein 
turnover, chaperones 0.0129 Spy0379 pflC 
pyruvate-formate lyase 
activating enzyme 0.2173* -1.27 
 
    
Energy production 
and conversion   Spy0380   
Exopolyphosphatase; 
Possible adhesin 
(intrageneric 
coaggregation-relevant 
adhesin) 0.4667* -0.70 
 
    function unknown   Spy0382   
conserved 
streptococcal 
hypothetical protein  0.0174 -0.70 
 
Spy043
9 - Spy0441 function unknown 0.0052 Spy0439   hypothetical protein  0.0067 1.01 
 
    
Lipid transport and 
metabolism    Spy0440 fabG 
3-ketoacyl-ACP 
reductase 0.0645* 1.18 
 
    
General function 
prediction only   Spy0441   
NAD-dependent 
oxidoreductase 0.1238* 1.10 
 
Spy056
7 - Spy0569 
General function 
prediction only 0.0493 Spy0567   
Predicted hydrolases of 
the HAD superfamily 0.2834* 0.90 
 
    
General function 
prediction only   Spy0568   
Predicted hydrolases of 
the HAD superfamily 0.7443* 0.63 
 
    
Intracellular 
trafficking and 
secretion   Spy0569 ftsY 
putative signal 
recognition particle 
(docking protein) 0.3685* 0.49 
 
Spy065
8 - Spy0667 Phage 0.0022 Spy0658   
(Φ370.1) putative Cro-
like protein, phage 
associated 0.3003* -0.67 
 
        Spy0659   
(Φ370.1) hypothetical 
protein, phage 
associated  0.6513* -0.67 
 
        Spy0660   
(Φ370.1) hypothetical 
protein, phage 
associated  0.3359* -0.73 
 
        Spy0661   
(Φ370.1) hypothetical 
protein, phage 
associated  0.0209 -0.72 
 
        Spy0663   
(Φ370.1) hypothetical 
protein, phage 
associated  0.9237* -0.51 
 
        Spy0664   
(Φ370.1) hypothetical 
protein, phage 0.6749* -0.61 
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associated  
        Spy0665   
(Φ370.1) hypothetical 
protein, phage 
associated  0.1435* -0.63 
 
        Spy0666   
(Φ370.1) replication, 
phage associated  0.2469* -0.59 
 
        Spy0667   
(Φ370.1) hypothetical 
protein, phage 
associated  0.3414* -0.63 
 
Spy068
0 - Spy0681 Phage 0.0073 Spy0680   
(Φ370.1) Head 
morphogenesis, phage 
associated  0.0575* -0.91 
 
        Spy0681   
(Φ370.1) Head 
morphogenesis 
(Portal protein), phage 
associated  0.0033 -0.98 
 
Spy079
1 - Spy0798 
Cell wall/membrane 
biogenesis 1.00E-04 Spy0791 rgpEc 
putative 
glycosyltransferase - 
possibly involved in cell 
wall localization and 
side chain formation of 
rhamnose-glucose 
polysaccharide 0.6189* 0.46 
 
        Spy0792 rgpFc 
conserved hypothetical 
protein - possibly 
involved in cell wall 
localization and side 
chain formation of 
rhamnose-glucose 
polysaccharide  0.1973* 0.65 
 
        Spy0793   
phosphoglycerol 
transferase related; 
alkaline phosphatase 
superfamily 0.1907* 0.85 
 
        Spy0794   
putative glycosyl 
transferase  0.0018 0.87 
 
    Function unknown   Spy0796   hypothetical protein 0.0062 1.34  
    virulence regulator   Spy0797 amrA 
[REGULATOR] 
Activation of Mga 
regulon  0.0052 1.05 
 
    Function unknown   Spy0798   
predicted membrane 
protein 0.0598* 1.29 
 
Spy087
3 - Spy0875 Function unknown 0.0179 Spy0873   
conserved hypothetical 
protein 0.1163* -0.57 
 
    
two component 
system   Spy0874 sptR 
(sptR-sptS) Important 
for persistence in 
human saliva; 
Activation of spd, speB, 
sic, has, and complex 0.5299* -0.37 
 
    
two component 
system   Spy0875 sptS 
carbohydrate utilization 
pathways 0.0749* -0.54 
 
Spy088
3 - Spy0887 
Coenzyme transport 
and metabolism 1.00E-04 Spy0883 dyr 
putative dihydrofolate 
reductase 0.8166* 0.40 
 
    Function unknown   Spy0884   hypothetical protein 0.0767* 0.88  
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Posttranslational 
modification / prottein 
turnover   Spy0885 clpX 
ATP-dependent Clp 
protease subunit X 0.0204 0.90 
 
    
General function 
prediction only   Spy0886 engB 
conserved hypothetical 
GTP-binding protein  0.0107 1.05 
 
    virulence regulator   Spy0887 vfr 
[REGULATOR] 
Repression of speB via 
RopB; No DNA binding 
activity 0 1.49 
 
Spy089
4 - Spy0895 
Nucleotide 
transport and 
metabolism 0.0191 Spy0894 deoD2 
putative purine 
nucleoside 
phosphorylase 0.0369 0.78 
 
    
General function 
prediction only   Spy0895   histidine protein kinase  0.1079* 0.95 
 
Spy091
6 - Spy0917 Function unknown  0.0461 Spy0916   hypothetical protein  0.623* -0.88 
 
    
Posttranslational 
modification, 
protein turnover, 
chaperones   Spy0917   
Glutathione S-
transferase 0.0746* -1.00 
 
Spy119
2 - Spy1193 
Energy production / 
conversion 0.0035 Spy1192 citC 
putative citrate lyase 
synthetase (citrate (pro-
3S)-lyase ligase) 0.0477 -0.60 
 
    Function unknown    Spy1193   hypothetical  0.0002 -1.08  
Spy140
2 - Spy1405 
Cell wall/membrane 
biogenesis 0.008 Spy1402   hypothetical protein  0.1363* -1.58 
 
    Function Unknown    Spy1404   hypothetical protein  0.0678* -1.54  
        Spy1405   hypothetical protein  0.0375 -1.71  
Spy142
5 - Spy1429 Function Unknown  0.0279 Spy1425   hypothetical protein  0.232* -1.84 
 
    
General function 
prediction only   Spy1427   
putative transcriptional 
regulator ? 0.1341* -2.07 
 
    
Carbohydrate 
transport and 
metabolism   Spy1429 gpmA 
putative 
phosphoglycerate 
mutase  0.6725* -0.48 
 
Spy143
8 - Spy1442 Phage  0.0053 
Spy0143
8   
(Φ370.3) Muramidase 
(flagellum-specific) 0.003 -1.10 
 
        
Spy0144
0   (Φ370.3) putative holin      
 
        
Spy0144
1   (Φ370.3) Tail fiber gene 0.0005 -1.06 
 
        
Spy0144
2   
(Φ370.3)  - phage 
associated 0.0309 -1.05 
 
Spy145
7 - Spy1465 Phage  2.00E-04 
Spy0145
7   
(Φ370.3) putative 
structural protein  0.0178 -1.01 
 
        
Spy0146
0   
(Φ370.3)  - phage 
associated 0.0005 -1.64 
 
    `   
Spy0146
2   
(Φ370.3)  - phage 
associated 0.3555* -1.17 
 
        
Spy0146
3   
(Φ370.3)  - phage 
associated 0.1166* -1.26 
 
        
Spy0146
4   
(Φ370.3)  Head 
morphogenesis 0.0002 -1.34 
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Spy0146
5   
(Φ370.3) putative 
structural protein  0.0002 -1.35 
 
Spy148
6 - Spy1487 Phage 0.0161 
Spy0148
6   
(Φ370.3)  putative 
repressor - phage 
associated  0.1819* -1.04 
 
        
Spy0148
7   (Φ370.3)  Lysogeny 0.0165 -0.92 
 
Spy151
0 - Spy1511 
Replication, 
recombination and 
repair 0.0479 
Spy0151
0 mutT putative mutator protein 0.0425 -1.18 
 
        
Spy0151
1   hypothetical protein  0.7238* -0.68 
 
Spy152
9 - Spy1530 
Carbohydrate 
transport and 
metabolism 0.0203 
Spy0152
9 glcK glucose kinase 0.1806* -0.56 
 
    Function unknown   
Spy0153
0   
conserved hypothetical 
protein  0.0336 -0.78 
 
Spy154
1 - Spy1547 
Amino acid 
transport & 
metabolism 0.0022 Spy1541 arcC 
putative carbamate 
kinase 0.1302* -1.00 
 
        Spy1542   
Dipeptidase 
(glutathione-mediated 
detox) 0.012 -1.21 
 
        Spy1543   
predicted membrane 
protein 0.3614* -1.45 
 
        Spy1544 arcB 
putative ornithine 
transcarbamylase  0.1573* -1.72 
 
        Spy1546   hypothetical protein  0.1856* -1.93  
        Spy1547 
sagP / 
(arcA) 
 arginine deiminase /                           
[VIRULENCE] 
Activator of SpeB 0.0584* -1.90 
 
Spy173
0 - Spy1731 
Cell cycle control, 
cell division 0.0068 Spy1730 hit 
putative cell-cycle 
regulation histidine triad 0.0435 -0.79 
 
    Function unknown    Spy1731     0.0042 -1.02  
Spy173
3 - Spy1736 Transcription 0.0088 Spy1733   
[REGULATOR] Cell 
envelope-related 
repressor 0.2927* 0.62 
 
    Lipid metabolism   Spy1734   
Acetyltransferase, 
including N-acetylases 
of ribsomal proteins 0.9782* 0.54 
 
    
General function 
prediction only   Spy1735   
hypthetical / COG802: 
Predicted ATPase or 
kinase 0.2225* 1.13 
 
    
General function 
prediction only   Spy1736     0.0005 1.64 
 
Spy194
4 - Spy1946 Function unknown  0.0083 Spy1944 cysE serine acetyltransferase 0.0553* 1.29 
 
    
Translation, 
ribosomal structure, 
and biogenesis   Spy1945   hypothetical protein  0.0314 1.90 
 
        Spy1946 pnpA 
putative polynucleotide 
phosphorylase, alpha 
chain  0.1783* 1.45 
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Spy211
2 - Spy2114 
Translation, 
ribosomal structure, 
and biogenesis 0.0199 Spy2112   
conserved hypothetical 
protein 0.3502* -0.57 
 
    
Replication, 
recombination and 
repair   Spy2113   
Predicted 
endonuclease involved 
in recombination  0.1506* -0.63 
 
    Function unknown    Spy2114   hypothetical protein 0.1451* -0.63  
Spy218
5 - Spy2186 
Cell cycle control, 
cell division 9.00E-04 Spy2185 gidA 
 tRNA uridine 5-
carboxymethylaminome
thyl modification 
enzyme 0 2.42 
 
    Function unknown   Spy2186   hypothetical protein 0.3646* 1.68  
Spy220
9 - Spy2211 Function unknown  0.0486 Spy2209   
conserved hypothetical 
protein 0.1952* 1.05 
 
    
Nucleotide 
transport and 
metabolism   Spy2210   
ABC transporter, ATP-
binding protein  0.9766* 0.23 
 
    Function unkown    Spy2211   
predicted membrane 
protein 0.1319* 1.07 
 
Spy060
3 - Spy0604 Function unknown  0.033 Spy0603   
Hypothetical protein 
(signal peptide) 0.5017* 1.08 
 
        Spy0604   hypothetical protein  0.023 0.67  
Spy094
5 - Spy0947 Phage 0.0054 Spy0945   
(Φ370.2) hypothetical 
protein, phage 
associated  0.0072 -1.05 
 
        Spy0946   
(Φ370.2) putative P1-
type antirepressor, 
phage associated 0.0799* -0.99 
 
        Spy0947   
(Φ370.2) hypothetical 
protein, phage 
associated  0.0692* -0.98 
 
Spy095
6 - Spy0963 Phage 0.0122 Spy0956   
(Φ370.2) hypothetical 
protein, phage 
associated  0.9042* -0.79 
 
        Spy0957   
(Φ370.2) hypothetical 
protein, phage 
associated  0.2373* -0.95 
 
        Spy0958   
(Φ370.2) hypothetical 
protein, phage 
associated  0.5753* -0.80 
 
        Spy0959   
(Φ370.2) hypothetical 
protein, phage 
associated  0.2934* -1.00 
 
        Spy0960   
(Φ370.2) hypothetical 
protein, phage 
associated  0.0994* -0.98 
 
        Spy0961   
(Φ370.2) hypothetical 
protein, phage 
associated  0.8586* -0.54 
 
        Spy0962   
(Φ370.2) hypothetical 
protein, phage 
associated  0.9604* -0.60 
 
        Spy0963   
(Φ370.2) hypothetical 
protein, phage 
associated  0.4782* -0.66 
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Spy107
5 - Spy1077 Phage  0.0447 Spy1075   
(Φ370-RD.1) 
hypothetical protein, 
phage associated  0.035 -1.11 
 
        Spy1077   
(Φ370-RD.1) putative 
methyl transferase, 
phage associated 0.7174* -0.97 
 
Spy215
3 - Spy2154 Function unknown 0.0045 Spy2153   
conserved hypothetical 
protein 0.0002 1.71 
 
    Function unknown   Spy2154   
Hypothetical protein 
[transmembrane]  0.2017* 1.09 
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6.2.3 SF370 pili play a significant role during adherence and invasion during co-
culture with HPTE and tonsil tumor-derived cell lines  
 
 
Among the notable Type I clusters identified, neighbor cluster Spy0127 – 
Spy0130 encoding the pilus forming operon within the GrAS FCT-2 (Fibronectin 
and Collage binding and T antigen) pathogenicity region was significantly up 
regulated in comparison with our control bacteria associated with Detroit cells. 
Previously, our lab determined this cluster was indeed an operon through in silico 
analysis and reverse transcription of deletion mutants (Ryan 2007). These 
findings were concurrently examined and verified by others.  (Abbot 2007, 
Manetti 2007). Ryan et al observed in their microarray studies that this cluster 
was upregulated during adherence to Detroit 562 monolayers as compared to 
control bacteria that were associated but not yet adhered. In our work presented 
here, we see a significant upregulation of the pilus operon, which indicates a role 
for the pili in preparation for, or subsequent adherence to, the tonsillar cells. Our 
finding that there is a significant increase in transcription of this operon as 
compared to the control (Detroit 562 cells) suggests that the pili, or transcription 
of one or all genes may be even more important to adherence to the bacterium’s 
target tissue (the tonsil) as compared to a proximal cell type (Detroit cell), We 
tested this hypothesis in studies with the pili knock-out mutant presented later in 
this work.  
 
Our finding that the pili operon genes are significantly upregulated at the 
association stage with tonsillar epithelial cells as compared to Detroit cells 
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suggests that pili may contribute to the tropism for tonsillar cells, if we assume 
that the mechanisms for adherence to the two cell types are the same.  
Increased expression during association may simply indicate earlier gene 
activation in the tonsil environment than in the Detroit 562 environment, or it 
might indicate the expression of more total number of pili being synthesized and 
organized at the bacterial cell surface. Since the mechanism for adherence to the 
tonsillar cell types has yet to be explored, this leads to a new avenue for 
research into the question of tropism.  
 
To confirm the effect of pili on interactions with our tonsil epithelial cells, we used 
a previously characterized deletion mutant of the pilus-associated sortase C1 
gene,ΔSpy0129, (Ryan 2007) in our standard adherence and invasion assay. 
This SF370 mutant is deficient in proper pili production and cell-surface 
presentation. As was demonstrated with Detroit 562 cells (Abbot 2007, Ryan 
2007), we found that the adherence of the pili-mutant to both primary and tumor-
derived tonsil epithelial cells was significantly decreased, (Figure. 6.1) Of note, 
adherence was not completely abolished by the absence of pili, indicating that 
other adhesins likely contribute to adherence, albeit to a lesser degree than the 
pili.  
 
We also assayed strain SF370 in invasion assays using both tonsillar cell lines. 
We report here that invasion capacity by strain SF370 is significantly decreased 
as compared to Detroit 562 cells. (Figure. 6.2)  
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Figure 6.1.  ∆Spy0129 deletion decreases Streptococcal adherence across all 
epithelial monolayers    
ΔSpy0129 mutant was created and verified as apiliated as previously 
described (Ryan 2007). Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE 
cell monolayers were grown to ~95% confluence on Falcon® 24-well tissue 
culture plates. Wells were inoculated with either ΔSpy0129 or parental strain 
SF370SMR (Wild Type, SF370 SMR) at Multiplicity of Infection 100:1 in DMEM 
without serum.  Associated bacteria were removed with PBS and colony 
forming units (cfu) were counted on blood agar as described in the methods.  
Results are the mean  standard deviation of at least three independent 
experiments performed on separate days in triplicate. Statistical significance 
(reported as p value) was determined by Student’s t-test. Asterisks indicates p 
< 0.0001  
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Figure 6.2.  Internalization of M type 1 ΔSpy0129 mutant is greatly decreased 
ΔSpy0129 mutant was created and verified as apiliated as previously 
described (Ryan 2007). Detroit 562, UT-SCC-60A, UT-SCC-60B, and HPTE 
cell monolayers were grown to ~95% confluence on Falcon® 24-well tissue 
culture plates. Wells were inoculated with either ΔSpy0129 or parental strain 
SF370SMR (Wild Type, SF370 SMR) at Multiplicity of Infection 100:1 in DMEM 
without serum.  Associated bacteria were removed by vigorous washing with 
PBS and subsequently treated with Antibiotics cocktail (Penicillin 100ng / µL+ 
Gentamicin 100ng / µL) and PlyC (0.05U / well).  Monolayers were washed 
with PBS and cfu’s were counted on blood agar as described in the methods.  
Results are the mean  standard deviation of at least three independent 
experiments performed on separate days in triplicate. Statistical significance 
(reported as p value) was determined by Student’s t-test. Asterisks indicates p 
< 0 .0001  
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6.3 Discussion 
 
6.3.1 Regulatory systems 
 
GrAS transcription is regulated through the concerted action of 13 conserved 
‘two-component’ signal transduction systems (TCS, containing a sensor kinase 
and a response regulator) and >60 ‘stand-alone’ transcription factors (named due 
to their ability to independently regulate transcription). Between our individual 
gene and cluster analyses, we identified one two-component system, sptR-sptS 
(Spy0874-Spy0875), which has been shown to be important for persistence in 
adult whole saliva. The role of this TCS during persistence in human saliva 
involves linking central metabolic processes with the production of a broad range 
of putative and known virulence factors (Shelburne 2005).  
 
We were also able to identify five putative and known regulators. The first, amrA  
(Spy0797) is so named for “activation of mga regulon” expression locus A. It was 
found to be directly involved with regulating this locus during knockout 
experiments, but the mechanism of this regulator remains unknown. Based on 
sequence homology, Ribardo et al also predicted that amrA may be a membrane 
protein involved in the transport of a polysaccharide component during bacterial 
cell wall production in addition to its modulatory role of mga. We additionally 
identified the regulator, vfr (Spy088) named for virulence factor regulator. The 
function ascribed has been to serve as a repressor of SpeB via RopB. The 
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putative cell wall envelope regulator, Spy1733 and the MarR Family regulators 
Spy1755, were identified in our analysis although their functions are currently 
unknown. All of the stand-alone regulators were up regulated in our analysis. The 
upregulation of vfr is consistent with our assumed mechanisms for adherence, as 
the bacteria would want to suppress SpeB from cleaving surface adhesins. The 
expression of amrA is consistent with its COG designation for cell wall 
biogenesis, as many other genes associated with this function were similarly 
upregulated. The mga locus, and associated virulence factors, showed no effect 
in our analysis so it is possible this regulator may plays dual functions when 
being expressed. As the mechanism for it’s regulation of mga continues to be 
explored, it will be interesting to consider if our finding reflects such a dual role. 
 
While virulence potential may not be fully described for all the identified TCS and 
regulatory systems, the direction of their expression change generally appears to 
be decreasing expression of enzymes that would disarm the bacterial surface 
proteins necessary for adhesion (vrf and sptR-sptS) as well as affecting 
metabolic strategies based on sensing environmental sources of nutrients 
(Spy1755 and sptR-sptS).  
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6.3.2 Complex carbohydrate vs lipid and secondary metabolic pathways for 
energy 
 
As was apparent from our initial analysis of individual genes (Table 6.1), the 
neighbor cluster data identified additional significantly regulated genes that were 
associated with COG designations Lipid Transport and Metabolism (14 out of 14 
genes with this COG), cell wall, membrane biogenesis (7/8), and post 
translational modification and protein turnover (7/10) were up regulated. This is in 
contrast to complex carbohydrate utilization pathways, which were mostly 
downregulated, an observation that is consistent with the downregulation of the 
SptR-SptS TCS.  
 
While it is clear the microenvironment of the tonsillar monolayer would not 
necessarily be rich in available carbohydrate sources, the increased expression 
of lipid transport and metabolism genes may be a unique feature induced by the 
tonsil epithelium monolayer. Juncosa et al reported no significant change in 
SF370 expression of the SptR-SptS TCS either during co-culture with pharyngeal 
conditioned media or following 2.5h associated with Detroit 562 monolayers 
(Juncosa 2012). Inversely, this TCS was reported as upregulated in SF370, 
which were adhered to Detroit 562 cells (Ryan 2007).  
 
To try to understand these observations in the broader context, we were drawn to 
the previously described mevalonic acid pathway, which has been linked to lipid 
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transport, and has recently been proposed as part of a model for bacterial 
persistence within the tonsil niche in vivo (Shea 2010). This pathway converts 
acetyl-CoA to isopentenyl-pyrophosphate (IPP), a short-chain phospholipid 
produced by GrAS that is identical to IPP produced by host epithelial cells and γ
/δ T cells. . A potential role relating the mevalonic acid biosynthesis pathway 
and the host T cell anergy / proliferation axis was proposed by Shea et al 2010 
during their longitudinal microarray-based study in macaques. This group was 
interested in the “interactome” between GrAS transcripts and their influence 
on concomitant host gene expression or vice versa. Throughout the stages of 
macaque infection, they found significant activation of mevalonic pathway 
enzymes correlating with host cell stress response and T cell regulation. In our 
analysis, we saw an upregulation of mevalonic pathway genes mvaS.1 
(Spy0880) and mvaS.2 (Spy0881) as well as the differential regulation of a 
number of other lipid metabolic pathways during association with tonsillar cells. 
We plan to continue these studies to determine if any such gene clusters play a 
role in persistence within the tonsillar environment.  
The mevalonic acid operon (Spy0880-Spy0881) is positioned directly 
downstream of the sptR-sptS TCS. Although Shea and colleagues hypothesized 
that expression of the melavonic acid genes, the activity of the sptR/sptS two-
component system, and consequent production of IPP, promoted enhanced 
GrAS survival in the oropharynx, they concede that additional information is 
needed on the exact role of the IPP stimulated γ/δ T cells (Shea 2010).  
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Recently, a sptR deletion mutant was created in the SF370 background 
(Shelburne 2005). This knockout resulted in an increase in gene expression 
within the FCT operon. In particular, the major shaft subunit (Spy0128) 
responsible for GrAS pilus length and stability was up regulated (Shea 2010). Pili 
expression was accompanied by downregulation of the sptR-sptS regulon. We 
observed a similar expression profile in our data: namely, the downregulation of 
the sptR-sptS TCS and the concomitant upregulation of pili genes with 
downregulation of nearly all differentially expressed carbohydrate metabolism 
associated genes (Tables 6.2 and 6.3). The similarities between our system and 
the SptR knockout simply reconfirm the proposed role of this TCS on regulating 
the expression of particular genes.  
6.3.3 Phage-related genes 
 
 
A survey of the known phage genes that were down-regulated (in both gene 
cluster and individual gene analyses) are consistent with previous reports from 
our lab on streptococcal association and adherence to Detroit 562 cells at a 2.5 
hour incubation time point. The specific downregulation of Φ370.3 -encoded 
muramidase and holin may indicate a decreased release of the phage, which 
would lyse the bacteria and prevent adherence to the target cell.  The 
experiments reported by Juncosa et al mirror our Detroit cell control conditions, 
demonstrated a relative down-regulation of all prophage genes in these cells as 
well compared to bacteria in fresh media. Taken together, the data presented 
here indicate that in the tonsil environment, streptococci are further repressing 
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expression of these phage genes beyond the downregulation already described 
for the Detroit cell environment.  It will be interesting to study why and how phage 
genes are so actively repressed in the tonsillar environment. 
 
The high number of phage-associated genes that have unknown or hypothetical 
functions indicates how little is known about the role of phages in GrAS 
pathogenesis. This is despite the fact that phage ORFs have been shown to 
account for up to 74% of the variability in a GrAS genome (Banks 2004) and 
undoubtedly play a large role in all forms of infection. 
 
 
6.3.4 Final Comment 
In this chapter, we investigated the relative global transcriptional differences 
exhibited by a single representative “throat specialist” emm pattern strain of 
streptococci when exposed to nasopharyngeal versus palatine tonsil-derived 
epithelium. It is clear that in vivo, this non-motile bacterium successfully infects 
the human palatine tonsil, entering either a carrier state or initiating a focal 
disease. Our previous studies have demonstrated that streptococci undergo 
adaptive transcriptional responses to the changing environment. Our current 
study, however, is the first demonstration of streptococcal tissue-specific 
responses between two anatomically relevant locations that would naturally be in 
contact with the pathogen. We have shown that the bacteria produces a unique 
response with features such as increased early activity of the GrAS pili encoded 
operon and a unique metabolism shift. These observations, though limited in 
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scope with what may be interpreted, surely offers the foundation for asking more 
precise questions about streptococcal pathogenesis and its mechanisms 
underlying this apparent tissue predilection.   
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§7.0 STREPTOCOCAL EPITHELIAL INTERNALIZATION  
 
7.1 Introduction 
 
 
S. pyogenes causes invasive disease, finding access to deep tissues of its host, 
to cause necrotizing fasciitis, abscesses, and disseminated sepsis. Although 
historically regarded as an extracellular mucosal pathogen, recent laboratory and 
clinical observations made over the past 20 years have challenged the earlier 
assumption of this pathogen’s obligate extracellular status. Noting similarities 
between group A streptococci and the gram positive Listeria monocytogenes, 
including internalin, which shares structural similarities to streptococcal surface 
proteins, LaPenta and colleagues sought to explore streptococcal internalization 
properties through in vitro modeling of upper airway streptococcal infection. In 
1994, they reported that group A streptococci are internalized by cultured human 
epithelial cells, which are a non-phagocytic cell type, at frequencies as high as 
Listeria in certain strains (LaPenta 1994). With these findings, they were among 
the first to propose that entry into epithelial cells might serve as an initial step 
towards tissue invasion. Since this report, models of GrAS invasion and 
subsequent dissemination have been expanded to include paracellular and 
transcellular mechanisms.  
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7.1.1 Paracellular Invasive Dissemination  
In the paracellular model, S. pyogenes interact with epithelial cell surface 
receptors, inducing changes in either epithelial or endothelial morphology to form 
gaps between an otherwise continuous tissue layer. Cywes et al demonstrated a 
CD44-dependent mechanism for GrAS binding that induced appreciable 
cytoskeletal rearrangements in human keratinocytes leading to membrane 
ruffling and disruption of intercellular junctions. In their model, extracellularly 
bound CD44 transduces an intracellular signal for Rac1-mediated actin 
polymerization. This event in turn results in local movement of the cell membrane 
to form lamellipodia and open intercellular junctions with neighboring cells 
permitting a paracellular entry point for invasive GrAS (Cywes 2001). Pancholi et 
al has additionally proposed a mechanism where the fibrinolytic digestion of 
intercellular junctions by proteolytically active plasminogen may enhance GrAS 
pericellular penetration through pharyngeal cell monolayers, as mediated by 
streptococcal enolase, SEN (Pancholi 2003).  
7.1.2 Transcellular Invasion  
 
In a transcellular model, the GrAS is internalized by epithelial cells and 
subsequently reemerges from the cells, presumably via the basolateral surface. 
Most transcellular models require a eukaryotic extracellular matrix “bridging 
molecule”, either fibronectin or collagen. One such model depends on binding of 
M protein to fibronectin which bridges the bacteria to alpha5beta1 integrin 
(Cleary, 2000) leading to a phosphatidylinositol 3-kinase (PI3K) (Purushothaman 
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et al., 2003)-dependent signaling cascade for cytoskeletal rearrangement and 
subsequent ingestion of streptococci (Dombek 1999). Similarly, in another model 
Sfbl is the main factor required for attachment and invasion using fibronectin as 
its bridging molecule and the alpha5beta1 integrin as cellular receptor. The 
mechanism of uptake in this model is characterized by the generation of large 
membrane invaginations at the bacteria-cell interface without evidence of actin 
recruitment or cellular injury (Molinari 2000).  
 
The virulence factor Sfb1is not present in all invasive strains, like in the well 
characterized clinical isolate A8 strain (Molinari 2000). Alternatively, during 
transcellular invasion by A8, a proteinaceous moiety was described, which does 
not interact with alpha5beta1 or need any known bridging molecule. Bacterial 
attachment stimulates elongation and massive recruitment of neighboring 
microvilli, fusing to surround streptococcal chains, eventually engulfing the 
bacteria (Molinari 2000). Furthermore, not all integrin-mediated transcellular 
invasion necessarily requires a bridging molecule as shown by Caswell et al. in 
2007 in their Scl1-dependent internalization model utilizing a M41 strain with 
HEp-2 epithelial cells. They were able to demonstrate direct interactions between 
the surface expressed Scl1 and the alpha2beta1 integrin that facilitated 
internalization (Caswell 2007).  
 
With the evolution of presumably many routes to the interior of human epithelial 
cells, many question the limit to the transiency this otherwise extracellular 
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bacterium necessarily must exhibit in transcellular models. Osterlund et al. were 
able to move beyond in vitro observations of potentially a laboratory artifact by 
providing clinical evidence of streptococcal internalization.  In their study, they 
reported the presence of viable intra- and extracellular streptococci on excised 
tonsil tissues using electron microscopy and immunohistochemistry. 
Convincingly, they found intracellular S. pyogenes in pharyngeal epithelial cells in 
13 of 14 patients with tonsillitis (93%). Furthermore, intracellular S. pyogenes 
were found in macrophage-like cells in eight (73%) and in epithelial cells in four 
(36%) tonsils from 11 asymptomatic S. pyogenes carriers. This observation led to 
the expanding of the suggestion that the tonsil may contain an intracellular 
reservoir of S. pyogenes that mediates recurrent infection by evading non-
penetrating antibiotics (Osterlund 1997, Cue 2000). Multiple groups have since 
contributed additional evidence towards a potential intracellular niche for the 
pathogen by demonstrating S. pyogenes intracellular survival for up to 7 days, in 
vitro across numerous immortalized human epithelial lines grown in an antibiotic 
supplemented medium. In some cases, the ability of viable S. pyogenes to be 
externalized and establish an extracellular infection has been assessed upon the 
removal of the extracellular antibiotic (Osterlund 1997).  
 
As different GrAS strains may utillize differing mechanisms for epithelial 
internalization, different host cells also engage a range of intracellular pathways 
when infected by streptococci. Among the numerous factors suggested that may 
influence these pathways are the serotype(s) of the invading streptococci, 
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environmental stresses, input signals, and the mounted bacterial transcriptional 
response.  To better understand the disparate mechanisms at play, several 
groups have investigated the intracellular pathways required for the uptake (or 
active invasion) process, from phenotypic (Pancholi 1997) (Wang 2006) 
(Nakagawa 2006) and global transcriptional perspectives (Argawal 2012) (Klenk 
2007) of both the host and pathogen.  
 
7.1.3 Potential Role of Autophagy  
 
Nakagawa et al reported that intracellular S. pyogenes are initially visualized in 
HeLa cell endocytes and then readily escape via Streptolysin O (SLO) to gain a 
replicative niche in the cytoplasm. The process for bacteria escape from these 
endocytes subsequently stimulates autophagy, a fundamental cellular 
homeostatsis pathway in the intracellular degredation and recycling pathways. 
Nearly 80% of cytomplasmic streptococci eventually become trapped in 
autophagosome-like compartments as determined by fluorescence microscopy. 
These compartments then become degraded upon fusion with lysosomes lending 
the investigators to conclude that autophagy plays a protective role during 
streptococcal infection (Nakagawa 2004). 
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7.1.4 Host Cell Response to Invasion  
 
On the epithelial side, Klenk and colleagues noted in HEp-2 cells 86 genes that 
were differentially transcribed following being co-cultured with a M49 GrAS strain 
including genes for cytoskeleton proteins, transcription factors and apoptosis-
related factors (Klenk 2005). In addition, apoptosis was phenotypically observed 
in his and other studies following streptococcal invasion, albeit by different 
apoptosis mechanisms in an often serotype-dependent manner (Tsai 1999, 
Klenk 2005, Klenk 2007, Argawal 2012). If the epithelium has been transiently 
damaged by previous or ongoing microbial infection, then Streptococcal 
infectivity may gain direct access to tonsillar interior. Because of the close 
proximity of non-epithelial cell types to the tonsil surface and crypt epithelium (ie. 
lymphocyte follicles, fibroblasts, PMNs, and monocytes), apoptosis may assure 
the dissemination of released streptococci to interact in these associated 
invasive niches. Wang et al demonstrated that GrAS interactions with human 
primary tonsil fibroblasts stimulated an increase in TGF-Beta, which in turn was 
able to signal pharyngeal epithelium to upregulate the expression of alpha5-
beta1 integrins at its surface in vitro. They then provided evidence for a proposed 
mechanism where increased alpha5-beta1 integrins on the epithelial monolayer 
leads to increased bacterial invasion when inoculated with GrAS through 
intracellular signaling (Wang 2006). 
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As presented in sections 5 and 6, we show that our representative throat 
specialist M type 1 S. pyogenes strain demonstrates a significantly divergent 
invasiveness phenotypes based on anatomic origin of epithelial cell. As has been 
established in the literature, internalization and intracellular fate depends on 
serotype and potentially tissue-type distinctions. In order to better understand the 
implications of the intracellular GrAS phenotype, in the context of our study, 
strain SF370 was co-cultured with three of our human epithelial cell lines (Detroit 
562, UT-SCC-60A, and UT-SCC-60B).  After permitting the pathogen to adhere 
and become internalized by the host cells we employ novel methods to prohibit 
bacteria re-emergence. Additionally, immunofluorescence microscopy provides 
us with preliminary data as the ground work for future studies investigating 
intracellular mechanisms underlying intracellular GrAS survival.   
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7.2 Results 
 
 
7.2.1 Streptococcal viability following internalization may be epithelial cell type-
dependent 
 
We employed a novel strategy for maintaining an intracellular bacterial 
population following co-culture with human oral epithelial monolayers as 
described in the Methods. Two anti-reemergence PlyC solutions (with- or without 
Tannic Acid [T.A.]) were applied to monolayers and viability of intracellular 
bacteria was assessed at times points over the course of 24 hrs. Our initial time 
point (T0), represented the baseline number of internalized bacteria for each 
monolayer, based on the number of bacteria internalized following the start of the 
2.5h co-culture. Consistent with what has been demonstrated in earlier chapters, 
our representative M type 1 strain of GrAS was preferentially internalized by the 
UT-SCC-60B epithelial monolayer (p < 0.0001). Following 2 h of selective anti-
reemergence pressure, the enumeration of total recovered intracellular GrAS 
from the tonsil-derived epithelial monolayers revealed an increase by nearly 6X 
that of the baseline recovered amount, irrespective of T.A. treatment. The 
number of bacteria recovered from the Detroit 562 monolayers only increased an 
insignificant amount in the T.A treated wells and decreased in the PlyC-only 
treated wells (Figure7.1).  The number of viable bacteria declined significantly by 
the 16h post-infection time point (T16). At this time, the number of bacteria 
recovered from the UT-SCC-60B monolayer had returned to near its baseline, 
maintaining this level of intracellular viability up to 24 h post infection. During this 
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same time, our ability to recover viable bacteria was just barely above 
undetectable.  
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Figure 7.1. S. pyogenes intracellular viability is cell type dependent 
M type 1 strain SF370 in serum-free DMEM (~1x 108 CFU) was co-cultured with UT-
SCC-60B and B) Detroit 562 epithelial cell monolayers for 120 min at 37ºC. 
Associated bacteria were removed by vigorous washing with PBS and subsequently 
treated with antiamidase lysin PlyC (0.05U / well) only (solid bars) -or- PlyC with the 
exocytosis inhibiting agent, Tannic Acid (striped bars) as described in Methods. Tx= 
Xhrs post initiation of PlyC selective pressure against bacterial reemergence.  Data 
presented is from a representative experiment of duplicate wells plated in triplicate. 
Difference between Detroit 562 and UT-SCC-60B cell types at every (condition-
matched) time point is highly significant (p < 0.000) as determined by student t-test.  
  174 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.   
 
 
 
 
0
1,000
2,000
3,000
4,000
5,000
6,000
T0 T2 T16 T24
V
ia
bl
e 
In
te
rn
al
iz
ed
 S
tr
ep
to
co
cc
i (
to
ta
l C
FU
) 
Time (hours) post PlyC treatment  
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
T0 T2 T16 T24
V
ia
bl
e 
In
te
rn
al
iz
ed
 S
tr
ep
to
co
cc
i (
to
ta
l C
FU
) 
A 
B 
  175 
 
 
7.2.2 Intracellular Compartment of internalized Streptococci  
 
Increased internalization is likely of no benefit to the pathogen if they are 
immediately destined to be cleared by the activities of lysosome-mediated 
degradation or similarly deleterious intracellular pathways.   Our experiments 
demonstrate GrAS increased adherence and internalization capacity during co-
culture with tonsil-derived epithelium. To gain an appreciation for the fate of 
internalized streptococci in our tonsil tumor epithelial cell system, we performed 
microscopy-based co-localization studies using markers from known pathways 
implicated in streptococcal intracellular persistence in non-phagocytic cells.   We 
focused principally on the UT-SCC-60 A and UT-SCC-60B epithelial cells in light 
of the pronounced sustained intracellular viability as compared to Detroit 562 
cells (Figure 7.1).  
 
As many of the integrin-mediated mechanisms proposed as routes for GrAS 
intracellular entry, ultimately enter bring the bacterium into the cell’s endocytic 
pathway, we first sought to identify whether the bacteria was found along 
vesicles associated with this process. Early endosomes are the first location 
within the endocytic pathway and is likely to reflect recently endocytosed debris 
and microorganisms. Consistent with this mode of transcellular entry, we 
consistently observed S. pyogenes in association with clustered groups of 
vesicles staining positively for the Early Endosome Antigen 1 (EEA1) (Figure 
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7.2A). We were also able to find GrAS co-localized within these vacuoles 
providing evidence suggestive that intracellular S. pyogenes within the UT-SCC-
60A and UT-SCC-60B epithelium at least in part are engaged with this process.  
 
Nakagawa et al have proposed that GrAS escape from endosomes into the 
epithelial cell cytoplasm, which stimulates autophagy. They’ve gone on to show 
that intracellular S. pyogenes is captured by LC3-positive autophagosome-like 
vacuoles and degraded upon fusion of these compartments with lysosomes in 
HeLa cells (Nakagawa 2004).  Using LC3 as an important marker for autophagy, 
we observed apparent co-localization of SF370 with LC3-positive vesicles with 
relatively similar frequency of distribution across the cell as was seen with the 
early endosomes (Figure 7.3).  
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Figure 7.2 S. pyogenes co-localizes with Early Endosomes at 2.5h post infection. 
Fluorescence micrographs of GrAS-associated Early Endosomes in UT-SCC-60A 
epithelial monolayers following co-culture with strain SF370. Extracellular bacteria 
were removed by antibiotic and lysin treatment. Monolayers were fixed, 
permeabolized and stained as described in Methods. DNA was labeled with DAPI 
unless otherwise noted. A) Early Endosome are visualized by anti-Early Endosome 
Antigen-1 (EEA1)-FITC mAb (green).   B) S. pyogenes was labeled with PlyCB-Alexa 
554. C-D) White arrow indicates S. pyogenes co-localizes with EEA1-positive 
compartment.   Images taken originally at 40X. White box demarcates the area 
digitally magnified x10 in D) 
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Figure 7.3 S. pyogenes also co-localizes with Autophagosome marker at 2.5h post 
infection. 
Fluorescence micrographs of LC3 distribution (green) in UT-SCC-60B epithelial 
monolayers following co-cultured with strain SF370. Extracellular bacteria were 
removed by antibiotic and lysin treatment. Monolayers were fixed, permeabolized 
and stained as described in Methods. DNA was labeled with DAPI unless otherwise 
noted. A). LC3-positive vacuoles were visualized using α-LC3-FITC mAb (green).  
B.) S. pyogenes was labeled with PlyCB-Alexa 554(red).  C-D.) White arrow 
indicates S. pyogenes colocalizes with LC3-positive compartment.   E. Early 
Endosomes were visualized by anti-Early Endosome Antigen-1 (EEA-1)-FITC mAb 
(green). Images taken originally at 40X. White box demarcates the area digitally 
magnified x7 in D). 
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7.3 Discussion: 
 
Depending on the S. pyogenes strain, the bacteria are killed within the vacuole, 
survive in a resting or even multiplying state, or leave the early phagocytic 
vacuole towards the cytosol, where they again either rest or multiply 
(Kreikemeyer 2004). In our study, once the S. pyogenes are internalized, they 
often remained viable and continued multiplying during the initial hours following 
invasion, possibly indicative of an amenable intracellular replicative niche. While 
GrAS that were internalized by UT-SCC-60B cells continued growing most 
markedly, we later saw an equally marked drop, likely demonstrative of some 
intracellular killing process. Importantly, however, we note sustained viability of 
internalized bacteria was evident in our tonsil-derived epithelial system for at 
least 24hrs.  
The intracellular status of GrAS could protect the bacteria from antibiotics and 
host defense mechanisms. It appears to be a prerequisite for GrAS persistence 
in host tissues, which in the case of tonsillar epithelium leads to recurrent 
infections or an asymptomatic carrier status. As patients with persistent GrAS are 
the only source for GrAS transmission in non-epidemic settings continued 
exploration of the underlying mechanisms of GrAS adherence and internalization 
processes may inform our strategies to address moving forward to effectively 
interfere with these processes. 
We also report here our use of PlyC in suspension with minimal media to provide 
the selective pressure against streptococcal reemerge from an otherwise 
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transient intracellular niche. This transiency is a necessary final requirement of 
the proposed theory for an intracellular sanctuary, or reservoir, as a cause for 
recurring infection.  The classic experimental set up for measuring intracellular 
viability continuously exposes the epithelial monolayer with antibiotic solutions 
(Osterlund 1995, Marouni 2004). These experiments, however, may not account 
for bacterial recalcitrance due to microcolony and / or biofilm formation (Marnetti 
2007). We have shown in earlier studies the ability for PlyC to effectively sterilize 
the monolayer surface as confirmed by microscopy (see section 5).  Numerous 
studies have supported the sterilizing capacity of PlyC against streptococcus spp 
providing significant support for the effectiveness of this narrow spectrum agent 
for a broad range of uses. To our knowledge, this is the first reported use of the 
phage lysin, PlyC (Fischetti 1971), for the purpose of applying a selective 
pressure against reemerging pathogens to investigate intracellular viability.   
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§8.0 CONCLUSIONS 
 
This study has extended our lab’s continued work on the transcription shifts 
observable in S. pyogenes from initial contact with host factors in suspension 
(conditioned media), to transient contact / association with neighboring epithelial 
cells (Detroit 562), to transient contact / association with palatine tonsil epithelium 
(UT-SCC-60B), to adherence with nasopharyngeal (Detroit 562) surface. It is 
clear that in vivo, the GrAS must experience adaptive transcriptional changes at 
every step of infection as shown convinsingly by our model. The bacteria may 
also adhere to non-tonsil tissues in the pharynx, particularly during asymptomatic 
carriage of the pathogen in the nasopharynx. While we have discovered 
numerous unique qualities that may be unique to the stage of infection modeled, 
improvements in models and annotation will only provide us the opportunity to 
ask even more precise questions. As there currently doesn’t exist a deposited 
tonsil cell line availbale through AT-CCL, our new UT-SCC-60A and UT-SCC-
60B tonsil epithelial model has been shown to be an affective surrogate for the 
more precious HPTE cells, mirroring effects during our in vitro experiments 
performed in parallel. We believe these tools will prove helpful to study this 
uniquely human disease process that is otherwise difficult to study in unnatural 
host animal models or otherwise poorly representative tissue lines.  
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APPENDIX 
 
 
 
 
 
APPENDIX4.1.   Immunofluorescence (IF) staining for epithelial and fibroblast 
markers 
Confocal microscopy images of cultured Detroit 562, UT-SCC-60A, UT-SCC-60B 
and Human Primary Tonsil Epithelial Cell (HPTEC) monolayers labeled with a 
mouse or rabbit antibody against keratins k8/18 (A, B), k19 (not shown), 
pankeratin (C,D), and vimentin (not shown). Secondary Alexa558-labeled goat 
antibody against either mouse or rabbit was applied for visualization by 
fluorescence. 
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Appendix 6.1 Dye swap microarray between streptococci “associated” 
with Detroit 562 (nasopharyngeal) or UT-SCC-60B (palatine-tonsil) 
epithelial monolayers Eight biological replicate experiments incorporating 
dye swaps [17] were performed to account for both biological and technical 
variability. Fluorophore-labeled cDNA samples were hybridized to custom 
arrays and scanned with an Agilent High-Resolution C Microarray Scanner at 
5 μm per pixel resolution. The resulting images were processed using the 
GenePix Pro program. Panel (A) represents “standard” arrays with cDNA from 
GrAS associated with Detroit 562 is labeled with Cy3, while cDNA from GrAS 
associated with UT-SCC-60B is labeled with Cy5. Panel (B) is the opposite 
dye confirmation.  
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Ratio 532 / 633 
Std color configuration 
(Associated)  
co-culture Date:10-21-11  
Ratio 532 / 633 
Std color configuration 
(Associated) 
co-culture Date:11-03-11  
Ratio 532 / 633 
Std color configuration 
(Associated) 
co-culture Date:10-30-11  
A 
B 
Std color configuration 
(Associated) 
co-culture Date:12-10-11  
Ratio 532 / 633 
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§A8. Supplementary Chapter. IDENTIFYING STREPTOCOCCAL BINDING 
PARTNERS WITH HUMAN ORAL EPITHELIUM   
 
A8.1 Introduction  
 
 
The interactions between group A streptococcus with its human host has been 
extensively studied. In 2000, Cunningham reviewed at least 11 streptococcal 
adhesins and potential virulence factors that have been shown to bind host cell 
receptors in some direct fashion. Bacterial lipoteichoic acid (LTA), an 
amphipathic molecule, appears to account for approximately 60% of adhesion to 
epithelial cells via electrostatic interactions with positively charged host 
extracellular matrix components such as fibronectin (Hasty 1996, Cunningham 
2000). Hasty and Courtney initially describes the action of LTA as the first step in 
their proposed 2-step model for streptococcal adherence. By this same model, it 
follows that the remaining 40% of the adhesion process is left to commence 
following LTA-mediated attachment, likely conferring receptor specificity with 
greater avidity. Their theory hinges on the idea of adhesin-host multiplicity where  
this interaction would require that multiple binding partners be engaged working 
in concert to promote GrAS adherence to the epithelial surface. Hasty and 
Courtney’s two step mechanism may in part explain the ability for GrAS to 
interact and possibly attach to numerous cell types in vitro, at times in lieu of 
natural anatomic relevance to the bacterium.   
 
Several extracellular host cell proteins have been implicated in as the pathogen’s 
receptors or surface moiety principally involved in conferring specific attachment 
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and / or internalization by group A streptococci including: fibronectin, fibrinogen, 
collagen, vitronectin, a fucosylated glycoprotein, and integral membrane proteins 
including CD46, the membrane cofactor protein on keratinocytes, and CD44, the 
hyaluronate- binding receptor on keratinocytes. While it is undisputed by the 
evidenced presented to argue the case for these numerous adhesins playing 
significant roles in GrAS adherence in the respective models tested, deciphering 
relative significance for site specific pathogenesis remains a challenge for 
researchers to rectify.  
Questions surrounding the contextual significance of one receptor/ligand pair 
over another have resulted in much contention in the field regarding definitive 
mechanisms. For example, the importance of CD46 as a cellular receptor for 
group A streptococci is uncertain. While CD46 binds M protein through factor H-
like repeats, transfection of L cells with cDNA encoding human CD46 failed to 
increase binding of group A streptococci (Abbot 2007). Additionally, Abbot et al., 
recently confirmed that tonsil epithelium was replete with CD44 receptors (Abbot 
2007), described by Cunningham to be the host receptor for the hyaluronic acid 
capsule of S. pyogenes. Abbot's group, however, noted that a ΔhasA capsule 
deficient SF370 strain did not alter adherence capabilities in their ex vivo tonsil 
system contradicting the relative importance of this described hyaluronic capsule 
– CD44 interaction as significant towards explaining the enhanced adherence 
phenotype seen clinically and in vitro towards the surface of the palatine tonsil.  
We have described in previous chapters observations that demonstrate 
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significantly different adherence and invasion phenotypes by M type 1 GrAS 
strain SF370 during co-culture with nasopharyngeal and tonsil epithelium.  
Notably, the streptococcal adherence efficiency to our palatine tonsil derived 
tumor lines was statistically indistinguishable from human primary tonsil 
epithelium.  Although purely circumstantial, we may speculate from these 
observations the possibility of retained similar surface topographies between our 
primary and tumor tonsil cell lines. Therefore, our UT-SCC-60A, UT-SCC-60B 
and HPTE cell cultures may provide contextually-applicable epithelial sources 
that may augment and facilitate the discovery of novel receptors earlier 
investigators missed due to sample limitations when exploring whole tonsil 
tissues or intrinsic inadequacies of the existing non-palatine tonsil cell in vitro 
models. Our described experimental findings from relevant tissue-specific 
association and adherence may also allow us to prioritize such exploration by 
key receptor-ligand pairs consistent with the gene expression profile during 
association at the tonsil surface.  
 To better understand the implications of our previous results, we have begun 
studies to describe host-pathogen interaction. Preliminarily, we sought to test our 
ability to identify the corresponding protein binding partner(s) between our tumor 
cell lines and a known streptococcal surface adhesins. We hypothesize that 
streptococci likely interact with unique surface proteins on UT-SCC-60B as 
compared to Detroit 562 cells, which may account for observed differences in 
adherence. This chapter provides our preliminary results, and introduces our 
data-informed future plans for additional screens to elucidate the cellular basis of 
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tonsil tissue tropism.  
 
A8.2 Results 
 
A8.2.1 Identification of epithelial cell wall proteins that bind recombinant group A 
streptococcal M6 protein  
 
 
Our earlier described studies have consistently demonstrated that Streptococcus 
pyogenes M type 1 strain SF370 adhere to tonsil epithelial cells with greater 
efficiency than the Detroit 562 nasopharyngeal cell type. Due to the novelty of 
using UT-SCC-60A and UT-SCC-60B cells to model streptococcal 
pharyngotonsillitis, however, their cell surface receptor distribution remains 
largely uncharacterized in the context of any host-pathogen interaction. As a 
means to determine similarities between these tonsil tumor cell lines and the 
otherwise well characterized Detroit 562 cell line, we decided to test a GrAS 
adhesin known to have multiple defined epitopes on epithelial cells.  Possibly the 
quintessential classic determinant of streptococcal virulence, M protein has been 
extensively studied by our lab and others as an important adhesion and invasion 
during streptococcal colonization of epithelial cells. Previous studies on the 
mechanism of M protein adherence have been conducted over the decades 
across numerous cell types yielding a cadre of putative receptors (Cunningham 
2000, Nobbs 2009). Our lab recently highlighted the ability of recombinant M type 
6 (rM6) protein to bind glucosaminoglycans (GAGs) and sialic acid containing cell 
surface proteins (Ryan 2001) during Detroit 562 epithelial cell adherence. Similar 
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to M type 1 strain SF370, the M type 6 is a member of the emm type pattern A-C 
described as a throat tropic.  
 
Based on our expansive experience with M protein and the availability of purified 
recombinant protein material, we used M type 6 protein our initial probe (or “bait”) 
protein to perform comparative co-immunoprecipitation experiments. These 
studies would determine whether different “M6 protein – human epithelial 
receptor” complexes might be distinguishable between epithelial cell membrane 
associated proteins from nasopharyngeal and palatine tonsil cells. 
 
Prior to the co-immunoprecipitation, we conducted preliminary co-culturing 
experiments using M type 6 strain D471 and the M6 isogenic knockout strain 
JRS75 respectively with Detroit 562, and UT-SCC-60B epithelial cell monolayers. 
As had been shown previously by our group and others, during co-culture with 
Detroit 562 cells, adherence was drastically diminished in the isogenic M6 protein 
knockout strain versus the wild type D471 strain. The adherence to the UT-SCC-
60B was similarly decreased in the absence of M protein although variability 
between independent experimental replicates in the wild type will necessitate that 
repeat experiments be performed to assess statistical significance (data not 
shown).  
 
Our co-immunoprecipitation experiments were performed as detailed in the 
methods. Briefly, recombinant M type 6 (rM6) protein was incubated with 
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epithelial surface proteins in mixed suspension from each respective cell line to 
encourage potential protein-protein interactions and identify natural binding 
partners. Protein complexes were captured by the 10.B6 mAb (α-M protein) 
bound to packed protein G beads. After washing away unbound proteins, rM6 
protein with accompanying complexes were eluted from the protein G beads, and 
analyzed by SDS-PAGE. 
 
We observed two unique protein bands at 30kD and 80kD, respectively, 
putatively representing components of complexes between Detroit 562 surface 
proteins and the streptococcal rM6 protein (Figure 8.1). These bands have yet to 
be analyzed by mass spectrometry for protein identification. Based solely on the 
molecular weights, however, these bands may indeed prove to be novel M 
protein binding partners as their weights are inconsistent with some of the known 
M protein ligands including: filamentous actin (MW = 42kD); CD46 (MW = 56 – 
66 kD); and the fibronectin (MW = 240kD)-α5β1 integrin (MW > 115kD) 
complex. This list of M protein receptors is not meant to be exhaustive (see Table 
1.2), however, and final confirmation of identity will need to be performed by 
more rigorous LC-MS/MS analysis.  
 
It may be significant that bands from known M protein binding partners were not 
evident following SDS-PAGE analysis. Based on the literature, it is evident that 
more M protein – host interactions with the Detroit 562 cells would be expected 
than what we observed following our co-immunoprecipitations. Notably, the UT-
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SCC-60B cell surface proteins did not elute with any observable proteins in 
complex with the rM6 protein. We recognize a number of technical 
considerations that may account for these results. One observation is the low 
concentration of epithelial cell membrane associated proteins and rM6 protein in 
flow through / wash lanes 5 and 8 (Figure 8.1). Additionally, it is unclear whether 
there is observable rM6 protein in our eluted lanes (4 and 7), as the band at ~50 
kDa may be the degraded heavy chain portion of our mAb, 10B6. Since we only 
used coomasie to visualize our bands, there is the possibility that we were 
unable to see fainter bands more readily observable following silver staining. In 
future iterations of this experiment, we may add more epithelial cell proteins as 
well as rM6 protein into our initial suspension to promote more interactions and 
potentially stronger banding patters. We may also consider a more stringent 
elution buffer or procedure to confirm our bound complexes do not remain in the 
column.  
 
Our co-immunoprecipitation, though preliminary, would qualify as the first time 
the UT-SCC-60B cell line has been probed for M protein binding potential and 
may reflect something novel about their surface topography. We also note, 
however, that recombinant M type 1 protein may yield a more impressive yield of 
protein – protein complexes.  
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Figure A8.1. Identification of binding complexes between epithelial cell membrane-
associated proteins (CMAP) and recombinant M6 protein. Detroit 562 and UT-SCC-
60B human epithelial CMAPs were placed in suspension with recombinant M6 protein. 
Protein-protein complexes were then affinity purified using a μMACSTM protein G 
MicroBeads column conjugated to 10.B6 (α-M protein) mAb. M protein-CMAP 
complexes were resolved by SDS-PAGE and stained with 0.1% (w/v Coomasie). Lane 
1) Bands at 75, 100, 150, and 250kDa determined to be “carryover” dye from MW 
ladder. Lane 4) Green arrow: putative D562 – rM6 complex #1, White arrow: suspected 
rM6 +/- 10.B6 mAb heavy chain, Red arrow: putative D562 – rM6 complex #2, Blue 
arrow: suspected 10.B6 mAb light chain.  
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A8.2.2 Click Chemistry metabolically labels newly synthesized streptococcal 
proteins 
 
We have reported on comparative genomic and mutagenesis studies to revela 
bacterial genes that are important for infection, but their precise biochemical 
mechanisms and temporal expression patterns are difficult to measure or truly 
speculate as a result of posttranslational regulation. Direct biochemical analysis 
of bacterial proteomes during infection may be a useful measure to elucidate 
these mechanisms informed by microarray transcriptome analysis. New 
strategies for selectively enriched bacterial proteins from host proteomes during 
infection have recently been described, including the use of non-natural amino 
acids to distinguish bacterial proteins from the host. (Grammel 2010).  
 
For example, Azide functionalized methionine surrogate, Azidohomoalanine 
(AHA) (Fiigure 8.2A) has been shown to be incorporated into the bacterial 
proteome by endogenously expressed methionyl-tRNA synthetase (MetRS) in 
Escherichia coli. The azide group is able to survive cellular metabolism and 
remains available to be subsequently reacted with a secondary reporter such as 
Alkyne-Rhodamine (Alk-Rho) detection tag by Cu1-catalyzed Azide-Alkyne 
Cycloaddition, also called “Click Chemistry”. This selective tagging can occur in 
mixed bacteria-host lysate solution and resolved by SDS-PAGE and in-gel 
fluorescence scanning. 
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To our knowledge, the ability of the streptococcal endogenous translational 
apparatus to incorporate alkyne- / azide-functionalized non-natural amino acids 
has yet to be tested. Additionally, the subsequent use of Click Chemistry to 
selectively label bacterial proteins during infective processes has yet be exploited 
for the study of streptococcal virulence.  
 
As our first step towards utilizing these new tools, we successfully demonstrated 
S. pyogenes incorporation of Azidohomoalanine (AHA) (Figure 8.2).  In our initial 
experiments, we added unlabeled streptococcal cell wall protein in excess to a 
well and resolved the band using SDS-PAGE. Previous investigators have 
reported levels of autofluorescence as a source of background signal and 
confounding noise during in-gel fluorescence analysis post Click Chemistry 
reactions. Similar to these previous reports, we also observed faint 
autofluorescence at 580nm, although the observed background remained 
distinguishable from AHA + Alk-Rho labeled samples (Figure 8.3C). Significantly, 
we also note that low expressing proteins that proved difficult to visualize by 
normal coomasie stain may be better analyzed with metabolic labeling and in-gel 
fluorescence (Figure 8C).  
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Figure A8.2.  In-Gel Fluorescence distinguishes metabolically labeled 
Streptococcal proteins using Click Chemistry. A) Structures of methionine 
(Met) and azidohomoalanine (AHA). S. pyogenes.was cultured in THY media to 
late log phase, and then diluted into methionine-free minimal media 
supplemented with AHA. Protein Bacteria were lysed and extracted cell wall 
fractions were either (B) directly resolved by SDS-PAGE or (C) reacted with the 
clickable fluorophore Alkyne-Rhodamine (Alk-Rho) via Cu1-catalyzed azide-
alkyne cycloaddition (“Click Chemistry”) immediately before resolving on SDS-
PAGE. Resulting gels were visualized with 1% (w/v) Coomasie stain (CM) or by 
In-Gel fluorescence scan (Fluor) at 580nm. AHA/Alk-Rho samples were 
compared to normal treated samples. 
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A8.3 Discussion  
 
Most of our current methods to determine protein-protein interactions between 
host and pathogens, including our co-immunoprecipitation, require that one of the 
proteins in the pair be a known entity. This has limited the field to consider the 
current scope of known adhesins when searching for binding partners. Numerous 
reports have demonstrated that M protein binds multiple eukaryotic proteins in 
human serum and on macrophages, fibroblasts, and keratinocytes. Our 
preliminary search for unique interactions between tonsil cell surface proteins 
only captured identifiable interactions with the Detroit 562 cell line. Additional 
analysis of the two resulting bands on SDS-PAGE may offer insight on 
differences in streptococcal interactions between these neighboring epithelial 
surfaces, although this remains to be determined. Moving forward, however, we 
plan to modify our exploratory search in a more directed manner informed by our 
microarray and adherence phenotype data.  
 
One area of immediate intended focus is on establishing tissue-specific roles for 
the components of the highly upregulated operon Spy0127 – Spy130. Our co-
culture phenotype and transcriptional expression data support that pili are 
important during GrAS strain SF370 association with –, adherence to –, and 
invasion of – tonsil epithelial cells. Recently reported adherence studies using 
purified recombinant S. pyogenes pilus ancillary proteins encoded by Spy0125 
(rSpy0125) and Spy0130 (rSpy0130) have shown that both of these SF370 pili 
subunits bind Detroit 562 (Manetti 2007) and HaCaT cell lines as well as intact 
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human tonsil epithelium (Smith 2010). Smith et al subsequently assigned subunit 
Spy0125 as the principle pili adhesin based on the ability for anti-rSpy1025 sera 
to inhibit adherence to tonsil epithelium (Smith 2010). Their report was unable to 
determine pili – host epithelial binding partners, leaving the exact mechanism for 
their observed adherence properties yet to be described. We would like to use 
these recombinant pili subunits, rSpy1025 and rSpy0130, and corresponding 
anti-sera to repeat co-immunoprecipitation and immobilized ligand assays 
comparing binding partners from UT-SCC-60A, UT-SCC-60B, HPTE, and Detroit 
562 cell lysates.  
 
As our M protein experiments may reveal, there may be tissue-specific or even 
bacterial –serotype differences in the engagement of particular bacterial 
adhesion-surface receptor complexes. This idea may be supported by Bessen et 
al’s recent characterization of throat tropic members of the emm pattern types A-
C.  The heterogeneity of genes imply horizontal gene transfers and mutations 
account for a convergence of adaptation for this oral niches, quite possibly by 
numerous mechanisms (Bessen 2011). 
 
Though not fruitful as of yet, metabolically labeled proteins able to be visualized 
through Click Chemistry is a safe means of tagging epithelial proteins for 
experiments that are less linked to identifying the protein of interest at the onset. 
Our lab has recently attempted mixing epithelial cell membrane associated 
proteins with metabolically labeled, Mitomycin C-killed, intact bacteria in a 
suspension that encourages naturally-occurring protein-protein complexes to 
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form. Using the same principles of our earlier co-imunoprecipitation column, this 
has allowed for an unbiased approach to identifying binding partners (not 
shown). We may consider pre-incubating the bacteria in tonsil-conditioned media 
to assure expression of relevant surface proteins likely present within the 
intended tonsil niche. While elution methods may have so far presented a 
challenge in capturing all host-pathogen complexes formed during co-
immunoprecipitation, crosslinking receptor-bound complexes using DTSSP (3,3´-
dithiobis[sulfosuccinimidylpropionate]), as well as using Click Chemistry may 
provide us stronger results in the future.  
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